{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 593, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:17:49Z", "timestamp": 1574482669606}, "reference-count": 56, "publisher": "Hindawi Limited", "license": [{"URL": "http://creativecommons.org/licenses/by/3.0/", "start": {"date-parts": [[2012, 1, 1]], "date-time": "2012-01-01T00:00:00Z", "timestamp": 1325376000000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"name": "Regione Autonoma della Sardegna", "award": ["MAB-A2009-614"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Parkinson's Disease"], "published-print": {"date-parts": [[2012]]}, "abstract": "<jats:p>Dyskinesia, a major complication of treatment of Parkinson\u2019s disease (PD), involves two phases: induction, which is responsible for dyskinesia onset, and expression, which underlies its clinical manifestation. The unique cellular and regional distribution of adenosine<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>receptors in basal ganglia areas that are richly innervated by dopamine, and their antagonistic role towards dopamine receptor stimulation, have positioned<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>receptor antagonists as an attractive nondopaminergic target to improve the motor deficits that characterize PD. In this paper, we describe the biochemical characteristics of<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>receptors and the effects of adenosine<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>antagonists in rodent and primate models of PD on L-DOPA-induced dyskinesia, together with relevant biomarker studies. We also review clinical trials of<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>antagonists as adjuncts to L-DOPA in PD patients with motor fluctuations. These studies have generally demonstrated that the addition of an<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>antagonist to a stable L-DOPA regimen reduces OFF time and mildly increases dyskinesia. However, limited clinical data suggest that the addition of an<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>antagonist along with a reduction of L-DOPA might maintain anti-Parkinsonian benefit and reduce dyskinesia. Whether<mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mrow><mml:mtext>2A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>antagonists might reduce the development of dyskinesia has not yet been tested clinically.</jats:p>", "DOI": "10.1155/2012/489853", "type": "journal-article", "created": {"date-parts": [[2012, 6, 18]], "date-time": "2012-06-18T02:49:15Z", "timestamp": 1339987755000}, "page": "1-8", "source": "Crossref", "is-referenced-by-count": 5, "title": ["A2AReceptor Antagonism and Dyskinesia in Parkinson\u2019s Disease"], "prefix": "10.1155", "volume": "2012", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": [{"name": "Department of Biomedical Sciences, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy"}, {"name": "CNR Institute of Neuroscience, 09042 Cagliari, Italy"}]}, {"given": "Fabio", "family": "Blandini", "sequence": "additional", "affiliation": [{"name": "Interdepartmental Research Center for Parkinson\u2019s Disease, National Neurological Institute C. Mondino, 27100 Pavia, Italy"}]}, {"given": "Nicola", "family": "Simola", "sequence": "additional", "affiliation": [{"name": "Department of Biomedical Sciences, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy"}]}, {"given": "Robert A.", "family": "Hauser", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, University of South Florida, Tampa, FL 33613, USA"}]}], "member": "98", "reference": [{"key": "1", "DOI": "10.1016/0169-328X(92)90173-9", "doi-asserted-by": "publisher"}, {"key": "2", "DOI": "10.1016/0304-3940(91)90391-6", "doi-asserted-by": "publisher"}, {"key": "3", "DOI": "10.1074/jbc.M306451200", "doi-asserted-by": "publisher"}, {"key": "4", "volume": "61", "issue": "11", "first-page": "S19", "year": "2003", "journal-title": "Neurology"}, {"key": "5", "DOI": "10.1074/jbc.M107731200", "doi-asserted-by": "publisher"}, {"key": "6", "DOI": "10.1016/j.neuroscience.2005.12.052", "doi-asserted-by": "publisher"}, {"key": "7", "DOI": "10.1016/j.pneurobio.2007.07.001", "doi-asserted-by": "publisher"}, {"key": "8", "DOI": "10.1002/syn.20410", "doi-asserted-by": "publisher"}, {"key": "9", "DOI": "10.2165/00002512-200522060-00002", "doi-asserted-by": "publisher"}, {"key": "10", "DOI": "10.1152/ajpregu.00840.2004", "doi-asserted-by": "publisher"}, {"key": "11", "volume": "173", "issue": "1", "first-page": "21", "year": "2004", "journal-title": "Journal of Immunology", "DOI": "10.4049/jimmunol.173.1.21", "doi-asserted-by": "crossref"}, {"key": "12", "DOI": "10.1093/brain/awh128", "doi-asserted-by": "publisher"}, {"key": "13", "DOI": "10.1016/S0014-2999(02)01818-6", "doi-asserted-by": "publisher"}, {"key": "14", "DOI": "10.1002/syn.20011", "doi-asserted-by": "publisher"}, {"key": "44", "DOI": "10.1097/WNF.0b013e3181d137D2", "doi-asserted-by": "publisher"}, {"key": "45", "DOI": "10.1371/journal.pone.0017338", "doi-asserted-by": "publisher"}, {"key": "15", "DOI": "10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K", "doi-asserted-by": "publisher"}, {"key": "16", "DOI": "10.1006/exnr.1998.6819", "doi-asserted-by": "publisher"}, {"key": "17", "DOI": "10.1016/j.bbr.2006.03.021", "doi-asserted-by": "publisher"}, {"key": "18", "DOI": "10.1016/j.ejphar.2007.03.021", "doi-asserted-by": "publisher"}, {"key": "19", "DOI": "10.1046/j.1471-4159.2003.01632.x", "doi-asserted-by": "publisher"}, {"key": "20", "volume": "52", "issue": "8", "first-page": "1673", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.52.8.1673", "doi-asserted-by": "crossref"}, {"key": "21", "DOI": "10.1016/j.expneurol.2010.07.011", "doi-asserted-by": "publisher"}, {"key": "22", "DOI": "10.1006/exnr.2000.7350", "doi-asserted-by": "publisher"}, {"key": "23", "DOI": "10.1016/S0014-4886(03)00250-4", "doi-asserted-by": "publisher"}, {"key": "24", "volume": "250", "issue": "4986", "first-page": "1429", "year": "1990", "journal-title": "Science", "DOI": "10.1126/science.2147780", "doi-asserted-by": "crossref"}, {"key": "25", "DOI": "10.1002/syn.10066", "doi-asserted-by": "publisher"}, {"key": "26", "DOI": "10.1046/j.1460-9568.2000.00988.x", "doi-asserted-by": "publisher"}, {"key": "27", "DOI": "10.1016/S0166-2236(97)01096-5", "doi-asserted-by": "publisher"}, {"key": "28", "volume": "61", "issue": "11", "first-page": "S12", "year": "2003", "journal-title": "Neurology"}, {"key": "29", "DOI": "10.1016/S0079-6123(10)83009-2", "doi-asserted-by": "publisher"}, {"key": "30", "volume": "61", "issue": "11", "first-page": "S107", "year": "2003", "journal-title": "Neurology"}, {"key": "31", "DOI": "10.1016/j.neuropharm.2004.01.008", "doi-asserted-by": "publisher"}, {"key": "32", "DOI": "10.1016/S1353-8020(08)70013-0", "doi-asserted-by": "publisher"}, {"key": "33", "DOI": "10.1196/annals.1300.061", "doi-asserted-by": "publisher"}, {"key": "34", "DOI": "10.1073/pnas.172393799", "doi-asserted-by": "publisher"}, {"key": "35", "DOI": "10.1523/JNEUROSCI.3660-05.2005", "doi-asserted-by": "publisher"}, {"key": "36", "DOI": "10.1016/j.neuropharm.2008.06.038", "doi-asserted-by": "publisher"}, {"key": "37", "DOI": "10.1124/jpet.110.166629", "doi-asserted-by": "publisher"}, {"key": "38", "DOI": "10.1038/sj.npp.1301375", "doi-asserted-by": "publisher"}, {"key": "39", "DOI": "10.1111/j.1476-5381.2010.00723.x", "doi-asserted-by": "publisher"}, {"key": "40", "volume": "59", "issue": "4", "first-page": "379", "year": "2007", "journal-title": "Pharmacological Reports"}, {"key": "41", "DOI": "10.1523/JNEUROSCI.3574-05.2006", "doi-asserted-by": "publisher"}, {"key": "42", "volume": "61", "issue": "11", "first-page": "S69", "year": "2003", "journal-title": "Neurology"}, {"key": "43", "DOI": "10.1002/syn.20423", "doi-asserted-by": "publisher"}, {"key": "46", "DOI": "10.1212/WNL.0b013e31821ccce4", "doi-asserted-by": "publisher"}, {"key": "47", "DOI": "10.1523/JNEUROSCI.2590-10.2010", "doi-asserted-by": "publisher"}, {"key": "48", "DOI": "10.1096/fj.09-141044", "doi-asserted-by": "publisher"}, {"key": "49", "volume": "61", "issue": "3", "first-page": "293", "year": "2003", "journal-title": "Neurology", "DOI": "10.1212/01.WNL.0000073136.00548.D4", "doi-asserted-by": "crossref"}, {"key": "50", "volume": "61", "issue": "3", "first-page": "297", "year": "2003", "journal-title": "Neurology", "DOI": "10.1212/01.WNL.0000081227.84197.0B", "doi-asserted-by": "crossref"}, {"key": "51", "DOI": "10.1002/ana.21315", "doi-asserted-by": "publisher"}, {"key": "52", "DOI": "10.1212/01.wnl.0000313834.22171.17", "doi-asserted-by": "publisher"}, {"key": "53", "DOI": "10.1002/mds.22095", "doi-asserted-by": "publisher"}, {"key": "54", "DOI": "10.1002/mds.23107", "doi-asserted-by": "publisher"}, {"key": "55", "DOI": "10.1177/0091270010363809", "doi-asserted-by": "publisher"}, {"key": "56", "DOI": "10.1016/S1474-4422(11)70012-6", "doi-asserted-by": "publisher"}], "container-title": ["Parkinson's Disease"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/pd/2012/489853.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/pd/2012/489853.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/pd/2012/489853.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T20:09:42Z", "timestamp": 1497989382000}, "score": 52.13756, "issued": {"date-parts": [[2012]]}, "references-count": 56, "alternative-id": ["489853", "489853"], "URL": "http://dx.doi.org/10.1155/2012/489853", "relation": {"cites": []}, "ISSN": ["2090-8083", "2042-0080"], "issn-type": [{"value": "2090-8083", "type": "print"}, {"value": "2042-0080", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T05:21:57Z", "timestamp": 1574227317441}, "reference-count": 88, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5-6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[2006, 9]]}, "DOI": "10.1097/00008877-200609000-00005", "type": "journal-article", "created": {"date-parts": [[2006, 8, 29]], "date-time": "2006-08-29T08:05:01Z", "timestamp": 1156838701000}, "page": "393-402", "source": "Crossref", "is-referenced-by-count": 21, "title": ["How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson??s disease?"], "prefix": "10.1097", "volume": "17", "author": [{"given": "Anna R.", "family": "Carta", "sequence": "first", "affiliation": []}, {"given": "Annalisa", "family": "Pinna", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "deposited": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T00:22:49Z", "timestamp": 1547338969000}, "score": 39.62155, "subtitle": [""], "issued": {"date-parts": [[2006, 9]]}, "references-count": 88, "journal-issue": {"issue": "5-6"}, "URL": "http://dx.doi.org/10.1097/00008877-200609000-00005", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T14:24:27Z", "timestamp": 1574173467526}, "reference-count": 38, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 11, 1]], "date-time": "2003-11-01T00:00:00Z", "timestamp": 1067644800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Experimental Neurology"], "published-print": {"date-parts": [[2003, 11]]}, "DOI": "10.1016/s0014-4886(03)00316-9", "type": "journal-article", "created": {"date-parts": [[2003, 9, 22]], "date-time": "2003-09-22T20:29:36Z", "timestamp": 1064262576000}, "page": "20-23", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease"], "prefix": "10.1016", "volume": "184", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Experimental Neurology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014488603003169?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014488603003169?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 24]], "date-time": "2019-02-24T00:22:53Z", "timestamp": 1550967773000}, "score": 30.62748, "issued": {"date-parts": [[2003, 11]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2003, 11]]}, "issue": "1"}, "alternative-id": ["S0014488603003169"], "URL": "http://dx.doi.org/10.1016/s0014-4886(03)00316-9", "ISSN": ["0014-4886"], "issn-type": [{"value": "0014-4886", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T22:29:42Z", "timestamp": 1575239382875}, "reference-count": 138, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 2, 2]], "date-time": "2018-02-02T00:00:00Z", "timestamp": 1517529600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "grant of the Autonomous Region of Sardinia", "award": []}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["J Neural Transm"], "published-print": {"date-parts": [[2018, 8]]}, "DOI": "10.1007/s00702-018-1848-6", "type": "journal-article", "created": {"date-parts": [[2018, 2, 2]], "date-time": "2018-02-02T15:57:36Z", "timestamp": 1517587056000}, "page": "1273-1286", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Role of adenosine A2A receptors in motor control: relevance to Parkinson\u2019s disease and dyskinesia"], "prefix": "10.1007", "volume": "125", "author": [{"ORCID": "http://orcid.org/0000-0002-4911-1735", "authenticated-orcid": false, "given": "Annalisa", "family": "Pinna", "sequence": "first", "affiliation": []}, {"given": "Marcello", "family": "Serra", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}, {"given": "Nicola", "family": "Simola", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 2, 2]]}, "reference": [{"key": "1848_CR1", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1002/syn.20195", "volume": "58", "author": "T Antonelli", "year": "2005", "unstructured": "Antonelli T, Fuxe K, Tomasini MC et al (2005) Effects of sarizotan on the corticostriatal glutamate pathways. Synapse 58:193\u2013199. \n                    https://doi.org/10.1002/syn.20195", "journal-title": "Synapse"}, {"key": "1848_CR2", "doi-asserted-by": "publisher", "first-page": "5848", "DOI": "10.1523/JNEUROSCI.20-15-05848.2000", "volume": "20", "author": "S Aoyama", "year": "2000", "unstructured": "Aoyama S, Kase H, Borrelli E (2000) Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. J Neurosci 20:5848\u20135852", "journal-title": "J Neurosci"}, {"key": "1848_CR3", "doi-asserted-by": "publisher", "first-page": "280", "DOI": "10.1016/j.pharmthera.2011.07.004", "volume": "132", "author": "MT Armentero", "year": "2011", "unstructured": "Armentero MT, Pinna A, Ferr\u00e9 S et al (2011) Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson\u2019s disease. Pharmacol Ther 132:280\u2013299. \n                    https://doi.org/10.1016/j.pharmthera.2011.07.004", "journal-title": "Pharmacol Ther"}, {"key": "1848_CR4", "doi-asserted-by": "publisher", "first-page": "204", "DOI": "10.1016/0169-328X(94)90048-5", "volume": "22", "author": "SJ Augood", "year": "1994", "unstructured": "Augood SJ, Emson PC (1994) Adenosine A2a receptor mRNA is expressed by enkephalin cells but not somatostatin cells in rat striatum: a co-expression study. Mol Brain Res 22:204\u2013210. \n                    https://doi.org/10.1016/0169-328X(94)90048-5", "journal-title": "Mol Brain Res"}, {"key": "1848_CR5", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1212/01.WNL.0000073136.00548.D4", "volume": "61", "author": "W Bara-Jimenez", "year": "2003", "unstructured": "Bara-Jimenez W, Sherzai A, Dimitrova T et al (2003) Adenosine A2A receptor antagonist treatment of Parkinson\u2019s disease. Neurology 61:293\u2013296. \n                    https://doi.org/10.1212/01.WNL.0000073136.00548.D4", "journal-title": "Neurology"}, {"key": "1848_CR6", "doi-asserted-by": "publisher", "first-page": "96", "DOI": "10.1016/j.pneurobio.2015.07.002", "volume": "132", "author": "MF Bastide", "year": "2015", "unstructured": "Bastide MF, Meissner WG, Picconi B et al (2015) Pathophysiology of l-dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog Neurobiol 132:96\u2013168. \n                    https://doi.org/10.1016/j.pneurobio.2015.07.002", "journal-title": "Prog Neurobiol"}, {"key": "1848_CR7", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1055/s-2007-979623", "volume": "2", "author": "HG Baumgarten", "year": "1995", "unstructured": "Baumgarten HG, Grozdanovic Z (1995) Psychopharmacology of central serotonergic systems. Pharmacopsychiatry 2:73\u201379. \n                    https://doi.org/10.1055/s-2007-979623", "journal-title": "Pharmacopsychiatry"}, {"key": "1848_CR8", "doi-asserted-by": "publisher", "first-page": "829", "DOI": "10.1093/brain/awu407", "volume": "138", "author": "E Bezard", "year": "2015", "unstructured": "Bezard E, Carta M (2015) Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson\u2019s disease? Brain 138:829\u2013830. \n                    https://doi.org/10.1093/brain/awu407", "journal-title": "Brain"}, {"key": "1848_CR9", "doi-asserted-by": "publisher", "first-page": "242", "DOI": "10.1016/j.neures.2013.10.002", "volume": "77", "author": "E Bezard", "year": "2013", "unstructured": "Bezard E, Mu\u00f1oz A, Tronci E et al (2013a) Anti-dyskinetic effect of anpirtoline in animal models of l-DOPA-induced dyskinesia. Neurosci Res 77:242\u2013246. \n                    https://doi.org/10.1016/j.neures.2013.10.002", "journal-title": "Neurosci Res"}, {"key": "1848_CR10", "doi-asserted-by": "publisher", "first-page": "1088", "DOI": "10.1002/mds.25366", "volume": "28", "author": "E Bezard", "year": "2013", "unstructured": "Bezard E, Tronci E, Pioli EY et al (2013b) Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Mov Disord 28:1088\u20131096. \n                    https://doi.org/10.1002/mds.25366", "journal-title": "Mov Disord"}, {"key": "1848_CR11", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1016/S0014-4886(03)00250-4", "volume": "184", "author": "F Bibbiani", "year": "2003", "unstructured": "Bibbiani F, Oh JD, Petzer JP et al (2003) A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson\u2019s disease. Exp Neurol 184:285\u2013294. \n                    https://doi.org/10.1016/S0014-4886(03)00250-4", "journal-title": "Exp Neurol"}, {"key": "1848_CR12", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/j.expneurol.2004.11.013", "volume": "192", "author": "F Bibbiani", "year": "2005", "unstructured": "Bibbiani F, Costantini LC, Patel R, Chase TN (2005) Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates. Exp Neurol 192:73\u201378. \n                    https://doi.org/10.1016/j.expneurol.2004.11.013", "journal-title": "Exp Neurol"}, {"key": "1848_CR13", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1002/cne.22751", "volume": "520", "author": "JW Bogenpohl", "year": "2012", "unstructured": "Bogenpohl JW, Ritter SL, Hall RA, Smith Y (2012) Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum. J Comp Neurol 520:570\u2013589. \n                    https://doi.org/10.1002/cne.22751", "journal-title": "J Comp Neurol"}, {"key": "1848_CR14", "doi-asserted-by": "publisher", "first-page": "1071", "DOI": "10.1038/cdd.2009.131", "volume": "17", "author": "D Boison", "year": "2010", "unstructured": "Boison D, Chen JF, Fredholm BB (2010) Adenosine signalling and function in glial cells. Cell Death Differ 17:1071\u20131082. \n                    https://doi.org/10.1038/cdd.2009.131", "journal-title": "Cell Death Differ"}, {"key": "1848_CR15", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1002/syn.10112", "volume": "46", "author": "J Bov\u00e9", "year": "2002", "unstructured": "Bov\u00e9 J, Marin C, Bonastre M, Tolosa E (2002) Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats. Synapse 46:251\u2013257. \n                    https://doi.org/10.1002/syn.10112", "journal-title": "Synapse"}, {"key": "1848_CR16", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1002/syn.20259", "volume": "59", "author": "J Bov\u00e9", "year": "2006", "unstructured": "Bov\u00e9 J, Serrats J, Mengod G et al (2006) Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats. Synapse 59:435\u2013444. \n                    https://doi.org/10.1002/syn.20259", "journal-title": "Synapse"}, {"key": "1848_CR17", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1016/S0197-4580(02)00065-9", "volume": "24", "author": "H Braak", "year": "2013", "unstructured": "Braak H, Del Tredici K, R\u00fcb U et al (2013) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. \n                    https://doi.org/10.1016/S0197-4580(02)00065-9", "journal-title": "Neurobiol Aging"}, {"key": "1848_CR18", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/978-94-007-4719-7_1", "volume": "986", "author": "G Burnstock", "year": "2013", "unstructured": "Burnstock G (2013) Introduction to purinergic signalling in the brain. Adv Exp Med Biol 986:1\u201312. \n                    https://doi.org/10.1007/978-94-007-4719-7_1", "journal-title": "Adv Exp Med Biol"}, {"issue": "8", "key": "1848_CR19", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.3389/fphar.2017.00661", "volume": "2017", "author": "G Burnstock", "year": "2017", "unstructured": "Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 2017(8):661. \n                    https://doi.org/10.3389/fphar.2017.00661", "journal-title": "Front Pharmacol"}, {"key": "1848_CR20", "doi-asserted-by": "publisher", "first-page": "2249", "DOI": "10.1038/sj.npp.1301375", "volume": "32", "author": "P Carriba", "year": "2007", "unstructured": "Carriba P, Ortiz O, Patkar K et al (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32:2249\u20132259. \n                    https://doi.org/10.1038/sj.npp.1301375", "journal-title": "Neuropsychopharmacology"}, {"key": "1848_CR21", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1038/nmeth.1229", "volume": "5", "author": "P Carriba", "year": "2008", "unstructured": "Carriba P, Navarro G, Ciruela F et al (2008) Detection of heteromerization of more than two proteins by sequential BRET\u2013FRET. Nat Methods 5:727\u2013733. \n                    https://doi.org/10.1038/nmeth.1229", "journal-title": "Nat Methods"}, {"key": "1848_CR22", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1016/j.neuroscience.2011.07.070", "volume": "198", "author": "M Carta", "year": "2011", "unstructured": "Carta M, Bezard E (2011) Contribution of pre-synaptic mechanisms to l-DOPA-induced dyskinesia. Neuroscience 198:245\u2013251. \n                    https://doi.org/10.1016/j.neuroscience.2011.07.070", "journal-title": "Neuroscience"}, {"key": "1848_CR23", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.3389/fneur.2014.00078", "volume": "5", "author": "M Carta", "year": "2014", "unstructured": "Carta M, Tronci E (2014) Serotonin system implication in l-DOPA-induced dyskinesia: from animal models to clinical investigations. Front Neurol 5:78. \n                    https://doi.org/10.3389/fneur.2014.00078", "journal-title": "Front Neurol"}, {"key": "1848_CR24", "doi-asserted-by": "publisher", "first-page": "1819", "DOI": "10.1093/brain/awm082", "volume": "130", "author": "M Carta", "year": "2007", "unstructured": "Carta M, Carlsson T, Kirik D, Bj\u00f6rklund A (2007) Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats. Brain 130:1819\u20131833. \n                    https://doi.org/10.1093/brain/awm082", "journal-title": "Brain"}, {"key": "1848_CR25", "doi-asserted-by": "publisher", "first-page": "381", "DOI": "10.1111/j.1471-4159.2006.04124.x", "volume": "99", "author": "MA Cenci", "year": "2006", "unstructured": "Cenci MA, Lundblad M (2006) Post-versus pre-synaptic plasticity in l-DOPA-induced dyskinesia. J Neurochem 99:381\u2013392. \n                    https://doi.org/10.1111/j.1471-4159.2006.04124.x", "journal-title": "J Neurochem"}, {"key": "1848_CR26", "doi-asserted-by": "publisher", "first-page": "777", "DOI": "10.1080/13543784.2017.1333598", "volume": "26", "author": "S Cerri", "year": "2017", "unstructured": "Cerri S, Siani F, Blandini F (2017) Investigational drugs in phase I and phase II for levodopa-induced dyskinesias. Expert Opin Investig Drugs 26:777\u2013791. \n                    https://doi.org/10.1080/13543784.2017.1333598", "journal-title": "Expert Opin Investig Drugs"}, {"key": "1848_CR27", "doi-asserted-by": "publisher", "first-page": "1490", "DOI": "10.2174/138161208784480126", "volume": "14", "author": "JF Chen", "year": "2008", "unstructured": "Chen JF, Pedata F (2008) Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors. Curr Pharm Des 14:1490\u20131499. \n                    https://doi.org/10.2174/138161208784480126", "journal-title": "Curr Pharm Des"}, {"key": "1848_CR28", "doi-asserted-by": "publisher", "first-page": "1970", "DOI": "10.1073/pnas.98.4.1970", "volume": "98", "author": "JF Chen", "year": "2001", "unstructured": "Chen JF, Moratalla R, Impagnatiello F et al (2001) The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci USA 98:1970\u20131975", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "1848_CR29", "doi-asserted-by": "publisher", "first-page": "2080", "DOI": "10.1523/JNEUROSCI.3574-05.2006", "volume": "26", "author": "F Ciruela", "year": "2006", "unstructured": "Ciruela F, Casad\u00f3 V, Rodrigues RJ et al (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1\u2013A2A receptor heteromers. J Neurosci 26:2080\u20132087. \n                    https://doi.org/10.1523/JNEUROSCI.3574-05.2006", "journal-title": "J Neurosci"}, {"key": "1848_CR30", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.3389/fnsys.2011.00049", "volume": "5", "author": "LE Collins-Praino", "year": "2011", "unstructured": "Collins-Praino LE, Paul NE, Rychalsky KL et al (2011) Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor. Front Syst Neurosci 5:49. \n                    https://doi.org/10.3389/fnsys.2011.00049", "journal-title": "Front Syst Neurosci"}, {"key": "1848_CR31", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1016/S0197-0186(00)00034-6", "volume": "38", "author": "RA Cunha", "year": "2001", "unstructured": "Cunha RA (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38:107\u2013125. \n                    https://doi.org/10.1016/S0197-0186(00)00034-6", "journal-title": "Neurochem Int"}, {"key": "1848_CR32", "first-page": "147", "volume": "16", "author": "PJ Delwaide", "year": "2001", "unstructured": "Delwaide PJ (2001) Parkinsonian rigidity. Funct Neurol 16:147\u2013156", "journal-title": "Funct Neurol"}, {"key": "1848_CR33", "doi-asserted-by": "publisher", "first-page": "1461", "DOI": "10.1111/j.1476-5381.1996.tb15561.x", "volume": "118", "author": "AK Dixon", "year": "1996", "unstructured": "Dixon AK, Gubitz AK, Sirinathsinghji DJ et al (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461\u20131468. \n                    https://doi.org/10.1111/j.1476-5381.1996.tb15561.x", "journal-title": "Br J Pharmacol"}, {"key": "1848_CR34", "doi-asserted-by": "publisher", "first-page": "875", "DOI": "10.1007/s40265-013-0066-7", "volume": "73", "author": "R Dungo", "year": "2013", "unstructured": "Dungo R, Deeks ED (2013) Istradefylline: first global approval. Drugs 73:875\u2013882. \n                    https://doi.org/10.1007/s40265-013-0066-7", "journal-title": "Drugs"}, {"key": "1848_CR35", "doi-asserted-by": "publisher", "first-page": "1357", "DOI": "10.1111/j.1476-5381.2011.01426.x", "volume": "164", "author": "S Duty", "year": "2011", "unstructured": "Duty S, Jenner P (2011) Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164:1357\u20131391. \n                    https://doi.org/10.1111/j.1476-5381.2011.01426.x", "journal-title": "Br J Pharmacol"}, {"key": "1848_CR36", "doi-asserted-by": "publisher", "first-page": "817", "DOI": "10.1002/mds.25395", "volume": "28", "author": "SA Factor", "year": "2013", "unstructured": "Factor SA, Wolski K, Togasaki DM et al (2013) Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson\u2019s disease. Mov Disord 28:817\u2013820. \n                    https://doi.org/10.1002/mds.25395", "journal-title": "Mov Disord"}, {"key": "1848_CR37", "first-page": "381", "volume": "49", "author": "I Feoktistov", "year": "1997", "unstructured": "Feoktistov I, Biaggioni I (1997) Adenosine A2B receptors. Pharmacol Rev 49:381\u2013402", "journal-title": "Pharmacol Rev"}, {"key": "1848_CR38", "doi-asserted-by": "publisher", "first-page": "482", "DOI": "10.1016/S0166-2236(97)01096-5", "volume": "20", "author": "S Ferr\u00e9", "year": "1997", "unstructured": "Ferr\u00e9 S, Fredholm BB, Morelli M et al (1997) Adenosine\u2013dopamine receptor\u2013receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482\u2013487. \n                    https://doi.org/10.1016/S0166-2236(97)01096-5", "journal-title": "Trends Neurosci"}, {"key": "1848_CR39", "doi-asserted-by": "publisher", "first-page": "11940", "DOI": "10.1073/pnas.172393799", "volume": "99", "author": "S Ferr\u00e9", "year": "2002", "unstructured": "Ferr\u00e9 S, Karcz-Kubicha M, Hope BT et al (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA 99:11940\u201311945. \n                    https://doi.org/10.1073/pnas.172393799", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "1848_CR40", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1111/j.1476-5381.2010.00723.x", "volume": "160", "author": "S Ferr\u00e9", "year": "2010", "unstructured": "Ferr\u00e9 S, Llu\u00eds C, Justinova Z et al (2010) Adenosine\u2013cannabinoid receptor interactions. Implications for striatal function. Br J Pharmacol 160:443\u2013453. \n                    https://doi.org/10.1111/j.1476-5381.2010.00723.x", "journal-title": "Br J Pharmacol"}, {"key": "1848_CR41", "doi-asserted-by": "publisher", "first-page": "1054", "DOI": "10.1523/JNEUROSCI.22-03-01054.2002", "volume": "22", "author": "S Fredduzzi", "year": "2002", "unstructured": "Fredduzzi S, Moratalla R, Monopoli A et al (2002) Persistent behavioral sensitization to chronic l-DOPA requires A2A adenosine receptors. J Neurosci 22:1054\u20131062", "journal-title": "J Neurosci"}, {"key": "1848_CR42", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1016/S0074-7742(05)63007-3", "volume": "63", "author": "BB Fredholm", "year": "2005", "unstructured": "Fredholm BB, Chen JF, Cunha RA et al (2005) Adenosine and brain function. Int Rev Neurobiol 63:191\u2013270. \n                    https://doi.org/10.1016/S0074-7742(05)63007-3", "journal-title": "Int Rev Neurobiol"}, {"key": "1848_CR43", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1124/pr.110.003285", "volume": "63", "author": "BB Fredholm", "year": "2011", "unstructured": "Fredholm BB, IJzerman AP, Jacobson KA et al (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update. Pharmacol Rev 63:1\u201334. \n                    https://doi.org/10.1124/pr.110.003285", "journal-title": "Pharmacol Rev"}, {"key": "1848_CR44", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.2217/nmt-2016-0005", "volume": "6", "author": "ME Freitas", "year": "2016", "unstructured": "Freitas ME, Fox SH (2016) Non dopaminergic treatments for Parkinson\u2019s disease: current and future prospects. Neurodegener Dis Manag 6:249\u2013268. \n                    https://doi.org/10.2217/nmt-2016-0005", "journal-title": "Neurodegener Dis Manag"}, {"key": "1848_CR45", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.2174/092986712803414259", "volume": "19", "author": "K Fuxe", "year": "2012", "unstructured": "Fuxe K, Borroto-Escuela DO, Marcellino D et al (2012) GPCR heteromers and their allosteric receptor-receptorinteractions. Curr Med Chem 19:356\u2013363. \n                    https://doi.org/10.2174/092986712803414259", "journal-title": "Curr Med Chem"}, {"key": "1848_CR46", "doi-asserted-by": "publisher", "first-page": "740", "DOI": "10.1111/jnc.13162", "volume": "134", "author": "MT Fuzzati-Armentero", "year": "2015", "unstructured": "Fuzzati-Armentero MT, Cerri S, Levandis G et al (2015) Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson\u2019s disease. J Neurochem 134:740\u2013747. \n                    https://doi.org/10.1111/jnc.13162", "journal-title": "J Neurochem"}, {"key": "1848_CR47", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/0197-0186(95)00137-9", "volume": "29", "author": "PJ Gebicke-Haerter", "year": "1996", "unstructured": "Gebicke-Haerter PJ, Christoffel F, Timmer J et al (1996) Both adenosine A1 and A2-receptors are required to stimulate microglial proliferation. Neurochem Int 29:37\u201342. \n                    https://doi.org/10.1016/0197-0186(95)00137-9", "journal-title": "Neurochem Int"}, {"key": "1848_CR48", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1016/S0014-2999(02)02301-4", "volume": "451", "author": "Z Gerevich", "year": "2002", "unstructured": "Gerevich Z, Wirkner K, Illes P (2002) Adenosine A2A receptors inhibit the N-methyl-d-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur J Pharmacol 451:161\u2013164. \n                    https://doi.org/10.1016/S0014-2999(02)02301-4", "journal-title": "Eur J Pharmacol"}, {"key": "1848_CR49", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/j.pharmthera.2007.09.002", "volume": "117", "author": "S Gessi", "year": "2008", "unstructured": "Gessi S, Merighi S, Varani K et al (2008) The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 117:123\u2013140. \n                    https://doi.org/10.1016/j.pharmthera.2007.09.002", "journal-title": "Pharmacol Ther"}, {"key": "1848_CR50", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1016/j.nbd.2015.11.022", "volume": "86", "author": "V Ghiglieri", "year": "2016", "unstructured": "Ghiglieri V, Mineo D, Vannelli A et al (2016) Modulation of serotonergic transmission by eltoprazine in l-DOPA-induced dyskinesia: behavioral, molecular and synapticmechanisms. Neurobiol Dis 86:140\u2013153. \n                    https://doi.org/10.1016/j.nbd.2015.11.022", "journal-title": "Neurobiol Dis"}, {"key": "1848_CR51", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1002/mds.21226", "volume": "22", "author": "CG Goetz", "year": "2007", "unstructured": "Goetz CG, Damier P, Hicking C et al (2007) Sarizotan as a treatment for dyskinesias in Parkinson\u2019s disease: a double-blind placebo-controlled trial. Mov Disord 22:179\u2013186. \n                    https://doi.org/10.1002/mds.21226", "journal-title": "Mov Disord"}, {"key": "1848_CR52", "doi-asserted-by": "publisher", "first-page": "1673", "DOI": "10.1212/WNL.52.8.1673", "volume": "52", "author": "R Grondin", "year": "1999", "unstructured": "Grondin R, B\u00e9dard PJ, Tahar AH et al (1999) Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 52:1673\u20131677", "journal-title": "Neurology"}, {"key": "1848_CR53", "doi-asserted-by": "publisher", "first-page": "1051", "DOI": "10.1046/j.1471-4159.2003.01919.x", "volume": "86", "author": "C Hammarberg", "year": "2003", "unstructured": "Hammarberg C, Schulte G, Fredholm BB (2003) Evidence for functional adenosine A3 receptors in microglia cells. J Neurochem 86:1051\u20131054. \n                    https://doi.org/10.1046/j.1471-4159.2003.01919.x", "journal-title": "J Neurochem"}, {"key": "1848_CR54", "doi-asserted-by": "publisher", "first-page": "297", "DOI": "10.1212/01.WNL.0000081227.84197.0B", "volume": "61", "author": "RA Hauser", "year": "2003", "unstructured": "Hauser RA, Hubble JP, Truong DD, Istradefylline US-001 Study Group (2003) Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD. Neurology 61:297\u2013303", "journal-title": "Neurology"}, {"key": "1848_CR55", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1016/S1474-4422(11)70012-6", "volume": "10", "author": "RA Hauser", "year": "2011", "unstructured": "Hauser RA, Cantillon M, Pourcher E et al (2011) Preladenant in patients with Parkinson\u2019s disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurol 10:221\u2013229. \n                    https://doi.org/10.1016/S1474-4422(11)70012-6", "journal-title": "Lancet Neurol"}, {"key": "1848_CR56", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1016/S1474-4422(14)70148-6", "volume": "13", "author": "RA Hauser", "year": "2014", "unstructured": "Hauser RA, Olanow CW, Kieburtz KD et al (2014) Tozadenant (SYN115) in patients with Parkinson\u2019s disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial. Lancet Neurol 13:767\u2013776. \n                    https://doi.org/10.1016/S1474-4422(14)70148-6", "journal-title": "Lancet Neurol"}, {"key": "1848_CR57", "doi-asserted-by": "publisher", "first-page": "1491", "DOI": "10.1001/jamaneurol.2015.2268", "volume": "72", "author": "RA Hauser", "year": "2015", "unstructured": "Hauser RA, Stocchi F, Rascol O et al (2015) Preladenant as an adjunctive therapy with levodopa in Parkinson disease: two randomized clinical trials and lessons learned. JAMA Neurol 72:1491\u20131500. \n                    https://doi.org/10.1001/jamaneurol.2015.2268", "journal-title": "JAMA Neurol"}, {"key": "1848_CR58", "doi-asserted-by": "publisher", "first-page": "334", "DOI": "10.1006/exnr.1998.6819", "volume": "151", "author": "B Henry", "year": "1998", "unstructured": "Henry B, Crossman AR, Brotchie JM (1998) Characterization of enhanced behavioral responses to l-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease. Exp Neurol 151:334\u2013342. \n                    https://doi.org/10.1006/exnr.1998.6819", "journal-title": "Exp Neurol"}, {"key": "1848_CR59", "doi-asserted-by": "publisher", "first-page": "472", "DOI": "10.1111/jnc.12751", "volume": "130", "author": "R Heumann", "year": "2014", "unstructured": "Heumann R, Moratalla R, Herrero MT et al (2014) Dyskinesia in Parkinson\u2019s disease: mechanisms and current non-pharmacological interventions. J Neurochem 130:472\u2013489. \n                    https://doi.org/10.1111/jnc.12751", "journal-title": "J Neurochem"}, {"key": "1848_CR60", "doi-asserted-by": "publisher", "first-page": "294", "DOI": "10.1124/jpet.108.149617", "volume": "330", "author": "RA Hodgson", "year": "2009", "unstructured": "Hodgson RA, Bertorelli R, Varty GB et al (2009) Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression. J Pharmacol Exp Ther 330:294\u2013303. \n                    https://doi.org/10.1124/jpet.108.149617", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1848_CR61", "doi-asserted-by": "publisher", "first-page": "384", "DOI": "10.1016/j.expneurol.2010.07.011", "volume": "225", "author": "RA Hodgson", "year": "2010", "unstructured": "Hodgson RA, Bedard PJ, Varty GB et al (2010) Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders. Exp Neurol 225:384\u2013390. \n                    https://doi.org/10.1016/j.expneurol.2010.07.011", "journal-title": "Exp Neurol"}, {"key": "1848_CR62", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1016/j.pneurobio.2011.08.004", "volume": "95", "author": "P Hout", "year": "2011", "unstructured": "Hout P, Fox SH, Brotchie JM (2011) The serotonergic system in Parkinson\u2019s disease. Prog Neurobiol 95:163\u2013212. \n                    https://doi.org/10.1016/j.pneurobio.2011.08.004", "journal-title": "Prog Neurobiol"}, {"key": "1848_CR63", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1152/physrev.1992.72.1.165", "volume": "72", "author": "BL Jacobs", "year": "1992", "unstructured": "Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165\u2013229", "journal-title": "Physiol Rev"}, {"key": "1848_CR64", "doi-asserted-by": "publisher", "first-page": "S11", "DOI": "10.1002/mds.20458", "volume": "11", "author": "J Jankovic", "year": "2005", "unstructured": "Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson\u2019s disease: clinical manifestations. Mov Disord 11:S11\u2013S16. \n                    https://doi.org/10.1002/mds.20458", "journal-title": "Mov Disord"}, {"key": "1848_CR65", "doi-asserted-by": "publisher", "first-page": "665", "DOI": "10.1038/nrn2471", "volume": "9", "author": "P Jenner", "year": "2008", "unstructured": "Jenner P (2008) Molecular mechanisms of l-DOPA-induced dyskinesia. Nat Rev Neurosci 9:665\u2013677. \n                    https://doi.org/10.1038/nrn2471", "journal-title": "Nat Rev Neurosci"}, {"key": "1848_CR66", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1016/B978-0-12-801022-8.00003-9", "volume": "119", "author": "P Jenner", "year": "2014", "unstructured": "Jenner P (2014) An overview of adenosine A2A receptor antagonists in Parkinson\u2019s disease. Int Rev Neurobiol 119:71\u201386. \n                    https://doi.org/10.1016/B978-0-12-801022-8.00003-9", "journal-title": "Int Rev Neurobiol"}, {"key": "1848_CR67", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1124/jpet.111.187443", "volume": "340", "author": "CK Jones", "year": "2012", "unstructured": "Jones CK, Bubser M, Thompson AD et al (2012) The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with l-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson\u2019s disease. J Pharmacol Exp Ther 340:404\u2013421. \n                    https://doi.org/10.1124/jpet.111.187443", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1848_CR68", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1016/j.brainresbull.2013.07.001", "volume": "98", "author": "N Jones", "year": "2013", "unstructured": "Jones N, Bleickardt C, Mullins D, Parker E, Hodgson R (2013) A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats. Brain Res Bull 98:163\u2013169. \n                    https://doi.org/10.1016/j.brainresbull.2013.07.001", "journal-title": "Brain Res Bull"}, {"key": "1848_CR69", "doi-asserted-by": "publisher", "first-page": "10414", "DOI": "10.1523/JNEUROSCI.3660-05.2005", "volume": "25", "author": "A Kachroo", "year": "2005", "unstructured": "Kachroo A, Orlando LR, Grandy DK et al (2005) Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci 25:10414\u201310419. \n                    https://doi.org/10.1523/JNEUROSCI.3660-05.2005", "journal-title": "J Neurosci"}, {"key": "1848_CR70", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/B978-0-12-801022-8.00006-4", "volume": "119", "author": "T Kanda", "year": "2014", "unstructured": "Kanda T, Uchida S (2014) Clinical/pharmacological aspect of adenosine A2A receptor antagonist for dyskinesia. Int Rev Neurobiol 119:127\u2013150. \n                    https://doi.org/10.1016/B978-0-12-801022-8.00006-4", "journal-title": "Int Rev Neurobiol"}, {"key": "1848_CR71", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1016/0014-2999(94)90551-7", "volume": "256", "author": "T Kanda", "year": "1994", "unstructured": "Kanda T, Shiozaki S, Shimada J et al (1994) KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. Eur J Pharmacol 256:263\u2013268. \n                    https://doi.org/10.1016/0014-2999(94)90551-7", "journal-title": "Eur J Pharmacol"}, {"key": "1848_CR72", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1002/ana.410430415", "volume": "43", "author": "T Kanda", "year": "1998", "unstructured": "Kanda T, Jackson MJ, Smith LA et al (1998) Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann Neurol 43:507\u2013513. \n                    https://doi.org/10.1002/ana.410430415", "journal-title": "Ann Neurol"}, {"key": "1848_CR73", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1006/exnr.2000.7350", "volume": "162", "author": "T Kanda", "year": "2000", "unstructured": "Kanda T, Jackson MJ, Smith LA et al (2000) Combined use of the adenosine A(2A) antagonist KW-6002 with l-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Exp Neurol 162:321\u2013327. \n                    https://doi.org/10.1006/exnr.2000.7350", "journal-title": "Exp Neurol"}, {"key": "1848_CR74", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1016/j.ejphar.2017.07.030", "volume": "813", "author": "WKD Ko", "year": "2017", "unstructured": "Ko WKD, Li Q, Cheng LY et al (2017) A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating l-DOPA-induced dyskinesia in Parkinson\u2019s disease. Eur J Pharmacol 813:10\u201316. \n                    https://doi.org/10.1016/j.ejphar.2017.07.030", "journal-title": "Eur J Pharmacol"}, {"key": "1848_CR75", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1016/S0014-2999(00)00745-7", "volume": "408", "author": "K Koga", "year": "2000", "unstructured": "Koga K, Kurokawa M, Ochi M et al (2000) Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats. Eur J Pharmacol 408:249\u2013255. \n                    https://doi.org/10.1016/S0014-2999(00)00745-7", "journal-title": "Eur J Pharmacol"}, {"key": "1848_CR76", "doi-asserted-by": "publisher", "first-page": "10067", "DOI": "10.1523/JNEUROSCI.6730-10.2011", "volume": "31", "author": "M Lazarus", "year": "2011", "unstructured": "Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, Bass CE, Winsky-Sommerer R, Semba K, Fredholm BB, Boison D, Hayaishi O, Urade Y, Chen JF (2011) Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 31:10067\u201310075. \n                    https://doi.org/10.1523/JNEUROSCI.6730-10.2011", "journal-title": "J Neurosci"}, {"key": "1848_CR77", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1002/ana.21315", "volume": "63", "author": "PA Lewitt", "year": "2008", "unstructured": "Lewitt PA, Guttman M, Tetrud JW et al (2008) Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces \u201coff\u201d time in Parkinson\u2019s disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann Neurol 63:295\u2013302. \n                    https://doi.org/10.1002/ana.21315", "journal-title": "Ann Neurol"}, {"key": "1848_CR78", "first-page": "379", "volume": "59", "author": "S \u0141ukasiewicz", "year": "2007", "unstructured": "\u0141ukasiewicz S, Blasiak E, Faron-Gorecka A et al (2007) Fluorescence studies of homooligomerization of adenosine A2A and serotonin 5-HT1A receptors reveal the specificity of receptor interactions in the plasma membrane. Pharmacol Rep 59:379\u2013392", "journal-title": "Pharmacol Rep"}, {"key": "1848_CR79", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1046/j.0953-816x.2001.01843.x", "volume": "15", "author": "M Lundblad", "year": "2002", "unstructured": "Lundblad M, Andersson M, Winkler C et al (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur J Neurosci 15:120\u2013132. \n                    https://doi.org/10.1046/j.0953-816x.2001.01843.x", "journal-title": "Eur J Neurosci"}, {"key": "1848_CR80", "doi-asserted-by": "publisher", "first-page": "1398", "DOI": "10.1046/j.1471-4159.2003.01632.x", "volume": "84", "author": "M Lundblad", "year": "2003", "unstructured": "Lundblad M, Vaudano E, Cenci MA (2003) Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia. J Neurochem 84:1398\u20131410. \n                    https://doi.org/10.1046/j.1471-4159.2003.01632.x", "journal-title": "J Neurochem"}, {"key": "1848_CR81", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1016/j.expneurol.2004.10.008", "volume": "192", "author": "C Marin", "year": "2005", "unstructured": "Marin C, Aguilar E, Bonastre M et al (2005) Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats. Exp Neurol 192:184\u2013193. \n                    https://doi.org/10.1016/j.expneurol.2004.10.008", "journal-title": "Exp Neurol"}, {"key": "1848_CR82", "doi-asserted-by": "publisher", "first-page": "1595", "DOI": "10.1002/mds.21010", "volume": "21", "author": "GE Meredith", "year": "2006", "unstructured": "Meredith GE, Kang UJ (2006) Behavioral models of Parkinson\u2019s disease in rodents: a new look at an old problem. Mov Disord 21:1595\u20131606. \n                    https://doi.org/10.1002/mds.21010", "journal-title": "Mov Disord"}, {"key": "1848_CR83", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1016/j.pneurobio.2007.07.001", "volume": "83", "author": "M Morelli", "year": "2007", "unstructured": "Morelli M, Di Paolo T, Wardas J et al (2007) Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications. Prog Neurobiol 83:293\u2013309. \n                    https://doi.org/10.1016/j.pneurobio.2007.07.001", "journal-title": "Prog Neurobiol"}, {"key": "1848_CR84", "doi-asserted-by": "publisher", "first-page": "489853", "DOI": "10.1155/2012/489853", "volume": "2012", "author": "M Morelli", "year": "2012", "unstructured": "Morelli M, Blandini F, Simola N, Hauser RA (2012) A(2A) receptor antagonism and dyskinesia in Parkinson\u2019s disease. Parkinsons Dis 2012:489853. \n                    https://doi.org/10.1155/2012/489853", "journal-title": "Parkinsons Dis"}, {"key": "1848_CR85", "doi-asserted-by": "publisher", "first-page": "3380", "DOI": "10.1093/brain/awn235", "volume": "131", "author": "A Mu\u00f1oz", "year": "2008", "unstructured": "Mu\u00f1oz A, Li Q, Gardoni F et al (2008) Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of l-DOPA-induced dyskinesia. Brain 131:3380\u20133394. \n                    https://doi.org/10.1093/brain/awn235", "journal-title": "Brain"}, {"key": "1848_CR86", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1007/s00213-010-2029-y", "volume": "213", "author": "S Navailles", "year": "2011", "unstructured": "Navailles S, De Deurwaerd\u00e8re P (2011) Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology 213:213\u2013242. \n                    https://doi.org/10.1007/s00213-010-2029-y", "journal-title": "Psychopharmacology"}, {"key": "1848_CR87", "doi-asserted-by": "publisher", "first-page": "1088", "DOI": "10.1100/tsw.2008.136", "volume": "8", "author": "G Navarro", "year": "2008", "unstructured": "Navarro G, Carriba P, Gand\u00eda J et al (2008) Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. Sci World J 8:1088\u20131097. \n                    https://doi.org/10.1100/tsw.2008.136", "journal-title": "Sci World J"}, {"key": "1848_CR88", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/j.neuroscience.2013.12.029", "volume": "260", "author": "N Nevalainen", "year": "2014", "unstructured": "Nevalainen N, Bjerk\u00e9n S, Gerhardt GA, Str\u00f6mberg I (2014) Serotonergic nerve fibers in l-DOPA-derived dopamine release and dyskinesia. Neuroscience 260:73\u201386. \n                    https://doi.org/10.1016/j.neuroscience.2013.12.029", "journal-title": "Neuroscience"}, {"key": "1848_CR89", "doi-asserted-by": "publisher", "first-page": "S8", "DOI": "10.1016/S1471-1931(00)00028-8", "volume": "23", "author": "JA Obeso", "year": "2000", "unstructured": "Obeso JA, Rodr\u00edguez-Oroz MC, Rodr\u00edguez M et al (2000) Pathophysiology of the basal ganglia in Parkinson\u2019s disease. Trends Neurosci 23:S8\u2013S19. \n                    https://doi.org/10.1016/S1471-1931(00)00028-8", "journal-title": "Trends Neurosci"}, {"key": "1848_CR90", "doi-asserted-by": "publisher", "first-page": "S17", "DOI": "10.1212/WNL.62.1_suppl_1.S17", "volume": "62", "author": "JA Obeso", "year": "2004", "unstructured": "Obeso JA, Rodriguez-Oroz M, Marin C et al (2004) The origin of motor fluctuations in Parkinson\u2019s disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 62:S17\u2013S30", "journal-title": "Neurology"}, {"key": "1848_CR91", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1016/j.neuroscience.2004.04.050", "volume": "127", "author": "M Ochi", "year": "2004", "unstructured": "Ochi M, Shiozaki S, Kase H (2004) Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson\u2019s disease. Neuroscience 127:223\u2013231. \n                    https://doi.org/10.1016/j.neuroscience.2004.04.050", "journal-title": "Neuroscience"}, {"key": "1848_CR92", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1007/s00726-001-0118-2", "volume": "23", "author": "JD Oh", "year": "2002", "unstructured": "Oh JD, Chase TN (2002) Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson\u2019s disease. Amino Acids 23:133\u2013139. \n                    https://doi.org/10.1007/s00726-001-0118-2", "journal-title": "Amino Acids"}, {"key": "1848_CR93", "doi-asserted-by": "publisher", "first-page": "104", "DOI": "10.1016/j.pneurobio.2015.09.005", "volume": "134", "author": "Y Ohno", "year": "2015", "unstructured": "Ohno Y, Shimizu S, Tokudome K et al (2015) New insight into the therapeutic role of the serotonergic system in Parkinson\u2019s disease. Prog Neurobiol 134:104\u2013121. \n                    https://doi.org/10.1016/j.pneurobio.2015.09.005", "journal-title": "Prog Neurobiol"}, {"key": "1848_CR94", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1146/annurev.neuro.22.1.123", "volume": "22", "author": "CW Olanow", "year": "1999", "unstructured": "Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson\u2019s disease. Annu Rev Neurosci 22:123\u2013144. \n                    https://doi.org/10.1146/annurev.neuro.22.1.123", "journal-title": "Annu Rev Neurosci"}, {"key": "1848_CR95", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1097/00002826-200403000-00003", "volume": "27", "author": "CW Olanow", "year": "2004", "unstructured": "Olanow CW, Damier P, Goetz CG et al (2004) Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). Clin Neuropharmacol 27:58\u201362. \n                    https://doi.org/10.1097/00002826-200403000-00003", "journal-title": "Clin Neuropharmacol"}, {"key": "1848_CR96", "doi-asserted-by": "publisher", "first-page": "S1", "DOI": "10.1212/WNL.0b013e3181a1d44c", "volume": "72", "author": "CW Olanow", "year": "2009", "unstructured": "Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of Parkinson disease. Neurology 72:S1\u2013S136. \n                    https://doi.org/10.1212/WNL.0b013e3181a1d44c", "journal-title": "Neurology"}, {"key": "1848_CR97", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1016/0006-8993(94)90796-X", "volume": "662", "author": "SM Papa", "year": "1994", "unstructured": "Papa SM, Engber TM, Kask AM, Chase TN (1994) Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration. Brain Res 662:69\u201374. \n                    https://doi.org/10.1016/0006-8993(94)90796-X", "journal-title": "Brain Res"}, {"key": "1848_CR98", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1126/science.1116916", "volume": "310", "author": "O Pascual", "year": "2005", "unstructured": "Pascual O, Casper KB, Kubera C et al (2005) Astrocytic purinergic signalling coordinates synaptic networks. Science 310:113\u2013116. \n                    https://doi.org/10.1126/science.1116916", "journal-title": "Science"}, {"key": "1848_CR99", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1016/j.neuropharm.2015.11.007", "volume": "104", "author": "F Pedata", "year": "2016", "unstructured": "Pedata F, Dettori I, Coppi E et al (2016) Purinergic signalling in brain ischemia. Neuropharmacology 104:105\u2013130. \n                    https://doi.org/10.1016/j.neuropharm.2015.11.007", "journal-title": "Neuropharmacology"}, {"key": "1848_CR100", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1007/s40263-014-0161-7", "volume": "28", "author": "A Pinna", "year": "2014", "unstructured": "Pinna A (2014) Adenosine A2A receptor antagonists in Parkinson\u2019s disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued. CNS Drugs 28:455\u2013474. \n                    https://doi.org/10.1007/s40263-014-0161-7", "journal-title": "CNS Drugs"}, {"key": "1848_CR101", "doi-asserted-by": "publisher", "first-page": "392", "DOI": "10.1007/s12640-013-9446-8", "volume": "25", "author": "A Pinna", "year": "2014", "unstructured": "Pinna A, Morelli M (2014) A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: the case of adenosine; A(2A) receptor antagonists. Neurotox Res 25:392\u2013401. \n                    https://doi.org/10.1007/s12640-013-9446-8", "journal-title": "Neurotox Res"}, {"key": "1848_CR102", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1002/1098-2396(20010301)39:3<233::aid-syn1004>3.0.co;2-k", "volume": "39", "author": "A Pinna", "year": "2001", "unstructured": "Pinna A, Fenu S, Morelli M (2001) Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. Synapse 39:233\u2013238. \n                    https://doi.org/10.1002/1098-2396(20010301)39:3<233::aid-syn1004>3.0.co;2-k", "journal-title": "Synapse"}, {"key": "1848_CR103", "doi-asserted-by": "publisher", "first-page": "3259", "DOI": "10.1016/j.lfs.2005.04.029", "volume": "77", "author": "A Pinna", "year": "2005", "unstructured": "Pinna A, Wardas J, Simola N, Morelli M (2005) New therapies for the treatment of Parkinson\u2019s disease: adenosine A2A receptor antagonists. Life Sci 77:3259\u20133267. \n                    https://doi.org/10.1016/j.lfs.2005.04.029", "journal-title": "Life Sci"}, {"key": "1848_CR104", "doi-asserted-by": "publisher", "first-page": "606", "DOI": "10.1002/syn.20410", "volume": "61", "author": "A Pinna", "year": "2007", "unstructured": "Pinna A, Pontis S, Borsini F, Morelli M (2007) Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson\u2019s disease. Synapse 61:606\u2013614. \n                    https://doi.org/10.1002/syn.20410", "journal-title": "Synapse"}, {"key": "1848_CR105", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1016/j.neuropharm.2009.11.012", "volume": "58", "author": "A Pinna", "year": "2010", "unstructured": "Pinna A, Tronci E, Schintu N et al (2010) A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. Neuropharmacology 58:613\u2013623. \n                    https://doi.org/10.1016/j.neuropharm.2009.11.012", "journal-title": "Neuropharmacology"}, {"key": "1848_CR106", "doi-asserted-by": "publisher", "first-page": "180", "DOI": "10.1016/j.expneurol.2013.12.021", "volume": "253", "author": "A Pinna", "year": "2014", "unstructured": "Pinna A, Bonaventura J, Farr\u00e9 D et al (2014) l-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies. Exp Neurol 253:180\u2013191. \n                    https://doi.org/10.1016/j.expneurol.2013.12.021", "journal-title": "Exp Neurol"}, {"key": "1848_CR107", "doi-asserted-by": "publisher", "first-page": "501", "DOI": "10.1002/mds.26475", "volume": "31", "author": "A Pinna", "year": "2016", "unstructured": "Pinna A, Ko WK, Costa G et al (2016) Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson\u2019s disease. Mov Disord 31:501\u2013511. \n                    https://doi.org/10.1002/mds.26475", "journal-title": "Mov Disord"}, {"key": "1848_CR108", "doi-asserted-by": "publisher", "first-page": "38", "DOI": "10.1126/scitranslmed.3000976", "volume": "2", "author": "M Politis", "year": "2010", "unstructured": "Politis M, Wu K, Loane C et al (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson\u2019s patients with neural transplants. Sci Transl Med 2:38\u201346. \n                    https://doi.org/10.1126/scitranslmed.3000976", "journal-title": "Sci Transl Med"}, {"key": "1848_CR109", "doi-asserted-by": "publisher", "first-page": "1340", "DOI": "10.1172/JCI71640", "volume": "124", "author": "M Politis", "year": "2014", "unstructured": "Politis M, Wu K, Loane C et al (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson\u2019s disease patients. J Clin Investig 124:1340\u20131349. \n                    https://doi.org/10.1172/JCI71640", "journal-title": "J Clin Investig"}, {"key": "1848_CR110", "doi-asserted-by": "publisher", "first-page": "664", "DOI": "10.2174/187152712803581100", "volume": "11", "author": "P Popoli", "year": "2012", "unstructured": "Popoli P, Pepponi R (2012) Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system. CNS Neurol Disord Drug Targets 11:664\u2013674. \n                    https://doi.org/10.2174/187152712803581100", "journal-title": "CNS Neurol Disord Drug Targets"}, {"key": "1848_CR111", "doi-asserted-by": "publisher", "first-page": "1451", "DOI": "10.1002/mds.26362", "volume": "30", "author": "O Rascol", "year": "2015", "unstructured": "Rascol O, Perez-Lloret S, Ferreira JJ (2015) New treatments for levodopa-induced motor complications. Mov Disord 30:1451\u20131460. \n                    https://doi.org/10.1002/mds.26362", "journal-title": "Mov Disord"}, {"key": "1848_CR112", "doi-asserted-by": "publisher", "first-page": "893", "DOI": "10.1016/j.neuroscience.2005.01.014", "volume": "132", "author": "N Rebola", "year": "2005", "unstructured": "Rebola N, Canas PM, Oliveira CR, Cunha RA (2005) Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. Neuroscience 132:893\u2013903. \n                    https://doi.org/10.1016/j.neuroscience.2005.01.014", "journal-title": "Neuroscience"}, {"key": "1848_CR113", "doi-asserted-by": "publisher", "first-page": "1025", "DOI": "10.1097/00001756-200004070-00026", "volume": "11", "author": "SA Rivkees", "year": "2000", "unstructured": "Rivkees SA, Thevananther S, Hao H (2000) Are A3 adenosine receptors expressed in the brain? NeuroReport 11:1025\u20131030", "journal-title": "NeuroReport"}, {"key": "1848_CR114", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1111/j.1471-4159.2004.02887.x", "volume": "92", "author": "RJ Rodrigues", "year": "2005", "unstructured": "Rodrigues RJ, Alfaro TM, Rebola N et al (2005) Colocalization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem 92:433\u2013441. \n                    https://doi.org/10.1111/j.1471-4159.2004.02887.x", "journal-title": "J Neurochem"}, {"key": "1848_CR115", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1016/j.ejphar.2006.07.017", "volume": "546", "author": "S Rose", "year": "2006", "unstructured": "Rose S, Jackson MJ, Smith LA et al (2006) The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of l-DOPA in MPTP treated common marmosets. Eur J Pharmacol 546:82\u201387. \n                    https://doi.org/10.1016/j.ejphar.2006.07.017", "journal-title": "Eur J Pharmacol"}, {"key": "1848_CR116", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1002/(sici)1096-9861(19981116)401:2<163::aid-cne2>3.0.co;2-d", "volume": "401", "author": "DL Rosin", "year": "1998", "unstructured": "Rosin DL, Robeva A, Woodard RL et al (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol 401:163\u2013186. \n                    https://doi.org/10.1002/(sici)1096-9861(19981116)401:2<163::aid-cne2>3.0.co;2-d", "journal-title": "J Comp Neurol"}, {"key": "1848_CR117", "doi-asserted-by": "publisher", "first-page": "3594", "DOI": "10.2741/2952", "volume": "13", "author": "JD Salamone", "year": "2008", "unstructured": "Salamone JD, Betz AJ, Ishiwari K et al (2008) Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism. Front Biosci 13:3594\u20133605. \n                    https://doi.org/10.2741/2952", "journal-title": "Front Biosci"}, {"key": "1848_CR118", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1038/nrn.2017.62", "volume": "18", "author": "AHV Schapira", "year": "2017", "unstructured": "Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450. \n                    https://doi.org/10.1038/nrn.2017.62", "journal-title": "Nat Rev Neurosci"}, {"key": "1848_CR119", "doi-asserted-by": "publisher", "first-page": "1062", "DOI": "10.1111/j.1471-4159.1991.tb08257.x", "volume": "57", "author": "SN Schiffmann", "year": "1991", "unstructured": "Schiffmann SN, Jacobs O, Vanderhaeghen JJ (1991) Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57:1062\u20131067. \n                    https://doi.org/10.1111/j.1471-4159.1991.tb08257.x", "journal-title": "J Neurochem"}, {"key": "1848_CR120", "doi-asserted-by": "publisher", "first-page": "647", "DOI": "10.1016/j.tins.2006.09.004", "volume": "29", "author": "MA Schwarzschild", "year": "2006", "unstructured": "Schwarzschild MA, Agnati L, Fuxe K et al (2006) Targeting adenosine A2A receptors in Parkinson\u2019s disease. Trends Neurosci 29:647\u2013654. \n                    https://doi.org/10.1016/j.tins.2006.09.004", "journal-title": "Trends Neurosci"}, {"key": "1848_CR121", "doi-asserted-by": "publisher", "first-page": "471", "DOI": "10.1007/978-3-540-89615-9_16", "volume": "193", "author": "AM Sebasti\u00e3o", "year": "2009", "unstructured": "Sebasti\u00e3o AM, Ribeiro JA (2009) Adenosine receptors and the central nervous system. Handb Exp Pharmacol 193:471\u2013534. \n                    https://doi.org/10.1007/978-3-540-89615-9_16", "journal-title": "Handb Exp Pharmacol"}, {"key": "1848_CR122", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1111/j.1469-7793.2001.0423f.x", "volume": "532", "author": "T Shindou", "year": "2001", "unstructured": "Shindou T, Mori A, Kase H, Ichimura M (2001) Adenosine A(2A) receptor enhances GABA(A)-mediated IPSCs in the rat globus pallidus. J Physiol 532:423\u2013434. \n                    https://doi.org/10.1111/j.1469-7793.2001.0423f.x", "journal-title": "J Physiol"}, {"key": "1848_CR123", "doi-asserted-by": "publisher", "first-page": "182", "DOI": "10.1016/j.expneurol.2004.05.027", "volume": "189", "author": "N Simola", "year": "2004", "unstructured": "Simola N, Fenu S, Baraldi PG et al (2004) Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Exp Neurol 189:182\u2013188. \n                    https://doi.org/10.1016/j.expneurol.2004.05.027", "journal-title": "Exp Neurol"}, {"key": "1848_CR124", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/j.expneurol.2006.05.015", "volume": "202", "author": "N Simola", "year": "2006", "unstructured": "Simola N, Fenu S, Baraldi PG et al (2006a) Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists. Exp Neurol 202:255\u2013257. \n                    https://doi.org/10.1016/j.expneurol.2006.05.015", "journal-title": "Exp Neurol"}, {"key": "1848_CR125", "doi-asserted-by": "publisher", "first-page": "48", "DOI": "10.1016/j.jns.2006.05.038", "volume": "248", "author": "N Simola", "year": "2006", "unstructured": "Simola N, Fenu S, Baraldi PG et al (2006b) Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson\u2019s disease. J Neurol Sci 248:48\u201352. \n                    https://doi.org/10.1016/j.jns.2006.05.038", "journal-title": "J Neurol Sci"}, {"key": "1848_CR126", "doi-asserted-by": "publisher", "first-page": "1475", "DOI": "10.2174/138161208784480072", "volume": "14", "author": "N Simola", "year": "2008", "unstructured": "Simola N, Morelli M, Pinna A (2008a) Adenosine A2A receptor antagonists and Parkinson\u2019s disease: state of the art and future directions. Curr Pharm Des 14:1475\u20131489. \n                    https://doi.org/10.2174/138161208784480072", "journal-title": "Curr Pharm Des"}, {"key": "1848_CR127", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1002/syn.20504", "volume": "62", "author": "N Simola", "year": "2008", "unstructured": "Simola N, Fenu S, Baraldi PG et al (2008b) Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists. Synapse 62:345\u2013351. \n                    https://doi.org/10.1002/syn.20504", "journal-title": "Synapse"}, {"key": "1848_CR128", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1007/s00213-015-4130-8", "volume": "233", "author": "N Simola", "year": "2016", "unstructured": "Simola N, Costa G, Morelli M (2016) Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation. Psychopharmacology 233:507\u2013519. \n                    https://doi.org/10.1007/s00213-015-4130-8", "journal-title": "Psychopharmacology"}, {"key": "1848_CR129", "doi-asserted-by": "publisher", "first-page": "2233", "DOI": "10.1212/01.wnl.0000313834.22171.17", "volume": "70", "author": "M Stacy", "year": "2008", "unstructured": "Stacy M, Silver D, Mendis T et al (2008) A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology 70:2233\u20132240. \n                    https://doi.org/10.1212/01.wnl.0000313834.22171.17", "journal-title": "Neurology"}, {"key": "1848_CR130", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.3389/fnins.2014.00113", "volume": "8", "author": "S Stayte", "year": "2014", "unstructured": "Stayte S, Vissel B (2014) Advances in non-dopaminergic treatments for Parkinson\u2019s disease. Front Neurosci 8:113. \n                    https://doi.org/10.3389/fnins.2014.00113", "journal-title": "Front Neurosci"}, {"key": "1848_CR131", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1002/(sici)1096-9861(19980921)399:2<229::aid-cne6>3.0.co;2-2", "volume": "399", "author": "P Svenningsson", "year": "1998", "unstructured": "Svenningsson P, Le Moine C, Aubert I, Burbaud P, Fredholm BB, Bloch B (1998) Cellular distribution of adenosine A2A receptor mRNA in the primate striatum. J Comp Neurol 399:229\u2013240. \n                    https://doi.org/10.1002/(sici)1096-9861(19980921)399:2<229::aid-cne6>3.0.co;2-2", "journal-title": "J Comp Neurol"}, {"key": "1848_CR132", "doi-asserted-by": "publisher", "first-page": "963", "DOI": "10.1093/brain/awu409", "volume": "138", "author": "P Svenningsson", "year": "2015", "unstructured": "Svenningsson P, Rosenblad C, Af Edholm Arvidsson K et al (2015) Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson\u2019s disease: a dose-finding study. Brain 138:963\u2013973. \n                    https://doi.org/10.1093/brain/awu409", "journal-title": "Brain"}, {"key": "1848_CR133", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1016/j.ejphar.2007.03.021", "volume": "566", "author": "E Tronci", "year": "2007", "unstructured": "Tronci E, Simola N, Borsini F et al (2007) Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. Eur J Pharmacol 566:94\u2013102. \n                    https://doi.org/10.1016/j.ejphar.2007.03.021", "journal-title": "Eur J Pharmacol"}, {"key": "1848_CR134", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1007/s00213-008-1214-8", "volume": "200", "author": "GB Varty", "year": "2008", "unstructured": "Varty GB, Hodgson RA, Pond AJ et al (2008) The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates. Psychopharmacology 200:393\u2013401. \n                    https://doi.org/10.1007/s00213-008-1214-8", "journal-title": "Psychopharmacology"}, {"key": "1848_CR135", "first-page": "155", "volume": "55", "author": "J Wardas", "year": "2003", "unstructured": "Wardas J (2003) Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and l-DOPA on the reserpine-induced muscle rigidity in rats. Pol J Pharmacol 55:155\u2013164", "journal-title": "Pol J Pharmacol"}, {"key": "1848_CR136", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1002/syn.1070", "volume": "41", "author": "J Wardas", "year": "2001", "unstructured": "Wardas J, Konieczny J, Lorenc-Koci E (2001) SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats. Synapse 41:160\u2013171. \n                    https://doi.org/10.1002/syn.1070", "journal-title": "Synapse"}, {"key": "1848_CR137", "doi-asserted-by": "publisher", "first-page": "13548", "DOI": "10.1523/JNEUROSCI.3554-06.2006", "volume": "26", "author": "D Xiao", "year": "2006", "unstructured": "Xiao D, Bastia E, Xu YH et al (2006) Forebrain adenosine A2A receptors contribute to l-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice. J Neurosci 26:13548\u201313555. \n                    https://doi.org/10.1523/JNEUROSCI.3554-06.2006", "journal-title": "J Neurosci"}, {"key": "1848_CR138", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.neures.2007.05.002", "volume": "59", "author": "H Yamada", "year": "2007", "unstructured": "Yamada H, Aimi Y, Nagatsu I et al (2007) Immunohistochemical detection of l-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats. Neurosci Res 59:1\u20137. \n                    https://doi.org/10.1016/j.neures.2007.05.002", "journal-title": "Neurosci Res"}], "container-title": ["Journal of Neural Transmission"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s00702-018-1848-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00702-018-1848-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00702-018-1848-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 2]], "date-time": "2019-02-02T00:34:59Z", "timestamp": 1549067699000}, "score": 29.357937, "issued": {"date-parts": [[2018, 2, 2]]}, "references-count": 138, "journal-issue": {"published-print": {"date-parts": [[2018, 8]]}, "issue": "8"}, "alternative-id": ["1848"], "URL": "http://dx.doi.org/10.1007/s00702-018-1848-6", "relation": {"cites": []}, "ISSN": ["0300-9564", "1435-1463"], "issn-type": [{"value": "0300-9564", "type": "print"}, {"value": "1435-1463", "type": "electronic"}], "subject": ["Biological Psychiatry", "Neurology", "Psychiatry and Mental health", "Clinical Neurology"], "assertion": [{"value": "7 November 2017", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "26 January 2018", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "2 February 2018", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T18:44:35Z", "timestamp": 1574448275187}, "reference-count": 33, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 10, 1]], "date-time": "2010-10-01T00:00:00Z", "timestamp": 1285891200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Experimental Neurology"], "published-print": {"date-parts": [[2010, 10]]}, "DOI": "10.1016/j.expneurol.2010.07.017", "type": "journal-article", "created": {"date-parts": [[2010, 7, 25]], "date-time": "2010-07-25T08:53:20Z", "timestamp": 1280048000000}, "page": "246-249", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Can dietary substances protect against Parkinson's disease? The case of caffeine"], "prefix": "10.1016", "volume": "225", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": []}, {"given": "Nicola", "family": "Simola", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Experimental Neurology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014488610002554?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014488610002554?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 31]], "date-time": "2019-05-31T16:01:31Z", "timestamp": 1559318491000}, "score": 28.187466, "issued": {"date-parts": [[2010, 10]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2010, 10]]}, "issue": "2"}, "alternative-id": ["S0014488610002554"], "URL": "http://dx.doi.org/10.1016/j.expneurol.2010.07.017", "ISSN": ["0014-4886"], "issn-type": [{"value": "0014-4886", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T16:30:12Z", "timestamp": 1575045012063}, "reference-count": 52, "publisher": "Wiley", "issue": "1-2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 5356, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Dev. Res."], "published-print": {"date-parts": [[2001, 1]]}, "DOI": "10.1002/ddr.1138", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T20:24:15Z", "timestamp": 1030307055000}, "page": "387-393", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Modulation by adenosine A2A receptors of dopamine-mediated motor behavior as a basis for antiparkinson?s disease drugs"], "prefix": "10.1002", "volume": "52", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": []}, {"given": "Annalisa", "family": "Pinna", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2001]]}, "reference": [{"key": "BIB01", "author": "Baraldi", "volume": "39", "first-page": "1164", "year": "1994", "journal-title": "J Med Chem", "DOI": "10.1021/jm950746l", "doi-asserted-by": "crossref"}, {"key": "BIB02", "author": "Barraco", "volume": "31", "first-page": "397", "year": "1993", "journal-title": "Brain Res Bull", "DOI": "10.1016/0361-9230(93)90233-2", "doi-asserted-by": "crossref"}, {"key": "BIB03", "author": "Cenci", "volume": "10", "first-page": "2694", "year": "1998", "journal-title": "Eur J Neurosci", "DOI": "10.1046/j.1460-9568.1998.00285.x", "doi-asserted-by": "crossref"}, {"key": "BIB04", "author": "Chen", "volume": "50", "first-page": "71", "year": "2000", "journal-title": "Drug Dev Res", "DOI": "10.1002/1098-2299(200007/08)50:3/4<258::AID-DDR9>3.0.CO;2-A", "doi-asserted-by": "crossref"}, {"key": "BIB05", "author": "Durcan", "volume": "168", "first-page": "285", "year": "1989", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/0014-2999(89)90789-9", "doi-asserted-by": "crossref"}, {"key": "BIB06", "author": "Fenu", "volume": "10", "first-page": "1878", "year": "1998", "journal-title": "Eur J Neurosci", "DOI": "10.1046/j.1460-9568.1998.00198.x", "doi-asserted-by": "crossref"}, {"key": "BIB07", "author": "Fenu", "volume": "321", "first-page": "143", "year": "1997", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/S0014-2999(96)00944-2", "doi-asserted-by": "crossref"}, {"key": "BIB08", "author": "Ferr\u00e9", "volume": "133", "first-page": "107", "year": "1997", "journal-title": "Psychopharmacology", "DOI": "10.1007/s002130050380", "doi-asserted-by": "crossref"}, {"key": "BIB09", "author": "Ferr\u00e9", "volume": "88", "first-page": "7238", "year": "1991", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.88.16.7238", "doi-asserted-by": "crossref"}, {"key": "BIB10", "author": "Ferr\u00e9", "volume": "20", "first-page": "482", "year": "1997", "journal-title": "Trends Neurosci", "DOI": "10.1016/S0166-2236(97)01096-5", "doi-asserted-by": "crossref"}, {"key": "BIB11", "author": "Fink", "volume": "14", "first-page": "186", "year": "1992", "journal-title": "Mol Brain Res", "DOI": "10.1016/0169-328X(92)90173-9", "doi-asserted-by": "crossref"}, {"key": "BIB12", "author": "Fredholm", "first-page": "48", "year": "1998", "unstructured": "1998. Adenosine receptors. In: The IUPHAR compendium of receptor characterization and classification. London: IUPHAR Media. p 48-57.", "volume-title": "Adenosine receptors. In: The IUPHAR compendium of receptor characterization and classification"}, {"key": "BIB13", "author": "Fredholm", "volume": "51", "first-page": "83", "year": "1999", "journal-title": "Pharmacol Rev"}, {"key": "BIB14", "author": "Fuxe", "volume": "52", "first-page": "48", "year": "1974", "journal-title": "Med Biol"}, {"key": "BIB15", "author": "Garrett", "volume": "57", "first-page": "533", "year": "1997", "journal-title": "Pharmacol Biochem Behav", "DOI": "10.1016/S0091-3057(96)00435-2", "doi-asserted-by": "crossref"}, {"key": "BIB16", "author": "Garrett", "volume": "47", "first-page": "89", "year": "1994", "journal-title": "Pharmacol Biochem Behav", "DOI": "10.1016/0091-3057(94)90115-5", "doi-asserted-by": "crossref"}, {"key": "BIB17", "author": "Gerfen", "volume": "250", "first-page": "1429", "year": "1990", "journal-title": "Science", "DOI": "10.1126/science.2147780", "doi-asserted-by": "crossref"}, {"key": "BIB18", "author": "Griebel", "volume": "103", "first-page": "541", "year": "1991", "journal-title": "Psychopharmacology", "DOI": "10.1007/BF02244256", "doi-asserted-by": "crossref"}, {"key": "BIB19", "author": "Grondin", "volume": "52", "first-page": "1673", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.52.8.1673", "doi-asserted-by": "crossref"}, {"key": "BIB20", "author": "Hauber", "volume": "8", "first-page": "1515", "year": "1997", "journal-title": "NeuroReport", "DOI": "10.1097/00001756-199704140-00038", "doi-asserted-by": "crossref"}, {"key": "BIB21", "author": "Henry", "volume": "151", "first-page": "334", "year": "1998", "journal-title": "Exp Neurol", "DOI": "10.1006/exnr.1998.6819", "doi-asserted-by": "crossref"}, {"key": "BIB22", "author": "Henry", "volume": "155", "first-page": "204", "year": "1999", "journal-title": "Exp Neurol", "DOI": "10.1006/exnr.1998.6996", "doi-asserted-by": "crossref"}, {"key": "BIB23", "author": "Herrera-Marschitz", "volume": "94", "first-page": "38", "year": "1988", "journal-title": "Psychopharmacology", "DOI": "10.1007/BF00735878", "doi-asserted-by": "crossref"}, {"key": "BIB24", "author": "Holtzman", "volume": "49", "first-page": "1563", "year": "1991", "journal-title": "Life Sci", "DOI": "10.1016/0024-3205(91)90329-A", "doi-asserted-by": "crossref"}, {"key": "BIB25", "author": "Jarvis", "volume": "168", "first-page": "243", "year": "1989", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/0014-2999(89)90571-2", "doi-asserted-by": "crossref"}, {"key": "BIB26", "author": "Jiang", "volume": "613", "first-page": "347", "year": "1993", "journal-title": "Brain Res", "DOI": "10.1016/0006-8993(93)90925-D", "doi-asserted-by": "crossref"}, {"key": "BIB27", "author": "Josselyn", "volume": "39", "first-page": "97", "year": "1991", "journal-title": "Pharmacol Biochem Behav", "DOI": "10.1016/0091-3057(91)90403-O", "doi-asserted-by": "crossref"}, {"key": "BIB28", "author": "Kanda", "volume": "43", "first-page": "507", "year": "1998", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410430415", "doi-asserted-by": "crossref"}, {"key": "BIB29", "author": "Kartzinel", "volume": "26", "first-page": "741", "year": "1976", "journal-title": "Neurology", "DOI": "10.1212/WNL.26.8.741", "doi-asserted-by": "crossref"}, {"key": "BIB30", "author": "Kopin", "volume": "32", "first-page": "467", "year": "1993", "journal-title": "Annu Rev Pharmacol Toxicol", "DOI": "10.1146/annurev.pa.33.040193.002343", "doi-asserted-by": "crossref"}, {"key": "BIB31", "author": "Le Moine", "volume": "17", "first-page": "8038", "year": "1997", "journal-title": "J Neurosci"}, {"key": "BIB32", "author": "Mally", "volume": "72", "first-page": "243", "year": "1996", "journal-title": "Pharmacol Ther", "DOI": "10.1016/S0163-7258(96)00119-2", "doi-asserted-by": "crossref"}, {"key": "BIB33", "author": "Monopoli", "volume": "9", "first-page": "3955", "year": "1998", "journal-title": "Neuroreport", "DOI": "10.1097/00001756-199812010-00034", "doi-asserted-by": "crossref"}, {"key": "BIB34", "author": "Morelli", "volume": "45", "first-page": "373", "year": "1998", "journal-title": "Drug Dev Res", "DOI": "10.1002/(SICI)1098-2299(199811/12)45:3/4<373::AID-DDR37>3.0.CO;2-6", "doi-asserted-by": "crossref"}, {"key": "BIB35", "author": "Morelli", "volume": "251", "first-page": "21", "year": "1994", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/0014-2999(94)90438-3", "doi-asserted-by": "crossref"}, {"key": "BIB36", "author": "Morelli", "volume": "67", "first-page": "48", "year": "1995", "journal-title": "Neuroscience", "DOI": "10.1016/0306-4522(94)00602-2", "doi-asserted-by": "crossref"}, {"key": "BIB37", "author": "Morissette", "volume": "49", "first-page": "55", "year": "1997", "journal-title": "Mol Brain Res", "DOI": "10.1016/S0169-328X(97)00123-X", "doi-asserted-by": "crossref"}, {"key": "BIB38", "author": "Olah", "volume": "35", "first-page": "581", "year": "1995", "journal-title": "Annu Rev Pharmacol Toxicol", "DOI": "10.1146/annurev.pa.35.040195.003053", "doi-asserted-by": "crossref"}, {"key": "BIB39", "author": "Ongini", "volume": "39", "first-page": "450", "year": "1996", "journal-title": "Drug Dev Res", "DOI": "10.1002/(SICI)1098-2299(199611/12)39:3/4<450::AID-DDR27>3.0.CO;2-3", "doi-asserted-by": "crossref"}, {"key": "BIB40", "author": "Papa", "volume": "662", "first-page": "69", "year": "1994", "journal-title": "Brain Res", "DOI": "10.1016/0006-8993(94)90796-X", "doi-asserted-by": "crossref"}, {"key": "BIB41", "author": "Phillis", "volume": "705", "first-page": "79", "year": "1995", "journal-title": "Brain Res", "DOI": "10.1016/0006-8993(95)01153-6", "doi-asserted-by": "crossref"}, {"key": "BIB42", "author": "Pinna", "volume": "8", "first-page": "1176", "year": "1996", "journal-title": "Eur J Neurosci", "DOI": "10.1111/j.1460-9568.1996.tb01285.x", "doi-asserted-by": "crossref"}, {"key": "BIB43", "author": "Popoli", "volume": "257", "first-page": "21", "year": "1994", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/0014-2999(94)90689-0", "doi-asserted-by": "crossref"}, {"key": "BIB44", "author": "Richardson", "volume": "18", "first-page": "338", "year": "1997", "journal-title": "Trends Pharmacol Sci", "DOI": "10.1016/S0165-6147(97)90660-X", "doi-asserted-by": "crossref"}, {"key": "BIB45", "author": "Rimondini", "volume": "17", "first-page": "81", "year": "1997", "journal-title": "Neuropsychopharmacology", "DOI": "10.1016/S0893-133X(97)00033-X", "doi-asserted-by": "crossref"}, {"key": "BIB46", "author": "Schenk", "volume": "5", "first-page": "153", "year": "1994", "journal-title": "Behav Pharmacol", "DOI": "10.1097/00008877-199404000-00006", "doi-asserted-by": "crossref"}, {"key": "BIB47", "author": "Schiffmann", "volume": "57", "first-page": "1062", "year": "1991", "journal-title": "J Neurochem", "DOI": "10.1111/j.1471-4159.1991.tb08257.x", "doi-asserted-by": "crossref"}, {"key": "BIB48", "author": "Schwarting", "volume": "49", "first-page": "215", "year": "1996", "journal-title": "Prog Neurobiol", "DOI": "10.1016/S0301-0082(96)00015-9", "doi-asserted-by": "crossref"}, {"key": "BIB49", "author": "Shoulson", "volume": "25", "first-page": "722", "year": "1975", "journal-title": "Neurology", "DOI": "10.1212/WNL.25.8.722", "doi-asserted-by": "crossref"}, {"key": "BIB50", "author": "Svenningsson", "volume": "79", "first-page": "753", "year": "1997", "journal-title": "Neuroscience", "DOI": "10.1016/S0306-4522(97)00046-8", "doi-asserted-by": "crossref"}, {"key": "BIB51", "author": "Svenningsson", "volume": "19", "first-page": "4011", "year": "1999", "journal-title": "J Neurosci"}, {"key": "BIB52", "author": "Vellucci", "volume": "111", "first-page": "383", "year": "1993", "journal-title": "Psychopharmacology", "DOI": "10.1007/BF02244956", "doi-asserted-by": "crossref"}], "container-title": ["Drug Development Research"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fddr.1138", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ddr.1138", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T02:53:56Z", "timestamp": 1533178436000}, "score": 27.535904, "issued": {"date-parts": [[2001, 1]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2001, 1]]}, "issue": "1-2"}, "URL": "http://dx.doi.org/10.1002/ddr.1138", "relation": {"cites": []}, "ISSN": ["0272-4391", "1098-2299"], "issn-type": [{"value": "0272-4391", "type": "print"}, {"value": "1098-2299", "type": "electronic"}], "subject": ["Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:41:43Z", "timestamp": 1574145703879}, "reference-count": 3, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1990, 7, 1]], "date-time": "1990-07-01T00:00:00Z", "timestamp": 646790400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[1990, 7]]}, "DOI": "10.1016/0014-2999(90)90066-f", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T06:32:49Z", "timestamp": 1039847569000}, "page": "611-612", "source": "Crossref", "is-referenced-by-count": 87, "title": ["MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease"], "prefix": "10.1016", "volume": "182", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": []}, {"given": "Gaetano", "family": "Di Chiara", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:001429999090066F?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:001429999090066F?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T17:53:03Z", "timestamp": 1554141183000}, "score": 25.793686, "issued": {"date-parts": [[1990, 7]]}, "references-count": 3, "journal-issue": {"published-print": {"date-parts": [[1990, 7]]}, "issue": "3"}, "alternative-id": ["001429999090066F"], "URL": "http://dx.doi.org/10.1016/0014-2999(90)90066-f", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:37:00Z", "timestamp": 1574314620251}, "publisher-location": "Berlin, Heidelberg", "reference-count": 143, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783540896142", "type": "print"}, {"value": "9783540896159", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-3-540-89615-9_18", "type": "book-chapter", "created": {"date-parts": [[2009, 7, 28]], "date-time": "2009-07-28T09:20:49Z", "timestamp": 1248772849000}, "page": "589-615", "source": "Crossref", "is-referenced-by-count": 70, "title": ["Adenosine A2A Receptors and Parkinson\u2019s Disease"], "prefix": "10.1007", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": []}, {"given": "Anna R.", "family": "Carta", "sequence": "additional", "affiliation": []}, {"given": "Peter", "family": "Jenner", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 5, 28]]}, "reference": [{"key": "18_CR1_18", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1016/S0893-133X(02)00290-7", "volume": "27", "author": "E Acquas", "year": "2002", "unstructured": "Acquas E, Tanda G, Di Chiara G (2002) Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology 27:182\u2013193", "journal-title": "Neuropsychopharmacology"}, {"key": "18_CR2_18", "doi-asserted-by": "crossref", "first-page": "1321", "DOI": "10.1016/0140-6736(91)92989-F", "volume": "337", "author": "Y Agid", "year": "1991", "unstructured": "Agid Y (1991) Parkinson\u2019s disease: pathophysiology. Lancet 337:1321\u20131324", "journal-title": "Lancet"}, {"key": "18_CR3_18", "doi-asserted-by": "crossref", "first-page": "1476", "DOI": "10.1212/01.wnl.0000277645.60799.0e", "volume": "69", "author": "JE Ahlskog", "year": "2007", "unstructured": "Ahlskog JE (2007) I can\u2019t get no satisfaction: still no neuroprotection for Parkinson disease. Neurology 69:1476\u20131477", "journal-title": "Neurology"}, {"key": "18_CR4_18", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1001/archneur.1994.00540160053008", "volume": "51", "author": "I Appollonio", "year": "1994", "unstructured": "Appollonio I, Grafman J, Clark K, Nichelli P, Zeffiro T, Hallett M (1994) Implicit and explicit memory in patients with Parkinson\u2019s disease with and without dementia. Arch Neurol 51:359\u2013367", "journal-title": "Arch Neurol"}, {"key": "18_CR5_18", "doi-asserted-by": "crossref", "first-page": "56", "DOI": "10.1002/ana.1052", "volume": "50", "author": "A Ascherio", "year": "2001", "unstructured": "Ascherio A, Zhang SM, Hern\u00e1n MA, Kawachi I, Colditz GA, Speizer FE, Willett WC (2001) Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363", "journal-title": "Ann Neurol"}, {"key": "18_CR6_18", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1212/01.WNL.0000073136.00548.D4", "volume": "61", "author": "W Bara-Jimenez", "year": "2003", "unstructured": "Bara-Jimenez W, Sherzai A, Dimitrova T, Favit A, Bibbiani F, Gillespie M, Morris MJ, Mouradian MM, Chase TN (2003) Adenosine A(2A) receptor antagonist treatment of Parkinson\u2019s disease. Neurology 61:293\u2013296", "journal-title": "Neurology"}, {"key": "18_CR7_18", "doi-asserted-by": "crossref", "first-page": "1438", "DOI": "10.1212/01.wnl.0000303818.38960.44", "volume": "70", "author": "C Becker", "year": "2008", "unstructured": "Becker C, Jick SS, Meier CR (2008) Use of antihypertensives and the risk of Parkinson disease. Neurology 70:1438\u20131444", "journal-title": "Neurology"}, {"key": "18_CR8_18", "first-page": "123", "volume": "Suppl", "author": "D Berg", "year": "2006", "unstructured": "Berg D (2006) Marker for a preclinical diagnosis of Parkinson\u2019s disease as a basis for neuroprotection. J Neural Transm Suppl:123\u2013132", "journal-title": "J Neural Transm"}, {"key": "18_CR9_18", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1016/S0014-4886(03)00250-4", "volume": "184", "author": "F Bibbiani", "year": "2003", "unstructured": "Bibbiani F, Oh JD, Petzer JP, Castagnoli N Jr, Chen JF, Schwarzschild MA (2003) A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson\u2019s disease. Exp Neurol 184:285\u2013294", "journal-title": "Exp Neurol"}, {"key": "18_CR10_18", "doi-asserted-by": "crossref", "first-page": "546", "DOI": "10.1093/brain/124.3.546", "volume": "124", "author": "T Boraud", "year": "2001", "unstructured": "Boraud T, Bezard E, Bioulac B, Gross CE (2001) Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain 124:546\u2013557", "journal-title": "Brain"}, {"key": "18_CR11_18", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1159/000108110", "volume": "28", "author": "M Bornebroek", "year": "2007", "unstructured": "Bornebroek M, de Lau LM, Haag MD, Koudstaal PJ, Hofman A, Stricker BH, Breteler MM (2007) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Neuroepidemiology 28:193\u2013196", "journal-title": "Neuroepidemiology"}, {"key": "18_CR12_18", "doi-asserted-by": "crossref", "first-page": "2042", "DOI": "10.1002/mds.21065", "volume": "21", "author": "H Braak", "year": "2006", "unstructured": "Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del TK (2006a) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21:2042\u20132051", "journal-title": "Mov Disord"}, {"key": "18_CR13_18", "unstructured": "Braak H, Muller CM, Rub U, Ackermann H, Bratzke H, de Vos RA, Del TK (2006b) Pathology associated with sporadic Parkinson\u2019s disease: where does it end? J Neural Transm Suppl 89\u201397", "DOI": "10.1007/978-3-211-45295-0_15", "doi-asserted-by": "crossref"}, {"key": "18_CR14_18", "doi-asserted-by": "crossref", "first-page": "1916", "DOI": "10.1212/01.wnl.0000312279.49272.9f", "volume": "70", "author": "H Braak", "year": "2008", "unstructured": "Braak H, Del TK (2008) Invited article: Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925", "journal-title": "Neurology"}, {"key": "18_CR15_18", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1002/syn.20539", "volume": "62", "author": "DJ Brooks", "year": "2008", "unstructured": "Brooks DJ, Doder M, Osman S, Luthra SK, Gunn R, Hirani E, Hume S, Kase H, Kilborn J, Martindill S, Mori A (2008) Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain. Synapse 62:671\u2013681", "journal-title": "Synapse"}, {"key": "18_CR16_18", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1016/S1474-4422(06)70600-7", "volume": "5", "author": "P Calabresi", "year": "2006", "unstructured": "Calabresi P, Picconi B, Parnetti L, Di FM (2006) A convergent model for cognitive dysfunctions in Parkinson\u2019s disease: the critical dopamine\u2013acetylcholine synaptic balance. Lancet Neurol 5:974\u2013983", "journal-title": "Lancet Neurol"}, {"key": "18_CR17_18", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/j.tins.2007.03.001", "volume": "30", "author": "P Calabresi", "year": "2007", "unstructured": "Calabresi P, Picconi B, Tozzi A, Di FM (2007) Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30:211\u2013219", "journal-title": "Trends Neurosci"}, {"key": "18_CR18_18", "doi-asserted-by": "crossref", "first-page": "166", "DOI": "10.1002/syn.10066", "volume": "44", "author": "AR Carta", "year": "2002", "unstructured": "Carta AR, Pinna A, Cauli O, Morelli M (2002) Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats. Synapse 44:166\u2013174", "journal-title": "Synapse"}, {"key": "18_CR19_18", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1016/S0014-4886(03)00292-9", "volume": "184", "author": "AR Carta", "year": "2003", "unstructured": "Carta AR, Tabrizi MA, Baraldi PG, Pinna A, Pala P, Morelli M (2003) Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata. Exp Neurol 184:679\u201387", "journal-title": "Exp Neurol"}, {"key": "18_CR20_18", "doi-asserted-by": "crossref", "first-page": "2694", "DOI": "10.1046/j.1460-9568.1998.00285.x", "volume": "10", "author": "MA Cenci", "year": "1998", "unstructured": "Cenci MA, Lee CS, Bjorklund A (1998) L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10:2694\u2013706", "journal-title": "Eur J Neurosci"}, {"key": "18_CR21_18", "doi-asserted-by": "crossref", "first-page": "S107", "DOI": "10.1212/01.WNL.0000095223.08711.48", "volume": "61", "author": "TN Chase", "year": "2003", "unstructured": "Chase TN, Bibbiani F, Bara-Jimenez W, Dimitrova T, Oh-Lee JD (2003) Translating A2A antagonist KW6002 from animal models to parkinsonian patients. Neurology 61:S107\u201311", "journal-title": "Neurology"}, {"key": "18_CR22_18", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1007/s11910-005-0072-6", "volume": "5", "author": "KR Chaudhuri", "year": "2005", "unstructured": "Chaudhuri KR, Yates L, Martinez-Martin P (2005) The non-motor symptom complex of Parkinson\u2019s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5:275\u2013283", "journal-title": "Curr Neurol Neurosci Rep"}, {"key": "18_CR23_18", "doi-asserted-by": "crossref", "first-page": "RC143", "DOI": "10.1523/JNEUROSCI.21-10-j0001.2001", "volume": "21", "author": "JF Chen", "year": "2001", "unstructured": "Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N Jr, Schwarzschild MA (2001) Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease. J Neurosci 21:RC143", "journal-title": "J Neurosci"}, {"key": "18_CR24_18", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.1016/j.pneurobio.2007.09.002", "volume": "83", "author": "JF Chen", "year": "2007", "unstructured": "Chen JF, Sonsalla PK, Pedata F, Melani A, Domenici MR, Popoli P, Geiger J, Lopes LV, de Mendon\u00e7a A (2007) Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and fine tuning modulation. Prog Neurobiol 83:310\u2013331", "journal-title": "Prog Neurobiol"}, {"key": "18_CR25_18", "doi-asserted-by": "crossref", "first-page": "1451", "DOI": "10.1038/sj.npp.1300444", "volume": "29", "author": "R Coccurello", "year": "2004", "unstructured": "Coccurello R, Breysse N, Amalric M (2004) Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology 29:1451\u201361", "journal-title": "Neuropsychopharmacology"}, {"key": "18_CR26_18", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/S0166-4328(03)00178-5", "volume": "148", "author": "M Correa", "year": "2004", "unstructured": "Correa M, Wisniecki A, Betz A, Dobson DR, O\u2019Neil MF, O\u2019Neil MJ, Salamone JD (2004) The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. Behav Brain Res 148:47\u201354", "journal-title": "Behav Brain Res"}, {"key": "18_CR27_18", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S0197-0186(00)00034-6", "volume": "38", "author": "RA Cunha", "year": "2001", "unstructured": "Cunha RA (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38:107\u2013125", "journal-title": "Neurochem Int"}, {"key": "18_CR28_18", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1212/01.wnl.0000247740.47667.03", "volume": "68", "author": "ER Dorsey", "year": "2007", "unstructured": "Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386", "journal-title": "Neurology"}, {"key": "18_CR29_18", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/j.expneurol.2007.02.008", "volume": "205", "author": "E Esposito", "year": "2007", "unstructured": "Esposito E, Di MV, Benigno A, Pierucci M, Crescimanno G, Di GG (2007) Non-steroidal anti-inflammatory drugs in Parkinson\u2019s disease. Exp Neurol 205:295\u2013312", "journal-title": "Exp Neurol"}, {"key": "18_CR30_18", "doi-asserted-by": "crossref", "first-page": "1379", "DOI": "10.1002/mds.21475", "volume": "22", "author": "G Fabbrini", "year": "2007", "unstructured": "Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG (2007) Levodopa-induced dyskinesias. Mov Disord 22:1379\u20131389", "journal-title": "Mov Disord"}, {"key": "18_CR31_18", "author": "S Fahn", "first-page": "1", "year": "2007", "unstructured": "Fahn S, Jankovic J (2007) Principles and practice of movement disorders. Elsevier, Philadelphia, pp 1\u2013652", "volume-title": "Principles and practice of movement disorders"}, {"issue": "Suppl 1", "key": "18_CR32_18", "first-page": "S87", "volume": "23", "author": "HH Fernandez", "year": "2008", "unstructured": "Fernandez HH, 6002-US-051 Clinical Investigator Group (2008) The safety and efficacy of istradephylline, an adenosine A2A antagonist, as monotherapy in Parkinson\u2019s Disease: results of the KW-6002-US-051 trial. Presented at the 12th International Congress of Parkinson\u2019s Disease and Movement Disorders, Chicago. Mov Disord 23(Suppl 1):S87", "journal-title": "Mov Disord"}, {"key": "18_CR33_18", "doi-asserted-by": "crossref", "first-page": "11940", "DOI": "10.1073/pnas.172393799", "volume": "99", "author": "S Ferr\u00e9", "year": "2002", "unstructured": "Ferr\u00e9 S, Karcz-Kubicha M, Hope BT, Popoli P, Burgue\u00f1o J, Guti\u00e9rrez MA, Casad\u00f3 V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA 99:11940\u201311945", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "18_CR34_18", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1016/0169-328X(92)90173-9", "volume": "14", "author": "JS Fink", "year": "1992", "unstructured": "Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, Reppert SM (1992) Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 14:186\u2013195", "journal-title": "Brain Res Mol Brain Res"}, {"key": "18_CR35_18", "doi-asserted-by": "crossref", "first-page": "1054", "DOI": "10.1523/JNEUROSCI.22-03-01054.2002", "volume": "22", "author": "S Fredduzzi", "year": "2002", "unstructured": "Fredduzzi S, Moratalla R, Monopoli A, Cuellar B, Xu K, Ongini E (2002) Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. J Neurosci 22:1054\u20131062", "journal-title": "J Neurosci"}, {"key": "18_CR36_18", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1111/j.1600-0773.1995.tb00135.x", "volume": "76", "author": "BB Fredholm", "year": "1995", "unstructured": "Fredholm BB (1995) Purinoceptors in the nervous system. Pharmacol Toxicol 76:228\u2013239", "journal-title": "Pharmacol Toxicol"}, {"key": "18_CR37_18", "first-page": "143", "volume": "46", "author": "BB Fredholm", "year": "1994", "unstructured": "Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143\u2013156", "journal-title": "Pharmacol Rev"}, {"key": "18_CR38_18", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1385/JMN:26:2-3:209", "volume": "26", "author": "K Fuxe", "year": "2005", "unstructured": "Fuxe K, Ferr\u00e9 S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg SR, Staines W, Jacobsen KX, Lluis C, Woods AS, Agnati LF, Franco R (2005) Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci 26:209\u2013220", "journal-title": "J Mol Neurosci"}, {"key": "18_CR39_18", "doi-asserted-by": "crossref", "first-page": "1990", "DOI": "10.1002/mds.21440", "volume": "22", "author": "K Fuxe", "year": "2007", "unstructured": "Fuxe K, Marcellino D, Genedani S, Agnati L (2007) Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson\u2019s disease. Mov Disord 22:1990\u20131917", "journal-title": "Mov Disord"}, {"key": "18_CR40_18", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1007/s007020170085", "volume": "108", "author": "A Galvan", "year": "2001", "unstructured": "Galvan A, Floran B, Erlij D, Aceves J (2001) Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. J Neural Transm 108:153\u2013166", "journal-title": "J Neural Transm"}, {"key": "18_CR41_18", "doi-asserted-by": "crossref", "first-page": "2836", "DOI": "10.1073/pnas.262796399", "volume": "100", "author": "WJ Gao", "year": "2003", "unstructured": "Gao WJ, Goldman-Rakic PS (2003) Selective modulation of excitatory and inhibitory microcircuits by dopamine. Proc Natl Acad Sci USA 100:2836\u20132841", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "Suppl 17", "key": "18_CR42_18", "doi-asserted-by": "crossref", "first-page": "S343", "DOI": "10.1002/mds.21676", "volume": "22", "author": "T Gasser", "year": "2007", "unstructured": "Gasser T (2007) Update on the genetics of Parkinson\u2019s disease. Mov Disord 22(Suppl 17):S343\u2013S350", "journal-title": "Mov Disord"}, {"key": "18_CR43_18", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/0166-2236(92)90355-C", "volume": "15", "author": "CR Gerfen", "year": "1992", "unstructured": "Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133\u2013139", "journal-title": "Trends Neurosci"}, {"key": "18_CR44_18", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1016/j.nlm.2006.05.004", "volume": "87", "author": "L Gim\u00e9nez-Llort", "year": "2007", "unstructured": "Gim\u00e9nez-Llort L, Schiffmann SN, Shmidt T, Canela L, Cam\u00f3n L, Wassholm M, Canals M, Terasmaa A, Fern\u00e1ndez-Teruel A, Tobe\u00f1a A, Popova E, Ferr\u00e9 S, Agnati L, Ciruela F, Mart\u00ednez E, Scheel-Kruger J, Lluis C, Franco R, Fuxe K, Bader M (2007) Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain. Neurobiol Learn Mem 87:42\u201356", "journal-title": "Neurobiol Learn Mem"}, {"key": "18_CR45_18", "doi-asserted-by": "crossref", "first-page": "1673", "DOI": "10.1212/WNL.52.8.1673", "volume": "52", "author": "R Grondin", "year": "1999", "unstructured": "Grondin R, Bedard PJ, Hadj Tahar A, Gregoire L, Mori A, Kase H (1999) Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 52:1673\u20131677", "journal-title": "Neurology"}, {"key": "18_CR46_18", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1227/01.neu.0000315998.58022.55", "volume": "62", "author": "J Guridi", "year": "2008", "unstructured": "Guridi J, Obeso JA, Rodriguez-Oroz MC, Lozano AA, Manrique M (2008) L-Dopa-induced dyskinesia and stereotactic surgery for Parkinson\u2019s disease. Neurosurgery 62:311\u201323", "journal-title": "Neurosurgery"}, {"issue": "Suppl. 15", "key": "18_CR47_18", "first-page": "S585", "volume": "21", "author": "M Guttman", "year": "2006", "unstructured": "Guttman M, 6002-US-018 Clinical Investigator Group (2006) Efficacy of istradephylline in Parkinson\u2019s disease patients treated with levodopa with motor response complications: results of the KW-6002-US-018 study. Presented at the 10th International Congress of Parkinson\u2019s Disease and Movement Disorders, Kyoto. Mov Disord 21(Suppl. 15):S585", "journal-title": "Mov Disord"}, {"key": "18_CR48_18", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/S0014-2999(00)00682-8", "volume": "406", "author": "L Halldner", "year": "2000", "unstructured": "Halldner L, Lozza G, Lindstr\u00f6m K, Fredholm BB (2000) Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist. Eur J Pharmacol 406:345\u2013354", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR49_18", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1002/ana.21022", "volume": "60", "author": "J Hardy", "year": "2006", "unstructured": "Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A (2006) Genetics of Parkinson\u2019s disease and parkinsonism. Ann Neurol 60:389\u2013398", "journal-title": "Ann Neurol"}, {"key": "18_CR50_18", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1016/S0301-0082(98)00041-0", "volume": "56", "author": "W Hauber", "year": "1998", "unstructured": "Hauber W (1998) Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 56:507\u2013540", "journal-title": "Prog Neurobiol"}, {"key": "18_CR51_18", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/S0166-4328(99)00102-3", "volume": "106", "author": "W Hauber", "year": "1999", "unstructured": "Hauber W, Lutz S (1999) Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav Brain Res 106:143\u2013150", "journal-title": "Behav Brain Res"}, {"key": "18_CR52_18", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1046/j.0953-816x.2001.01759.x", "volume": "14", "author": "W Hauber", "year": "2001", "unstructured": "Hauber W, Neuscheler P, Nagel J, Muller CE (2001) Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur J Neurosci 14:1287\u201393", "journal-title": "Eur J Neurosci"}, {"key": "18_CR53_18", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1212/01.WNL.0000081227.84197.0B", "volume": "61", "author": "RA Hauser", "year": "2003", "unstructured": "Hauser RA, Hubble JP, Truong DD (2003) Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD. Neurology 61:297\u2013303", "journal-title": "Neurology"}, {"key": "18_CR54_18", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.2165/00002512-200522060-00002", "volume": "22", "author": "RA Hauser", "year": "2005", "unstructured": "Hauser RA, Schwarzschild MA (2005). Adenosine A2A receptor antagonists for Parkinson\u2019s disease: rationale, therapeutic potential and clinical experience. Drugs Aging 22:471\u2013482", "journal-title": "Drugs Aging"}, {"issue": "Suppl 15", "key": "18_CR55_18", "first-page": "S510", "volume": "21", "author": "R Hauser", "year": "2006", "unstructured": "Hauser R, 6002-US-013 Clinical Investigator Group (2006) Effects of istradephylline (KW-6002) in levodopa treated Parkinson\u2019s disease patients with motor response complications: secondary efficacy results of the KW-6002-US-013 study. Presented at the 10th International Congress of Parkinson\u2019s Disease and Movement Disorders, Kyoto. Mov Disord 21(Suppl 15):S510", "journal-title": "Mov Disord"}, {"key": "18_CR56_18", "doi-asserted-by": "crossref", "first-page": "2177", "DOI": "10.1002/mds.22095", "volume": "23", "author": "RA Hauser", "year": "2008", "unstructured": "Hauser RA, Shulman LM, Trugman JM, Roberts J, Mori A, Ballerini R, Sussman NM (2008) Study of istradefylline in patients with Parkinson\u2019s disease on levodopa with motor fluctuations. Mov Disord 23:2177\u20132185", "journal-title": "Mov Disord"}, {"key": "18_CR57_18", "doi-asserted-by": "crossref", "first-page": "18091", "DOI": "10.1074/jbc.M107731200", "volume": "277", "author": "J Hillion", "year": "2002", "unstructured": "Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, Franco R, Ferre S, Fuxe K (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277:18091\u201318097", "journal-title": "J Biol Chem"}, {"key": "18_CR58_18", "doi-asserted-by": "crossref", "first-page": "1170", "DOI": "10.1111/j.1468-1331.2006.01547.x", "volume": "13", "author": "M Horstink", "year": "2006", "unstructured": "Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C (2006a) Review of the therapeutic management of Parkinson\u2019s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society\u2013European Section. Part I: early (uncomplicated) Parkinson\u2019s disease. Eur J Neurol 13:1170\u20131185", "journal-title": "Eur J Neurol"}, {"key": "18_CR59_18", "doi-asserted-by": "crossref", "first-page": "1186", "DOI": "10.1111/j.1468-1331.2006.01548.x", "volume": "13", "author": "M Horstink", "year": "2006", "unstructured": "Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C (2006b) Review of the therapeutic management of Parkinson\u2019s disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society\u2013European Section (MDS-ES). Part II: late (complicated) Parkinson\u2019s disease. Eur J Neurol 13:1186\u20131202", "journal-title": "Eur J Neurol"}, {"key": "18_CR60_18", "doi-asserted-by": "crossref", "first-page": "2242", "DOI": "10.1002/mds.21706", "volume": "22", "author": "G Hu", "year": "2007", "unstructured": "Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J (2007) Coffee and tea consumption and the risk of Parkinson\u2019s disease. Mov Disord 22:2242\u20132248", "journal-title": "Mov Disord"}, {"key": "18_CR61_18", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1097/WCO.0b013e32826388d6", "volume": "20", "author": "AY Hung", "year": "2007", "unstructured": "Hung AY, Schwarzschild MA (2007) Clinical trials for neuroprotection in Parkinson\u2019s disease: overcoming angst and futility? Curr Opin Neurol 20:477\u2013483", "journal-title": "Curr Opin Neurol"}, {"key": "18_CR62_18", "doi-asserted-by": "crossref", "first-page": "262", "DOI": "10.1046/j.0022-3042.2001.00694.x", "volume": "80", "author": "K Ikeda", "year": "2002", "unstructured": "Ikeda K, Kurokawa M, Aoyama S, Kuwana Y (2002) Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson\u2019s disease. J Neurochem 80:262\u2013270", "journal-title": "J Neurochem"}, {"issue": "Suppl 11", "key": "18_CR63_18", "doi-asserted-by": "crossref", "first-page": "S11", "DOI": "10.1002/mds.20458", "volume": "20", "author": "J Jankovic", "year": "2005", "unstructured": "Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson\u2019s disease: clinical manifestations. Mov Disord 20(Suppl 11):S11\u2013S16", "journal-title": "Mov Disord"}, {"key": "18_CR64_18", "first-page": "682", "volume": "73", "author": "J Jankovic", "year": "2006", "unstructured": "Jankovic J (2006) An update on the treatment of Parkinson\u2019s disease. Mt Sinai J Med 73:682\u2013689", "journal-title": "Mt Sinai J Med"}, {"key": "18_CR65_18", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.2165/00023210-200721080-00005", "volume": "21", "author": "J Jankovic", "year": "2007", "unstructured": "Jankovic J, Stacy M (2007) Medical management of levodopa-associated motor complications in patients with Parkinson\u2019s disease. CNS Drugs 21:677\u2013692", "journal-title": "CNS Drugs"}, {"key": "18_CR66_18", "unstructured": "Jellinger KA (2002) Recent developments in the pathology of Parkinson\u2019s disease. J Neural Transm Suppl 347\u2013376", "DOI": "10.1007/978-3-7091-6139-5_33", "doi-asserted-by": "crossref"}, {"key": "18_CR67_18", "doi-asserted-by": "crossref", "first-page": "S32", "DOI": "10.1212/01.WNL.0000095209.59347.79", "volume": "61", "author": "P Jenner", "year": "2003", "unstructured": "Jenner P (2003) A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD. Neurology 61:S32\u2013S38", "journal-title": "Neurology"}, {"key": "18_CR68_18", "doi-asserted-by": "crossref", "first-page": "S24", "DOI": "10.1212/WNL.66.10_suppl_4.S24", "volume": "66", "author": "P Jenner", "year": "2006", "unstructured": "Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson\u2019s disease. Neurology 66:S24\u2013S36", "journal-title": "Neurology"}, {"key": "18_CR69_18", "doi-asserted-by": "crossref", "first-page": "10414", "DOI": "10.1523/JNEUROSCI.3660-05.2005", "volume": "25", "author": "A Kachroo", "year": "2005", "unstructured": "Kachroo A, Orlando LR, Grandy DK, Chen JF, Young AB, Schwarzschild MA (2005) Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci 25:10414\u201319", "journal-title": "J Neurosci"}, {"key": "18_CR70_18", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/0014-2999(94)90551-7", "volume": "256", "author": "T Kanda", "year": "1994", "unstructured": "Kanda T, Shiozaki S, Shimada J, Suzuki F, Nakamura J (1994) KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. Eur J Pharmacol 256:263\u2013268", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR71_18", "doi-asserted-by": "crossref", "first-page": "2857", "DOI": "10.1097/00001756-199808240-00032", "volume": "9", "author": "T Kanda", "year": "1998", "unstructured": "Kanda T, Tashiro T, Kuwana Y, Jenner P. (1998a) Adenosine A2A receptors modify motor function in MPTP-treated common marmosets. Neuroreport 9:2857\u20132860", "journal-title": "Neuroreport"}, {"key": "18_CR72_18", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1002/ana.410430415", "volume": "43", "author": "T Kanda", "year": "1998", "unstructured": "Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, Kuwana Y, Jenner P (1998b) Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann Neurol 43:507\u2013513", "journal-title": "Ann Neurol"}, {"key": "18_CR73_18", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1006/exnr.2000.7350", "volume": "162", "author": "T Kanda", "year": "2000", "unstructured": "Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H (2000) Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Exp Neurol 162:321\u2013327", "journal-title": "Exp Neurol"}, {"key": "18_CR74_18", "doi-asserted-by": "crossref", "first-page": "S97", "DOI": "10.1212/01.WNL.0000095219.22086.31", "volume": "61", "author": "H Kase", "year": "2003", "unstructured": "Kase H, Aoyama S, Ichimura M, Ikeda K, Ishii A, Kanda T, Koga K, Koike N, Kurokawa M, Kuwana Y, Mori A, Nakamura J, Nonaka H, Ochi M, Saki M, Shimada J, Shindou T, Shiozaki S, Suzuki F, Takeda M, Yanagawa K, Richardson PJ, Jenner P, Bedard P, Borrelli E, Hauser RA, Chase TN (2003) Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson\u2019s disease. Neurology 61:S97\u2013S100", "journal-title": "Neurology"}, {"key": "18_CR75_18", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1038/ncpneuro0491", "volume": "3", "author": "K Kieburtz", "year": "2007", "unstructured": "Kieburtz K, Ravina B (2007) Why hasn\u2019t neuroprotection worked in Parkinson\u2019s disease? Nat Clin Pract Neurol 3:240\u2013241", "journal-title": "Nat Clin Pract Neurol"}, {"key": "18_CR76_18", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1016/S0014-2999(00)00745-7", "volume": "408", "author": "K Koga", "year": "2000", "unstructured": "Koga K, Kurokawa M, Ochi M, Nakamura J, Kuwana Y (2000) Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats. Eur J Pharmacol 408:249\u2013255", "journal-title": "Eur J Pharmacol"}, {"issue": "4", "key": "18_CR77_18", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1002/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F", "volume": "15", "author": "J Kulisevsky", "year": "2000", "unstructured": "Kulisevsky J, Garc\u00eda-S\u00e1nchez C, Berthier ML, Barbanoj M, Pascual-Sedano B, Gironell A, Est\u00e9vez-Gonz\u00e1lez A (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson\u2019s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15(4):613\u2013626", "journal-title": "Mov Disord"}, {"key": "18_CR78_18", "doi-asserted-by": "publisher", "first-page": "1882", "DOI": "10.1046/j.1471-4159.1996.66051882.x", "volume": "66", "author": "M Kurokawa", "year": "1996", "unstructured": "Kurokawa M, Koga K, Kase H, Nakamura J, Kuwana Y (1996) Adenosine A2A receptor-mediated modulation of striatal acetylcholine release in vivo. J Neurochem 66:1882\u20131888", "journal-title": "J Neurochem"}, {"key": "18_CR79_18", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1002/(SICI)1098-1136(19990115)25:2<120::AID-GLIA3>3.0.CO;2-D", "volume": "25", "author": "BM K\u00fcst", "year": "1999", "unstructured": "K\u00fcst BM, Biber K, van Calker D, Gebicke-Haerter PJ (1999) Regulation of K\u2009+\u2009 channel mRNA expression by stimulation of adenosine A2A-receptors in cultured rat microglia. Glia 25:120\u2013130", "journal-title": "Glia"}, {"key": "18_CR80_18", "first-page": "113", "volume": "Suppl", "author": "PA LeWitt", "year": "2006", "unstructured": "LeWitt PA (2006) Neuroprotection for Parkinson\u2019s disease. J Neural Transm Suppl:113\u2013122", "journal-title": "J Neural Transm"}, {"issue": "Suppl 9", "key": "18_CR81_18", "first-page": "S222", "volume": "19", "author": "PA LeWitt", "year": "2004", "unstructured": "LeWitt PA, 6002-US-005/6002-US-006 Clinical Investigator Group (2004) OFF time reduction from adjunctive use of istradephylline (KW-6002) in levodopa-treated patients with advanced Parkinson\u2019s disease. Presented at 8th International Congress of Parkinson\u2019s Disease and Movement Disorders, Rome. Mov Disord 19(Suppl 9):S222", "journal-title": "Mov Disord"}, {"key": "18_CR82_18", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1002/ana.21315", "volume": "63", "author": "PA LeWitt", "year": "2008", "unstructured": "LeWitt PA, Guttman M, Tetrud JW, Tuite PJ, Mori A, Chaikin P, Sussman NM (2008) Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces OFF time in Parkinson\u2019s disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann Neurol 63:295\u2013302", "journal-title": "Ann Neurol"}, {"key": "18_CR83_18", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1097/nen.0b013e3180415e42", "volume": "66", "author": "I Litvan", "year": "2007", "unstructured": "Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D Jr, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, Duyckaerts C, Dickson DW, Ben-Shlomo Y, Goetz CG, Melamed E (2007a) The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol 66:251\u2013257", "journal-title": "Part I. J Neuropathol Exp Neurol"}, {"key": "18_CR84_18", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1097/nen.0b013e318053716a", "volume": "66", "author": "I Litvan", "year": "2007", "unstructured": "Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D Jr, Price DL (2007b) The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol 66:329\u2013336", "journal-title": "Part II. J Neuropathol Exp Neurol"}, {"key": "18_CR85_18", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0163-7258(96)00119-2", "volume": "72", "author": "J Mally", "year": "1996", "unstructured": "Mally J, Stone TW (1996) Potential role of adenosine antagonist therapy in pathological tremor disorders. Pharmacol Ther 72:243\u2013250", "journal-title": "Pharmacol Ther"}, {"issue": "Suppl 10", "key": "18_CR86_18", "first-page": "S93", "volume": "20", "author": "MH Mark", "year": "2005", "unstructured": "Mark MH, 6002-US-007 Clinical Investigator Group (2005) Long-term efficacy of istradephylline in patients with advanced Parkinson\u2019s disease. Presented at 9th International Congress of Parkinson\u2019s disease and Movement Disorders, New Orleans. Mov Disord 20(Suppl 10):S93", "journal-title": "Mov Disord"}, {"key": "18_CR87_18", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1007/s00439-008-0466-z", "volume": "123", "author": "CC McCulloch", "year": "2008", "unstructured": "McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H (2008) Exploring gene\u2013environment interactions in Parkinson\u2019s disease. Hum Genet 123:257\u2013265", "journal-title": "Hum Genet"}, {"key": "18_CR88_18", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1002/mds.21751", "volume": "23", "author": "PL McGeer", "year": "2008", "unstructured": "McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23:474\u2013483", "journal-title": "Mov Disord"}, {"key": "18_CR89_18", "doi-asserted-by": "crossref", "first-page": "708", "DOI": "10.1124/jpet.107.121962", "volume": "323", "author": "T Mihara", "year": "2007", "unstructured": "Mihara T, Mihara K, Yarimizu J, Mitani Y, Matsuda R, Yamamoto H, Aoki S, Akahane A, Iwashita A, Matsuoka N (2007) Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson\u2019s disease and cognition.J Pharmacol Exp Ther 323:708\u2013719", "journal-title": "J Pharmacol Exp Ther"}, {"key": "18_CR90_18", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1016/S0014-4886(03)00316-9", "volume": "184", "author": "M Morelli", "year": "2003", "unstructured": "Morelli M (2003) Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson\u2019s disease. Exp Neurol 184:20\u201323", "journal-title": "Exp Neurol"}, {"key": "18_CR91_18", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1016/0014-2999(94)90438-3", "volume": "251", "author": "M Morelli", "year": "1994", "unstructured": "Morelli M, Fenu S, Pinna A, Di Chiara G (1994) Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 251:21\u201325", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR92_18", "doi-asserted-by": "crossref", "first-page": "1322", "DOI": "10.1073/pnas.0237126100", "volume": "100", "author": "A Nishi", "year": "2003", "unstructured": "Nishi A, Liu F, Matsuyama S, Hamada M, Higashi H, Nairn AC, Greengard P (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc Natl Acad Sci USA 100:1322\u20131327", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "18_CR93_18", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1002/glia.10100", "volume": "39", "author": "T Nishizaki", "year": "2002", "unstructured": "Nishizaki T, Nagai K, Nomura T, Tada H, Kanno T, Tozaki H, Li XX, Kondoh T, Kodama N, Takahashi E, Sakai N, Tanaka K, Saito N (2002) A new neuromodulatory pathway with a glial contribution mediated via A(2a) adenosine receptors. Glia 39:133\u2013147", "journal-title": "Glia"}, {"key": "18_CR94_18", "doi-asserted-by": "crossref", "first-page": "S8", "DOI": "10.1016/S1471-1931(00)00028-8", "volume": "23", "author": "JA Obeso", "year": "2000", "unstructured": "Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW (2000) Pathophysiology of the basal ganglia in Parkinson\u2019s disease. Trends Neurosci 23:S8\u2013S19", "journal-title": "Trends Neurosci"}, {"key": "18_CR95_18", "doi-asserted-by": "crossref", "first-page": "S17", "DOI": "10.1212/WNL.62.1_suppl_1.S17", "volume": "62", "author": "JA Obeso", "year": "2004", "unstructured": "Obeso JA, Rodriguez-Oroz M, Marin C, Alonso F, Zamarbide I, Lanciego JL, Rodriguez-Diaz M (2004) The origin of motor fluctuations in Parkinson\u2019s disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 62:S17\u2013S30", "journal-title": "Neurology"}, {"key": "18_CR96_18", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.expneurol.2006.07.004", "volume": "202", "author": "JA Obeso", "year": "2006", "unstructured": "Obeso JA, Rodriguez-Oroz MC, Javier Blesa F, Guridi J (2006) The globus pallidus pars externa and Parkinson\u2019s disease. Ready for prime time? Exp Neurol 202:1\u20137", "journal-title": "Exp Neurol"}, {"key": "18_CR97_18", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/j.neuroscience.2004.04.050", "volume": "127", "author": "M Ochi", "year": "2004", "unstructured": "Ochi M, Shiozaki S, Kase H (2004) Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson\u2019s disease. Neuroscience 127:223\u2013231", "journal-title": "Neuroscience"}, {"key": "18_CR98_18", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1007/s00213-005-0240-z", "volume": "184", "author": "M O\u2019Neill", "year": "2006", "unstructured": "O\u2019Neill M, Brown VJ (2006) The effect of the adenosine A(2A) antagonist KW-6002 on motor and motivational processes in the rat. Psychopharmacology 184:46\u201355", "journal-title": "Psychopharmacology"}, {"key": "18_CR99_18", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1002/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q", "volume": "46", "author": "SM Papa", "year": "1999", "unstructured": "Papa SM, Desimone R, Fiorani M, Oldfield EH (1999) Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 46:732\u2013738", "journal-title": "Ann Neurol"}, {"key": "18_CR100_18", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/j.neuropharm.2004.11.009", "volume": "48", "author": "M Pierri", "year": "2005", "unstructured": "Pierri M, Vaudano E, Sager T, Englund U (2005) KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse. Neuropharmacology 48:517\u2013524", "journal-title": "Neuropharmacology"}, {"key": "18_CR101_18", "doi-asserted-by": "crossref", "first-page": "1176", "DOI": "10.1111/j.1460-9568.1996.tb01285.x", "volume": "8", "author": "A Pinna", "year": "1996", "unstructured": "Pinna A, di Chiara G, Wardas J, Morelli M (1996) Blockade of A2A adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats. Eur J Neurosci 8:1176\u20131181", "journal-title": "Eur J Neurosci"}, {"key": "18_CR102_18", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K", "volume": "39", "author": "A Pinna", "year": "2001", "unstructured": "Pinna A, Fenu S, Morelli M (2001) Motor stimulants effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine lesioned rats. Synapse 39:233\u2013239", "journal-title": "Synapse"}, {"key": "18_CR103_18", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/S0014-2999(02)01818-6", "volume": "446", "author": "A Pinna", "year": "2002", "unstructured": "Pinna A, Corsi C, Carta AR, Valentini V, Pedata F, Morelli M (2002) Modification of adenosine extracellular levels and adenosine A2A receptor mRNA by dopamine denervation. Eur J Pharmacol 446:75\u201382", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR104_18", "doi-asserted-by": "crossref", "first-page": "606", "DOI": "10.1002/syn.20410", "volume": "61", "author": "A Pinna", "year": "2007", "unstructured": "Pinna A, Pontis S, Morelli M (2007) Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson\u2019s disease. Synapse 61:606\u2013614", "journal-title": "Synapse"}, {"key": "18_CR105_18", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/S0006-8993(96)01036-0", "volume": "743", "author": "AE Pollack", "year": "1996", "unstructured": "Pollack AE, Fink JS (1996) Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats. Brain Res 743:124\u2013130", "journal-title": "Brain Res"}, {"key": "18_CR106_18", "doi-asserted-by": "crossref", "first-page": "1967", "DOI": "10.1523/JNEUROSCI.22-05-01967.2002", "volume": "22", "author": "P Popoli", "year": "2002", "unstructured": "Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, P\u00e8zzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M (2002) Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J Neurosci 22:1967\u20131975", "journal-title": "J Neurosci"}, {"issue": "Suppl 15", "key": "18_CR107_18", "first-page": "S508", "volume": "21", "author": "E Pourcher", "year": "2006", "unstructured": "Pourcher E, 6002-US-018 Clinical Investigator Group (2006) Safety and tolerability of istradephylline (KW-6002) in Parkinson\u2019s disease with motor response complications: results of the KW-6002-US-018 study. Presented at the 10th International Congress of Parkinson\u2019s Disease and Movement Disorders, Kyoto. Mov Disord 21(Suppl 15):S508", "journal-title": "Mov Disord"}, {"key": "18_CR108_18", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1002/mds.21782", "volume": "23", "author": "KM Powers", "year": "2008", "unstructured": "Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H (2008) Combined effects of smoking, coffee, and NSAIDs on Parkinson\u2019s disease risk. Mov Disord 23:88\u201395", "journal-title": "Mov Disord"}, {"issue": "Suppl", "key": "18_CR109_18", "first-page": "PIII-89", "volume": "83", "author": "N Rao", "year": "2005", "unstructured": "Rao N, Uchimura T, Mori A (2005a) Evaluation of safety, tolerability, and multiple dose pharmacokinetics of istradephylline in healthy subjects. Clin Pharmacol Ther 83(Suppl):PIII-89", "journal-title": "Clin Pharmacol Ther"}, {"issue": "Suppl", "key": "18_CR110_18", "first-page": "PIII-88", "volume": "83", "author": "N Rao", "year": "2005", "unstructured": "Rao N, Uchimura T, Mori A (2005b) Evaluation of safety, tolerability, and multiple dose pharmacokinetics of istradephylline in Parkinson\u2019s disease patients. Clin Pharmacol Ther 83(Suppl):PIII-88", "journal-title": "Clin Pharmacol Ther"}, {"key": "18_CR111_18", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.1001/archneur.64.7.990", "volume": "64", "author": "B Ritz", "year": "2007", "unstructured": "Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64:990\u2013997", "journal-title": "Arch Neurol"}, {"key": "18_CR112_18", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1111/j.1471-4159.2004.02887.x", "volume": "92", "author": "RJ Rodrigues", "year": "2005", "unstructured": "Rodrigues RJ, Alfaro TM, Rebola N, Oliveira CR, Cunha RA (2005) Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem 92:433\u2013441", "journal-title": "J Neurochem"}, {"key": "18_CR113_18", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/j.brainres.2006.10.038", "volume": "1133", "author": "S Rose", "year": "2007", "unstructured": "Rose S, Ramsay Croft N, Jenner P. The novel adenosine A2A antagonist (2007) ST1535 potentiates the effects of a threshold dose of L-dopa in unilaterally 6-OHDA-lesioned rats. Brain Res 1133:110\u2013114", "journal-title": "Brain Res"}, {"key": "18_CR114_18", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1002/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D", "volume": "401", "author": "DL Rosin", "year": "1998", "unstructured": "Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol 401:163\u2013186", "journal-title": "J Comp Neurol"}, {"key": "18_CR115_18", "doi-asserted-by": "crossref", "first-page": "S12", "DOI": "10.1212/01.WNL.0000095205.33940.99", "volume": "61", "author": "DL Rosin", "year": "2003", "unstructured": "Rosin DL, Hettinger BD, Lee A, Linden J (2003) Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function. Neurology 61:S12\u2013S18", "journal-title": "Neurology"}, {"key": "18_CR116_18", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1016/S0301-0082(98)00053-7", "volume": "56", "author": "JD Salamone", "year": "1998", "unstructured": "Salamone JD, Mayorga AJ, Trevitt JT, Cousins MS, Conlan A, Nawab A (1998) Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol 56:591\u2013611", "journal-title": "Prog Neurobiol"}, {"issue": "Suppl 1", "key": "18_CR117_18", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1111/j.1468-1331.2008.02055.x", "volume": "15", "author": "AH Schapira", "year": "2008", "unstructured": "Schapira AH (2008) Progress in neuroprotection in Parkinson\u2019s disease. Eur J Neurol 15(Suppl 1):5\u201313", "journal-title": "Eur J Neurol"}, {"key": "18_CR118_18", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1111/j.1471-4159.1991.tb08257.x", "volume": "57", "author": "SN Schiffmann", "year": "1991", "unstructured": "Schiffmann SN, Jacobs O, Vanderhaeghen JJ (1991) Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57:1062\u20131067", "journal-title": "J Neurochem"}, {"key": "18_CR119_18", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1016/j.pneurobio.2007.05.001", "volume": "83", "author": "SN Schiffmann", "year": "2007", "unstructured": "Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferr\u00e9 S (2007) Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 83:277\u2013292", "journal-title": "Prog Neurobiol"}, {"key": "18_CR120_18", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1016/j.tins.2006.09.004", "volume": "29", "author": "MA Schwarzschild", "year": "2006", "unstructured": "Schwarzschild MA, Agnati L, Fuxe K, Chen JF, Morelli M (2006) Targeting adenosine A2A receptors in Parkinson\u2019s disease. Trends Neurosci 29:647\u2013654", "journal-title": "Trends Neurosci"}, {"key": "18_CR121_18", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/j.neulet.2003.08.059", "volume": "352", "author": "T Shindou", "year": "2003", "unstructured": "Shindou T, Richardson PJ, Mori A, Kase H, Ichimura M (2003) Adenosine modulates the striatal GABAergic inputs to the globus pallidus via adenosine A2A receptors in rats. Neurosci Lett 352:167\u2013170", "journal-title": "Neurosci Lett"}, {"key": "18_CR122_18", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1007/s002130051146", "volume": "147", "author": "S Shiozaki", "year": "1999", "unstructured": "Shiozaki S, Ichikawa S, Nakamura J, Kitamura S, Yamada K, Kuwana Y (1999) Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology 147:90\u201395", "journal-title": "Psychopharmacology"}, {"issue": "Suppl 15", "key": "18_CR123_18", "first-page": "S488", "volume": "21", "author": "LM Shulman", "year": "2006", "unstructured": "Shulman LM, 6002-US-013 Clinical Investigator Group (2006) The safety profile of istradephylline (KW-6002) in Parkinson\u2019s disease with motor response complications on levodopa/carbidopa: results of KW-6002-US-013 study. Presented at 10th International Congress of Parkinson\u2019s Disease and Movement Disorders, Kyoto. Mov Disord 21(Suppl 15):S488", "journal-title": "Mov Disord"}, {"key": "18_CR124_18", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1007/s11910-006-0021-z", "volume": "6", "author": "A Siderowf", "year": "2006", "unstructured": "Siderowf A, Stern MB (2006) Preclinical diagnosis of Parkinson\u2019s disease: are we there yet? Curr Neurol Neurosci Rep 6:295\u2013301", "journal-title": "Curr Neurol Neurosci Rep"}, {"key": "18_CR125_18", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1016/j.expneurol.2004.05.027", "volume": "189", "author": "N Simola", "year": "2004", "unstructured": "Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M (2004) Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Exp Neurol 189:182\u2013188", "journal-title": "Exp Neurol"}, {"key": "18_CR126_18", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/j.expneurol.2006.05.015", "volume": "202", "author": "N Simola", "year": "2006", "unstructured": "Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M (2006) Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists. Exp Neurol 202:255\u2013257", "journal-title": "Exp Neurol"}, {"key": "18_CR127_18", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1002/syn.20504", "volume": "62", "author": "N Simola", "year": "2008", "unstructured": "Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M (2008) Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists. Synapse 62:345\u2013351", "journal-title": "Synapse"}, {"key": "18_CR128_18", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1097/WNF.0b013e318065b088", "volume": "31", "author": "M Stacy", "year": "2008", "unstructured": "Stacy M, Galbreath A (2008) Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia. Clin Neuropharmacol 31:51\u201356", "journal-title": "Clin Neuropharmacol"}, {"issue": "Suppl 9", "key": "18_CR129_18", "first-page": "S215", "volume": "19", "author": "M Stacy", "year": "2004", "unstructured": "Stacy M, 6002-US-005/6002-US-006 Clinical Investigator Group (2004) Istradephylline (KW-6002) as adjunctive therapy in patients with advanced Parkinson\u2019s disease: a positive safety profile with supporting efficacy. Presented at 8th International Congress on Parkinson\u2019s Disease and Movement Disorders, Rome. Mov Disord 19(Suppl 9):S215", "journal-title": "Mov Disord"}, {"key": "18_CR130_18", "doi-asserted-by": "crossref", "first-page": "2233", "DOI": "10.1212/01.wnl.0000313834.22171.17", "volume": "70", "author": "M Stacy", "year": "2008", "unstructured": "Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P, Sussman NM (2008) A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology 70:2233\u20132240", "journal-title": "Neurology"}, {"key": "18_CR131_18", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1097/NRL.0b013e31816606a7", "volume": "14", "author": "W Stamey", "year": "2008", "unstructured": "Stamey W, Jankovic J (2008) Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist 14:89\u201399", "journal-title": "Neurologist"}, {"issue": "Suppl 2", "key": "18_CR132_18", "doi-asserted-by": "crossref", "first-page": "S73", "DOI": "10.1016/S1353-8020(03)00021-X", "volume": "9", "author": "F Stocchi", "year": "2003", "unstructured": "Stocchi F (2003) Prevention and treatment of motor fluctuations. Parkinsonism Relat Disord 9(Suppl 2):S73\u2013S81", "journal-title": "Parkinsonism Relat Disord"}, {"key": "18_CR133_18", "doi-asserted-by": "crossref", "first-page": "590", "DOI": "10.1016/S1474-4422(05)70177-0", "volume": "4", "author": "F Stocchi", "year": "2005", "unstructured": "Stocchi F (2005) Pathological gambling in Parkinson\u2019s disease. Lancet Neurol 4:590\u2013592", "journal-title": "Lancet Neurol"}, {"issue": "Suppl 3", "key": "18_CR134_18", "doi-asserted-by": "crossref", "first-page": "S87", "DOI": "10.1002/ana.10488", "volume": "53", "author": "F Stocchi", "year": "2003", "unstructured": "Stocchi F, Olanow CW (2003) Neuroprotection in Parkinson\u2019s disease: clinical trials. Ann Neurol 53(Suppl 3):S87\u2013S97", "journal-title": "Ann Neurol"}, {"key": "18_CR135_18", "doi-asserted-by": "crossref", "first-page": "2614", "DOI": "10.2741/2870", "volume": "13", "author": "RN Takahashi", "year": "2008", "unstructured": "Takahashi RN, Pamplona FA, Prediger RD (2008) Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front Biosci 13:2614\u20132632", "journal-title": "Front Biosci"}, {"key": "18_CR136_18", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1016/j.ejphar.2007.03.021", "volume": "566", "author": "E Tronci", "year": "2007", "unstructured": "Tronci E, Simola N, Borsini F, Schintu N, Frau L, Carminati P, Morelli M (2007) Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. Eur J Pharmacol 566:94\u2013102", "journal-title": "Eur J Pharmacol"}, {"issue": "Suppl 15", "key": "18_CR137_18", "first-page": "S513", "volume": "21", "author": "JM Trugman", "year": "2006", "unstructured": "Trugman JM, 6002-US-013 Clinical Investigator Group (2006) Efficacy of istradephylline (KW-6002) in levodopa-treated Parkinson\u2019s disease patients with motor response complications: primary efficacy results of the KW-6002-US-013 study. Presented at 10th International Congress of Parkinson\u2019s Disease and Movement Disorders, Kyoto. Mov Disord 21(Suppl 15):S513", "journal-title": "Mov Disord"}, {"key": "18_CR138_18", "doi-asserted-by": "crossref", "first-page": "494", "DOI": "10.1111/j.1440-1789.2007.00803.x", "volume": "27", "author": "K Wakabayashi", "year": "2007", "unstructured": "Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27:494\u2013506", "journal-title": "Neuropathology"}, {"key": "18_CR139_18", "doi-asserted-by": "crossref", "first-page": "438", "DOI": "10.1016/j.expneurol.2006.01.005", "volume": "199", "author": "JH Wang", "year": "2006", "unstructured": "Wang JH, Ma YY, van den Buuse M (2006) Improved spatial recognition memory in mice lacking adenosine A2A receptors. Exp Neurol 199:438\u2013445", "journal-title": "Exp Neurol"}, {"key": "18_CR140_18", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1002/syn.1070", "volume": "41", "author": "J Wardas", "year": "2001", "unstructured": "Wardas J, Konieczny J, Lorenc-Koci E (2001) SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats. Synapse 41:160\u2013171", "journal-title": "Synapse"}, {"key": "18_CR141_18", "first-page": "S40", "volume": "14", "author": "D Weintraub", "year": "2008", "unstructured": "Weintraub D, Comella CL, Horn S (2008a) Parkinson\u2019s disease\u2014Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Manag Care 14:S40\u2013S48", "journal-title": "Am J Manag Care"}, {"key": "18_CR142_18", "first-page": "S49", "volume": "14", "author": "D Weintraub", "year": "2008", "unstructured": "Weintraub D, Comella CL, Horn S (2008b) Parkinson\u2019s disease\u2014Part 2: Treatment of motor symptoms. Am J Manag Care 14:S49\u2013S58", "journal-title": "Am J Manag Care"}, {"key": "18_CR143_18", "first-page": "S59", "volume": "14", "author": "D Weintraub", "year": "2008", "unstructured": "Weintraub D, Comella CL, Horn S (2008c) Parkinson\u2019s disease\u2014Part 3: Neuropsychiatric symptoms. Am J Manag Care 14:S59\u2013S69", "journal-title": "Am J Manag Care"}], "container-title": ["Adenosine Receptors in Health and Disease", "Handbook of Experimental Pharmacology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-540-89615-9_18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 21]], "date-time": "2019-05-21T18:48:01Z", "timestamp": 1558464481000}, "score": 25.195744, "issued": {"date-parts": [[2009]]}, "ISBN": ["9783540896142", "9783540896159"], "references-count": 143, "URL": "http://dx.doi.org/10.1007/978-3-540-89615-9_18", "relation": {"cites": []}, "ISSN": ["0171-2004", "1865-0325"], "issn-type": [{"value": "0171-2004", "type": "print"}, {"value": "1865-0325", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:21:15Z", "timestamp": 1574216475578}, "publisher-location": "Boston", "reference-count": 31, "publisher": "Kluwer Academic Publishers", "isbn-type": [{"value": "0387280650", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/0-387-28066-9_35", "type": "book-chapter", "created": {"date-parts": [[2006, 6, 26]], "date-time": "2006-06-26T01:43:49Z", "timestamp": 1151286229000}, "page": "371-378", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Changes in the Expression of Tonic and Phasic Neurochemical Markers of Activity in a Rat Model of L-DOPA Induced Dyskinesia"], "prefix": "10.1007", "author": [{"given": "Anna R.", "family": "Carta", "sequence": "first", "affiliation": []}, {"given": "Annalisa", "family": "Pinna", "sequence": "additional", "affiliation": []}, {"given": "Elisabetta", "family": "Tronci", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "35_CR1", "doi-asserted-by": "crossref", "first-page": "9930", "DOI": "10.1523/JNEUROSCI.21-24-09930.2001", "volume": "21", "author": "M. Andersson", "year": "2001", "unstructured": "Andersson M., Konradi C., and Cenci M.A., 2001, cAMP response element-binding protein is required for dopamine dependent gene expression in the intact but not the dopamine-denervated striatum, J. Neurosci. 21:9930.", "journal-title": "J. Neurosci."}, {"key": "35_CR2", "first-page": "1483", "volume": "273", "author": "K.E. Asin", "year": "1995", "unstructured": "Asin, K.E., Bednarz, L., Nikkel, A., and Perner, R., 1995, Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa., J. Pharmacol. Exp. Ther. 273:1483.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "35_CR3", "first-page": "S189", "volume": "47", "author": "A.L. Benabid", "year": "2000", "unstructured": "Benabid, A.L., Benazzouz, A., Limousin, P., Koudsie, A., Krack, P., Piallat, B., and Pollak, P., 2000, Dyskinesias and the subthalamic nucleus., Ann. Neurol. 47:S189.", "journal-title": "Ann. Neurol."}, {"key": "35_CR4", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1016/S0006-8993(97)01563-1", "volume": "787", "author": "T. Boraud", "year": "1998", "unstructured": "Boraud, T., Bezard, E., Guehl, D., Bioulac, B., and Gross, C., 1998, Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey, Brain Res. 787:157.", "journal-title": "Brain Res."}, {"key": "35_CR5", "doi-asserted-by": "publisher", "first-page": "546", "DOI": "10.1093/brain/124.3.546", "volume": "124", "author": "T. Boraud", "year": "2001", "unstructured": "Boraud, T., Bezard, E., Bioulac, B., and Gross, C.E., 2001, Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey, Brain 124:546.", "journal-title": "Brain"}, {"key": "35_CR6", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1002/syn.10066", "volume": "44", "author": "A.R. Carta", "year": "2002", "unstructured": "Carta, A.R., Pinna, A., Cauli, O., and Morelli, M., 2002, Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-DOPA and A2A receptor blockade plus L-DOPA in dopamine-denervated rats, Synapse. 44:166.", "journal-title": "Synapse."}, {"key": "35_CR7", "doi-asserted-by": "publisher", "first-page": "679", "DOI": "10.1016/S0014-4886(03)00292-9", "volume": "184", "author": "A.R. Carta", "year": "2003", "unstructured": "Carta, A.R., Tabrizi, M.A., Baraldi, P.G., Pinna, A., Pala, P., and Morelli, M., 2003, Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata, Exp. Neurol. 184:679.", "journal-title": "Exp. Neurol."}, {"key": "35_CR8", "doi-asserted-by": "publisher", "first-page": "2563", "DOI": "10.1046/j.1460-9568.2003.02983.x", "volume": "18", "author": "A.R. Carta", "year": "2003", "unstructured": "Carta, A.R., Fenu, S., Pala, P., Tronci, E., and Morelli, M., 2003b, Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats, Eur. J. Neurosci. 18:2563.", "journal-title": "Eur. J. Neurosci."}, {"key": "35_CR9", "doi-asserted-by": "publisher", "first-page": "2694", "DOI": "10.1046/j.1460-9568.1998.00285.x", "volume": "10", "author": "M.A. Cenci", "year": "1998", "unstructured": "Cenci, M.A., Lee, C.S., and Bjorklund, A., 1998, L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA., Eur. J. Neurosci. 10:2694.", "journal-title": "Eur. J. Neurosci."}, {"key": "35_CR10", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1111/j.1460-9568.1996.tb01220.x", "volume": "8", "author": "J.P. Doucet", "year": "1996", "unstructured": "Doucet, J.P., Nakabeppu, Y., Bedard, P.J., Hope, B.T., Nestler, E.J., Jasmin, B.J., Chen, J.S., Iadarola, M.J., St-Jean, M., Wigle, N., Blanchet, P., Grondin, R., and Robertson, G.S., 1996, Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum, Eur. J. Neurosci. 8:81.", "journal-title": "Eur. J. Neurosci."}, {"key": "35_CR11", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1016/0006-8993(91)90586-K", "volume": "547", "author": "M. Filion", "year": "1991", "unstructured": "Filion, M., Tremblay, L., and Bedard, P.J., 1991, Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism, Brain Res. 547:152.", "journal-title": "Brain Res."}, {"key": "35_CR12", "doi-asserted-by": "crossref", "first-page": "5042", "DOI": "10.1523/JNEUROSCI.22-12-05042.2002", "volume": "22", "author": "C.R. Gerfen", "year": "2002", "unstructured": "Gerfen, C.R., Miyachi, S., Paletzki, R., and Brown, P., 2002, D1 dopamine receptor supersensitivity in the dopaminedepleted striatum results from a switch in the rgulation of ERK1/2 MAPkinase, J. Neurosci. 22:5042.", "journal-title": "J. Neurosci."}, {"key": "35_CR13", "doi-asserted-by": "publisher", "first-page": "458", "DOI": "10.1016/S0014-4886(03)00064-5", "volume": "183", "author": "B. Henry", "year": "2003", "unstructured": "Henry, B., Duty, S., Fox, S.H., Crossman, A.R., and Brotchie, J.M., 2003, Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson\u2019s disease, Exp. Neurol. 183:458.", "journal-title": "Exp. Neurol."}, {"key": "35_CR14", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1212/WNL.47.1.219", "volume": "47", "author": "M.T. Herrero", "year": "1996", "unstructured": "Herrero, M.T., Levy, R., Ruberg, M., Luquin, M.R., Villares, J., Guillen, J., Faucheux, B., Javoy-Agid, F., Guridi, J., Agid, Y., Obeso, J.A., and Hirsch, E.C., 1996, Consequence of nigrostriatal denervation and L-DOPA therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum, Neurology 47:219.", "journal-title": "Neurology"}, {"key": "35_CR15", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1002/ana.410420513", "volume": "42", "author": "W.D. Hutchinson", "year": "1997", "unstructured": "Hutchinson, W.D., Levy, R., Dostrovsky, J.O., Lozano, A.M., and Lang, A.E., 1997, Effects of apomorphine on globus pallidus neurons in parkinsonian patients, Ann. Neurol. 42:767.", "journal-title": "Ann. Neurol."}, {"key": "35_CR16", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1002/(SICI)1097-4547(19990101)55:1<71::AID-JNR8>3.0.CO;2-G", "volume": "55", "author": "S.M. Khan", "year": "1999", "unstructured": "Khan, S.M., Smith, T.S., and Bennett, J.P. Jr., 1999, Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions, J. Neurosci. Res 55:71.", "journal-title": "J. Neurosci. Res"}, {"key": "35_CR17", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1152/jn.2001.86.1.249", "volume": "86", "author": "R. Levy", "year": "2001", "unstructured": "Levy, R., Dostrovsky, J.O., Lang, A.E., Sime, E., Hutchison, W.D., and Lozano, A.M., 2001, Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson\u2019s disease, J. Neurophysiol. 86:249.", "journal-title": "J. Neurophysiol."}, {"key": "35_CR18", "doi-asserted-by": "publisher", "first-page": "S141", "DOI": "10.1002/1531-8249(200002)47:2<141::AID-ANA1>3.0.CO;2-6", "volume": "47", "author": "A.M. Lozano", "year": "2000", "unstructured": "Lozano, A.M., Lang, A.E., Levy, R., Hutchison, W., and Dostrovsky, J., 2000, Neuronal recordings in Parkinson\u2019s disease patients with dyskinesias induced by apomorphine, Ann. Neurol. 47:S141.", "journal-title": "Ann. Neurol."}, {"key": "35_CR19", "doi-asserted-by": "publisher", "first-page": "334", "DOI": "10.1016/0006-8993(93)91449-3", "volume": "623", "author": "M. Morelli", "year": "1993", "unstructured": "Morelli, M., Cozzolino, A., Pinna, A., Fenu, S., Carta, A., and Di Chiara, G., 1993, L-DOPA stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors, Brain Res. 623:334.", "journal-title": "Brain Res."}, {"key": "35_CR20", "doi-asserted-by": "publisher", "first-page": "421", "DOI": "10.1146/annurev.ne.14.030191.002225", "volume": "14", "author": "J.I. Morgan", "year": "1991", "unstructured": "Morgan, J.I., and Curran, T., 1991, Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci. 14:421.", "journal-title": "Annu. Rev. Neurosci."}, {"key": "35_CR21", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1006/exnr.2002.7976", "volume": "177", "author": "A. Mura", "year": "2002", "unstructured": "Mura, A., Mintz, M., and Feldon, J., 2002, Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesion of the nigrostriatal system, Exp. Neurol. 177:252.", "journal-title": "Exp. Neurol."}, {"key": "35_CR22", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1016/j.neuroscience.2003.08.010", "volume": "123", "author": "K.M. Nielsen", "year": "2004", "unstructured": "Nielsen, K.M., and Soghomonian, J.J., 2004, Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa, Neuroscience 123:31.", "journal-title": "Neuroscience"}, {"key": "35_CR23", "first-page": "S22", "volume": "47", "author": "J.A. Obeso", "year": "2000", "unstructured": "Obeso, J.A., Rodriguez-Oroz, M.C., Rodriguez, M., DeLong, M.R., and Olanow, C.W., 2000, Pathophysiology of levodopa-induced dyskinesias in Parkinson\u2019s disease: problems with the current model, Ann. Neurol. 47:S22.", "journal-title": "Ann. Neurol."}, {"key": "35_CR24", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.1002/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q", "volume": "46", "author": "S.M. Papa", "year": "1999", "unstructured": "Papa, S.M., Desimone, R., Fiorani, M., and Oldfield, E.H., 1999, Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias, Ann. Neurol. 46:732.", "journal-title": "Ann. Neurol."}, {"key": "35_CR25", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1016/0014-2999(89)90049-6", "volume": "159", "author": "G.S. Robertson", "year": "1989", "unstructured": "Robertson, G.S., Herrera, D.G., Dragunow, M., and Robertson, H.A., 1989, L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra, Eur. J. Pharmacol. 159:99.", "journal-title": "Eur. J. Pharmacol."}, {"key": "35_CR26", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1016/0896-6273(90)90106-P", "volume": "4", "author": "M. Sheng", "year": "1990", "unstructured": "Sheng, M., and Greenberg, M.E., 1990, The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron. 4:477.", "journal-title": "Neuron."}, {"key": "35_CR27", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1016/0169-328X(96)00078-2", "volume": "39", "author": "J.J. Soghomonian", "year": "1996", "unstructured": "Soghomonian, J.J., Pedneault, S., Blanchet, P.J., Goulet, M., Di Paolo, T., and Bedard, P.J., 1996, L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys. Brain Res. Mol. Brain Res. 39:237.", "journal-title": "Brain Res. Mol. Brain Res."}, {"key": "35_CR28", "doi-asserted-by": "crossref", "first-page": "5066", "DOI": "10.1523/JNEUROSCI.13-12-05066.1993", "volume": "13", "author": "H. Steiner", "year": "1993", "unstructured": "Steiner, H., and Gerfen, C.R., 1993, Cocaine-induced c-fos messanger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:5066.", "journal-title": "J. Neurosci."}, {"key": "35_CR29", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.1016/S0306-4522(98)00241-3", "volume": "88", "author": "H. Steiner", "year": "1999", "unstructured": "Steiner, H., and Gerfen, C.R., 1999, Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience 88:795.", "journal-title": "Neuroscience"}, {"key": "35_CR30", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/syn.1113", "volume": "43", "author": "S.V. Witte Van de", "year": "2002", "unstructured": "Van de Witte, S.V., Groenewegen, H.J., and Voorn, P., 2002, MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons, Synapse 43:1.", "journal-title": "Synapse"}, {"key": "35_CR31", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/0306-4522(95)00100-W", "volume": "68", "author": "J.Q. Wang", "year": "1995", "unstructured": "Wang, J.Q., Smith, A.J.W., and McGinty, J.F., 1995, A single injection of amphetamine or methamphetamine induced dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain, Neuroscience 68:83.", "journal-title": "Neuroscience"}], "container-title": ["Advances in Behavioral Biology", "The Basal Ganglia VIII"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/0-387-28066-9_35", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 21]], "date-time": "2019-01-21T17:51:04Z", "timestamp": 1548093064000}, "score": 23.663717, "issued": {"date-parts": [[null]]}, "ISBN": ["0387280650"], "references-count": 31, "URL": "http://dx.doi.org/10.1007/0-387-28066-9_35", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:03:47Z", "timestamp": 1574312627800}, "reference-count": 154, "publisher": "Springer Science and Business Media LLC", "issue": "3-4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 9, 1]], "date-time": "2007-09-01T00:00:00Z", "timestamp": 1188604800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["neurotox res"], "published-print": {"date-parts": [[2007, 9]]}, "DOI": "10.1007/bf03033565", "type": "journal-article", "created": {"date-parts": [[2009, 7, 20]], "date-time": "2009-07-20T17:40:52Z", "timestamp": 1248111652000}, "page": "151-167", "source": "Crossref", "is-referenced-by-count": 148, "title": ["The 6-Hydroxydopamine model of parkinson\u2019s disease"], "prefix": "10.1007", "volume": "11", "author": [{"given": "Nicola", "family": "Simola", "sequence": "first", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}, {"given": "Anna R.", "family": "Carta", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BF03033565_CR1", "doi-asserted-by": "crossref", "first-page": "972", "DOI": "10.1111/j.1460-9568.1995.tb01085.x", "volume": "7", "author": "M Amalric", "year": "1995", "unstructured": "Amalric M, H Moukhles, A Nieoullon and A Daszuta (1995) Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat.Eur. J. Neurosci. 7, 972\u2013980.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR2", "doi-asserted-by": "crossref", "first-page": "9930", "DOI": "10.1523/JNEUROSCI.21-24-09930.2001", "volume": "21", "author": "M Andersson", "year": "2001", "unstructured": "Andersson M, C Konradi and MA Cenci (2001) cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.J. Neurosci. 21, 9930\u20139943.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR3", "doi-asserted-by": "crossref", "first-page": "1175", "DOI": "10.1007/BF00978370", "volume": "18", "author": "R Andrew", "year": "1993", "unstructured": "Andrew R, DG Watson, SA Best, JM Midgley, H Wenlong and RK Petty (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.Neurochem. Res. 18, 1175\u20131177.", "journal-title": "Neurochem. Res."}, {"key": "BF03033565_CR4", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1111/j.1471-4159.2004.02190.x", "volume": "88", "author": "OV Anichtchik", "year": "2004", "unstructured": "Anichtchik OV, J Kaslin, N Peitsaro, M Scheinin and P Panula (2004) Neurochemical and behavioural changes in zebrafishDanio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.J. Neurochem. 88, 443\u2013453.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR5", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1037/0735-7044.112.1.102", "volume": "112", "author": "MP Arts", "year": "1998", "unstructured": "Arts MP and AR Cools (1998) Bilateral 6-hydroxydopamine lesion in the dopaminergic A8 cell group produces long-lasting deficits in motor programming of cats.Behav. Neurosci. 112, 102\u2013115.", "journal-title": "Behav. Neurosci."}, {"key": "BF03033565_CR6", "doi-asserted-by": "crossref", "first-page": "907", "DOI": "10.1016/S0306-4522(97)00665-9", "volume": "85", "author": "M Asanuma", "year": "1998", "unstructured": "Asanuma M, H Hirata and JL Cadet (1998) Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice.Neuroscience 85, 907\u2013917.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR7", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1080/00207450490512669", "volume": "115", "author": "MR Avila-Costa", "year": "2005", "unstructured": "Avila-Costa MR, L Colin-Barenque, P Aley-Medina, AL Valdez, JL Librado, EF Martinez and TI Fortoul (2005) Bilateral increase of perforated synapses after unilateral dopamine depletion.Int. J. Neurosci. 115, 79\u201386.", "journal-title": "Int. J. Neurosci."}, {"key": "BF03033565_CR8", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1046/j.1460-9568.2000.00896.x", "volume": "12", "author": "P Barneoud", "year": "2000", "unstructured": "Barneoud P, E Descombris, N Aubin and DN Abrous (2000) Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system.Eur. J. Neurosci. 12, 322\u2013336.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR9", "doi-asserted-by": "crossref", "first-page": "867", "DOI": "10.1016/0306-4522(94)90409-X", "volume": "61", "author": "P Barone", "year": "1994", "unstructured": "Barone P, M Morelli, M Popoli, G Cicarelli, G Campanella and G Di Chiara (1994) Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation.Neuroscience 61, 867\u2013873.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR10", "doi-asserted-by": "crossref", "first-page": "3231", "DOI": "10.1046/j.1460-9568.1998.00345.x", "volume": "10", "author": "JC Bensadoun", "year": "1998", "unstructured": "Bensadoun JC, O Mirochnitchenko, M Inouye, P Aebischer and AD Zurn (1998) Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice.Eur. J. Neurosci. 10, 3231\u20133236.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR11", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1016/j.expneurol.2003.12.012", "volume": "187", "author": "R Betarbet", "year": "2004", "unstructured": "Betarbet R, O Poisik, TB Sherer and JT Greenamyre (2004) Differential expression and ser897 phosphorylation of striatalN-methyl-D-aspartate receptor subunit NR1 in animal models of Parkinson\u2019s disease.Exp. Neurol. 187, 76\u201385.", "journal-title": "Exp. Neurol."}, {"key": "BF03033565_CR12", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1111/j.1460-9568.2006.05285.x", "volume": "25", "author": "F Blandini", "year": "2007", "unstructured": "Blandini F, G Levandis, E Bazzini, G Nappi and MT Armentero (2007) Time-course of nigrostriatal damage, sal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.Eur. J. Neurosci. 25, 397\u2013405.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR13", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/S0301-0082(01)00003-X", "volume": "65", "author": "D Blum", "year": "2001", "unstructured": "Blum D, S Torch, N Lambeng, M Nissou, AL Benabid, R Sadoul and JM Verna (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease.Prog. Neurobiol. 65, 135\u2013172", "journal-title": "Prog. Neurobiol."}, {"key": "BF03033565_CR14", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1111/j.1476-5381.1972.tb07257.x", "volume": "44", "author": "GR Breese", "year": "1972", "unstructured": "Breese GR and TD Traylor (1972) Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.Br. J. Pharmacol. 44, 210\u2013222.", "journal-title": "Br. J. Pharmacol."}, {"key": "BF03033565_CR15", "first-page": "343", "volume": "231", "author": "GR Breese", "year": "1984", "unstructured": "Breese GR, AA Baumeister, TJ McCown, SG Emerick, GD Frye, K Crotty and RA Mueller (1984) Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.J. Pharmacol. Exp. Ther. 231, 343\u2013354.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BF03033565_CR16", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1016/j.brainresrev.2004.08.004", "volume": "48", "author": "GR Breese", "year": "2005", "unstructured": "Breese GR, DJ Knapp, HE Criswell, SS Moy, ST Papadeas and BL Blake (2005) The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles.Brain Res. Rev. 48, 57\u201373.", "journal-title": "Brain Res. Rev."}, {"key": "BF03033565_CR17", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/S0197-0186(97)00031-4", "volume": "32", "author": "JL Cadet", "year": "1998", "unstructured": "Cadet JL and C Brannock (1998) Free radicals and the pathobiology of brain dopamine systems.Neurochem. Int. 32, 117\u2013131.", "journal-title": "Neurochem. Int."}, {"key": "BF03033565_CR18", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/0006-8993(89)91530-8", "volume": "476", "author": "JL Cadet", "year": "1989", "unstructured": "Cadet JL, M Katz, V Jackson-Lewis and S Fahn (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence.Brain Res. 476, 10\u201315.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR19", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1093/brain/116.2.433", "volume": "116", "author": "P Calabresi", "year": "1993", "unstructured": "Calabresi P, NB Mercuri, G Sancesario and G Bernardi (1993) Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson\u2019s disease.Brain 116, 433\u2013452.", "journal-title": "Brain"}, {"key": "BF03033565_CR20", "doi-asserted-by": "crossref", "first-page": "18536", "DOI": "10.1074/jbc.M413224200", "volume": "280", "author": "J Callio", "year": "2005", "unstructured": "Callio J, TD Oury and CT Chu (2005) Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.J. Biol. Chem. 280, 18536\u201318542.", "journal-title": "J. Biol. Chem."}, {"key": "BF03033565_CR21", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/S0742-8413(99)00020-1", "volume": "123", "author": "B Caronti", "year": "1999", "unstructured": "Caronti B, V Margotta, A Merante, FE Pontieri and G Palladini (1999) Treatment with 6-hydroxydopamine in planaria (Dugesia gonocephala s.l.): morphological and behavioral study.Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 123, 201\u2013207.", "journal-title": "Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol."}, {"key": "BF03033565_CR22", "doi-asserted-by": "crossref", "first-page": "2563", "DOI": "10.1046/j.1460-9568.2003.02983.x", "volume": "18", "author": "AR Carta", "year": "2003", "unstructured": "Carta AR, S Fenu, P Pala, E Tronci and M Morelli (2003) Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.Eur. J. Neurosci. 18, 2563\u20132572.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR23", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/j.brainres.2004.12.009", "volume": "1034", "author": "WA Cass", "year": "2005", "unstructured": "Cass WA, LE Peters and MP Smith (2005) Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson\u2019s disease.Brain Res. 1034, 153\u2013161.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR24", "doi-asserted-by": "crossref", "first-page": "2694", "DOI": "10.1046/j.1460-9568.1998.00285.x", "volume": "10", "author": "MA Cenci", "year": "1998", "unstructured": "Cenci MA, CS Lee and A Bjorklund (1998) L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.Eur. J. Neurosci. 10, 2694\u20132706.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR25", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1016/S0306-4522(98)00217-6", "volume": "88", "author": "JW Chang", "year": "1999", "unstructured": "Chang JW, SR Wachtel, D Young and UJ Kang (1999) Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson\u2019s disease: studies on medial forebrain bundle and striatal lesions.Neuroscience 88, 617\u2013628.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR26", "doi-asserted-by": "crossref", "first-page": "S86", "DOI": "10.1016/S1471-1931(00)00018-5", "volume": "23", "author": "TN Chase", "year": "2000", "unstructured": "Chase TN and JD Oh (2000) Striatal dopamine- and gluta- mate-mediated dysregulation in experimental parkinsonism.Trends Neurosci. 23, S86-S91.", "journal-title": "Trends Neurosci."}, {"key": "BF03033565_CR27", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E", "volume": "57", "author": "WS Choi", "year": "1999", "unstructured": "Choi WS, SY Yoon, TH Oh, EJ Choi, KL O\u2019Malley and YJ Oh (1999) Two distinct mechanisms are involved in 6-hydroxy-dopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK.J. Neurosci. Res. 57, 86\u201394.", "journal-title": "J. Neurosci. Res."}, {"key": "BF03033565_CR28", "first-page": "77", "volume": "5", "author": "G Cohen", "year": "1984", "unstructured": "Cohen G (1984) Oxy-radical toxicity in catecholamine neurons.Neurotoxicology 5, 77\u201382.", "journal-title": "Neurotoxicology"}, {"key": "BF03033565_CR29", "first-page": "336", "volume": "199", "author": "G Cohen", "year": "1976", "unstructured": "Cohen G, RE Heikkila, B Allis, F Cabt, D Dembiec, D MacNamee, C Mytilineou and B Winston (1976) Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, dieth-yldithiocarmate, methimazole, cysteamine, ethanol and n-butanol.J. Pharmacol. Exp. Ther. 199, 336\u2013352.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BF03033565_CR30", "doi-asserted-by": "crossref", "first-page": "813", "DOI": "10.1016/0896-6273(95)90225-2", "volume": "14", "author": "RL Cole", "year": "1995", "unstructured": "Cole RL, C Konradi, J Douglass and SE Hyman (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum.Neuron 14, 813\u2013823.", "journal-title": "Neuron"}, {"key": "BF03033565_CR31", "doi-asserted-by": "crossref", "first-page": "1183", "DOI": "10.1016/S0306-4522(98)00390-X", "volume": "89", "author": "S Consolo", "year": "1999", "unstructured": "Consolo S, M Morelli, M Rimoldi, S Giorgi and G Di Chiara (1999) Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats.Neuroscience 89, 1183\u20131187.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR32", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1016/0006-8993(96)00519-7", "volume": "732", "author": "MS Cousins", "year": "1996", "unstructured": "Cousins MS and JD Salamone (1996) Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization.Brain Res. 732,186\u2013194.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR33", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/S0169-328X(97)00281-7", "volume": "53", "author": "SJ Crocker", "year": "1998", "unstructured": "Crocker SJ, M Morelli, N Wigle, Y Nakabeppu and GS Robertson (1998) D1- Receptor-related priming is attenuated by antisense-meditated \u2018knockdown\u2019 offos-B expression.Mol. Brain Res. 53, 69\u201377.", "journal-title": "Mol. Brain Res."}, {"key": "BF03033565_CR34", "doi-asserted-by": "crossref", "first-page": "1015", "DOI": "10.1093/cercor/11.11.1015", "volume": "11", "author": "HS Crofts", "year": "2001", "unstructured": "Crofts HS, JW Dalley, P Collins, JC Van Denderen, BJ Everitt, TW Robbins and AC Roberts (2001) Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set.Cereb. Cortex 11, 1015\u20131026.", "journal-title": "Cereb. Cortex"}, {"key": "BF03033565_CR35", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1016/0028-3932(94)90146-5", "volume": "32", "author": "A Cronin-Golomb", "year": "1994", "unstructured": "Cronin-Golomb A, S Corkin and JH Growdon (1994) Impaired problem solving in Parkinson\u2019s disease: impact of a set-shifting deficit.Neuropsychologia 32, 579\u2013593.", "journal-title": "Neuropsychologia"}, {"key": "BF03033565_CR36", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1016/S0165-0173(01)00067-4", "volume": "36", "author": "R D\u2019Hooge", "year": "2001", "unstructured": "D\u2019Hooge R and PP De Deyn (2001) Applications of the Morris water maze in the study of learning and memory.Brain Res. Rev. 36, 60\u201390.", "journal-title": "Brain Res. Rev."}, {"key": "BF03033565_CR37", "doi-asserted-by": "crossref", "first-page": "5061", "DOI": "10.1073/pnas.88.11.5061", "volume": "88", "author": "PK Dash", "year": "1991", "unstructured": "Dash PK, KA Karl, MA Colicos, R Prywes and ER Kandel (1991) cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase.Proc. Natl. Acad. Sci. USA 88, 5061\u20135065.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "BF03033565_CR38", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1016/S0896-6273(03)00568-3", "volume": "39", "author": "W Dauer", "year": "2003", "unstructured": "Dauer W and S Przedborski (2003) Parkinson\u2019s disease: mechanisms and models.Neuron 39, 889\u2013909.", "journal-title": "Neuron"}, {"key": "BF03033565_CR39", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1038/nn1632", "volume": "9", "author": "M Day", "year": "2006", "unstructured": "Day M, Z Wang, J Ding, X An, CA Ingham, AF Shering, D Wokosin, E Ilijic, Z Sun, AR Sampson, E Mugnaini, AY Deutch, SR Sesack, GW Arbuthnott and DJ Surmeier (2006) Selective elimination of glutamatergic synapses on striato-pallidal neurons in Parkinson disease models.Nat. Neurosci. 9, 251\u2013259.", "journal-title": "Nat. Neurosci."}, {"key": "BF03033565_CR40", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1006/exnr.2002.7891", "volume": "175", "author": "R Deumens", "year": "2002", "unstructured": "Deumens R, A Blokland and J Prickaerts (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.Exp. Neurol. 175, 303\u2013317.", "journal-title": "Exp. Neurol."}, {"key": "BF03033565_CR41", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1159/000480624", "volume": "18", "author": "G Chiara Di", "year": "1992", "unstructured": "Di Chiara G, M Morelli, P Barone and F Pontieri (1992) Priming as a model of behavioural sensitization.Dev. Pharmacol. Ther. 18, 223\u2013227.", "journal-title": "Dev. Pharmacol. Ther."}, {"key": "BF03033565_CR42", "doi-asserted-by": "crossref", "first-page": "2492", "DOI": "10.1046/j.1471-4159.1998.70062492.x", "volume": "70", "author": "KL Double", "year": "1998", "unstructured": "Double KL, M Maywald, M Schmittel, P Riederer and M Gerlach (1998)In vitro studies of ferritin iron release and neurotoxicity.J. Neurochem. 70, 2492\u20132499.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR43", "doi-asserted-by": "crossref", "first-page": "5546", "DOI": "10.1523/JNEUROSCI.21-15-05546.2001", "volume": "21", "author": "AW Dunah", "year": "2001", "unstructured": "Dunah AW and DG Standaert (2001) Dopamine D1 receptordependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.J. Neurosci. 21, 5546\u20135558.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR44", "first-page": "342", "volume": "57", "author": "AW Dunah", "year": "2000", "unstructured": "Dunah AW, Y Wang, RP Yasuda, K Kameyama, RL Huganir, BB Wolfe and DG Standaert (2000) Alterations in subunit expression, composition, and phosphorylation of striatalN-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson\u2019s disease.Mol. Pharmacol. 57, 342\u2013352.", "journal-title": "Mol. Pharmacol."}, {"key": "BF03033565_CR45", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1002/neu.20047", "volume": "60", "author": "H Endepols", "year": "2004", "unstructured": "Endepols H, J Schul, HC Gerhardt and W Walkowiak (2004) 6-hydroxydopamine lesions in anuran amphibians: a new model system for Parkinson\u2019s disease?J. Neurobiol. 60, 395\u2013410.", "journal-title": "J. Neurobiol."}, {"key": "BF03033565_CR46", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1016/S0014-4886(03)00139-0", "volume": "183", "author": "A Eslamboli", "year": "2003", "unstructured": "Eslamboli A, HF Baker, RM Ridley and LE Annett (2003) Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson\u2019s disease in marmoset monkeys.Exp. Neurol. 183, 418\u2013429.", "journal-title": "Exp. Neurol."}, {"key": "BF03033565_CR47", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1016/S0166-2236(97)01096-5", "volume": "20", "author": "S Ferr\u00e9", "year": "1997", "unstructured": "Ferr\u00e9 S, BB Fredholm, M Morelli, P Popoli and K Fuxe (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the sal ganglia.Trends Neurosci. 20, 482\u2013487.", "journal-title": "Trends Neurosci."}, {"key": "BF03033565_CR48", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0091-3057(96)00385-1", "volume": "57", "author": "M Finn", "year": "1997", "unstructured": "Finn M, A Jassen, P Baskin and JD Salamone (1997) Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions.Pharmacol. Biochem. Behav. 57, 243\u2013249.", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "BF03033565_CR49", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/0006-8993(88)91350-9", "volume": "438", "author": "L Franklin", "year": "1988", "unstructured": "Franklin L, L Bauce and QJ Pittman (1988) Depletion of central catecholamines reduces pressor responses to arginine vasopressin.Brain Res. 438, 295\u2013298.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR50", "doi-asserted-by": "crossref", "first-page": "1054", "DOI": "10.1523/JNEUROSCI.22-03-01054.2002", "volume": "22", "author": "S Fredduzzi", "year": "2002", "unstructured": "Fredduzzi S, R Moratalla, A Monopoli, B Cuellar, K Xu, E Ongini, F Impagnatiello, MA Schwarzschild and JF Chen (2002) Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors.J. Neurosci. 22, 1054\u20131062.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR51", "doi-asserted-by": "crossref", "first-page": "1189", "DOI": "10.1016/0306-4522(84)90294-X", "volume": "13", "author": "TF Freund", "year": "1984", "unstructured": "Freund TF, JF Powell and AD Smith (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines.Neuroscience 13, 1189\u20131215.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR52", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1016/S0306-4522(01)00005-7", "volume": "103", "author": "A Ganguly", "year": "2001", "unstructured": "Ganguly A and KA Keefe (2001) Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons.Neuroscience 103, 405\u2013412.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR53", "doi-asserted-by": "crossref", "first-page": "7609", "DOI": "10.1074/jbc.M009922200", "volume": "276", "author": "F Gardoni", "year": "2001", "unstructured": "Gardoni F, C Bellone, F Cattabeni and M Di Luca (2001) Protein kinase C activation modulates alpha-calmodulin kinase II binding to NR2A subunit of N-methyl-D-aspartate receptor complex.J. Biol. Chem. 276, 7609\u20137613.", "journal-title": "J. Biol. Chem."}, {"key": "BF03033565_CR54", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/0009-2797(89)90120-8", "volume": "69", "author": "CD Garner", "year": "1989", "unstructured": "Garner CD and JP Nachtman (1989) Manganese catalyzed auto-oxidation of dopamine to 6-hydroxydopaminein vitro.Chem. Biol. Interact. 69, 345\u2013351.", "journal-title": "Chem. Biol. Interact."}, {"key": "BF03033565_CR55", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1016/0306-4522(96)00202-3", "volume": "74", "author": "A Gasrri", "year": "1996", "unstructured": "Gasrri A, A Sulli, R Innocenzi, C Pacitti and JD Brioni (1996) Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat.Neuroscience 74, 1037\u20131044.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR56", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1177/1073858403255839", "volume": "9", "author": "CR Gerfen", "year": "2003", "unstructured": "Gerfen CR (2003) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson\u2019s disease.Neuroscientist 9, 455\u2013462.", "journal-title": "Neuroscientist"}, {"key": "BF03033565_CR57", "doi-asserted-by": "crossref", "first-page": "1429", "DOI": "10.1126/science.2147780", "volume": "250", "author": "CR Gerfen", "year": "1990", "unstructured": "Gerfen CR, TM Engber, LC Mahan, Z Susel, TN Chase, FJ Monsma Jr and DR Sibley (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and stria-topallidal neurons.Science 250, 1429\u20131432.", "journal-title": "Science"}, {"key": "BF03033565_CR58", "doi-asserted-by": "crossref", "first-page": "5042", "DOI": "10.1523/JNEUROSCI.22-12-05042.2002", "volume": "22", "author": "CR Gerfen", "year": "2002", "unstructured": "Gerfen CR, S Miyachi, R Paletzki and P Brown (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.J. Neurosci. 22, 5042\u20135054.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR59", "first-page": "329", "volume": "292", "author": "Y Glinka", "year": "1995", "unstructured": "Glinka Y and MB Youdim (1995) Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine.Eur. J. Pharmacol. 292, 329\u2013332.", "journal-title": "Eur. J. Pharmacol."}, {"key": "BF03033565_CR60", "doi-asserted-by": "crossref", "first-page": "2004", "DOI": "10.1046/j.1471-4159.1996.66052004.x", "volume": "66", "author": "Y Glinka", "year": "1996", "unstructured": "Glinka Y, KF Tipton and MB Youdim (1996) Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine.J. Neurochem. 66, 2004\u20132010.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR61", "doi-asserted-by": "crossref", "first-page": "4690", "DOI": "10.1523/JNEUROSCI.0792-06.2006", "volume": "26", "author": "PJ Hallett", "year": "2006", "unstructured": "Hallett PJ, R Spoelgen, BT Hyman, DG Standaert and AW Dunah (2006) Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking.J. Neurosci. 26, 4690\u20134700.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR62", "doi-asserted-by": "crossref", "first-page": "691", "DOI": "10.1007/s007020200058", "volume": "109", "author": "C Heim", "year": "2002", "unstructured": "Heim C, L Sova, T Kurz, W Kolasiewicz, H Schwegler and KH Sontag (2002) Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area - model of the early beginning of Parkinson\u2019s symptom- atology?J. Neural Transm. 109, 691\u2013709.", "journal-title": "J. Neural Transm."}, {"key": "BF03033565_CR63", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1046/j.1460-9568.1998.00077.x", "volume": "10", "author": "JM Henderson", "year": "1998", "unstructured": "Henderson JM, LE Annett, EM Torres and SB Dunnett (1998) Behavioural effects of subthalamic nucleus lesions in the hemiparkinsonian marmoset(Callithrix jacchus). Eur. J. Neurosci.10, 689\u2013698.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR64", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1006/exnr.1998.6819", "volume": "151", "author": "B Henry", "year": "1998", "unstructured": "Henry B, AR Crossman and JM Brotchie (1998) Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease.Exp. Neurol. 151, 334\u2013342.", "journal-title": "Exp. Neurol."}, {"key": "BF03033565_CR65", "doi-asserted-by": "crossref", "first-page": "20805", "DOI": "10.1074/jbc.272.33.20805", "volume": "272", "author": "C Hisatsune", "year": "1997", "unstructured": "Hisatsune C, H Umemori, T Inoue, T Michikawa, K Kohda, K Mikoshi and T Yamamoto (1997) Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin.J. Biol. Chem. 272, 20805\u201320810.", "journal-title": "J. Biol. Chem."}, {"key": "BF03033565_CR66", "doi-asserted-by": "crossref", "first-page": "1297", "DOI": "10.1046/j.1471-4159.2003.01952.x", "volume": "86", "author": "GU Hoglinger", "year": "2003", "unstructured": "Hoglinger GU, G Carrard, PP Michel, F Medja, A Lombes, M Ruberg, B Friguet and EC Hirsch (2003) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson\u2019s disease.J. Neurochem. 86, 1297\u20131307.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR67", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/0006-8993(93)90576-9", "volume": "626", "author": "JL Hudson", "year": "1993", "unstructured": "Hudson JL, CG van Horne, I Stromberg, S Brock, J Clayton, J Masserano, BJ Hoffer and GA Gerhardt (1993) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.Brain Res. 626, 167\u2013174.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR68", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.bbr.2005.02.023", "volume": "162", "author": "R Iancu", "year": "2005", "unstructured": "Iancu R, P Mohapel, P Brundin and G Paul (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\u2019s disease in mice.Behav. Brain Res. 162, 1\u201310.", "journal-title": "Behav. Brain Res."}, {"key": "BF03033565_CR69", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1007/BF00227776", "volume": "93", "author": "CA Ingham", "year": "1993", "unstructured": "Ingham CA, SH Hood, B Van Maldegem, A Weenink and GW Arbuthnott (1993) Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway.Exp. Brain Res. 93, 17\u201327.", "journal-title": "Exp. Brain Res."}, {"key": "BF03033565_CR70", "doi-asserted-by": "crossref", "first-page": "4732", "DOI": "10.1523/JNEUROSCI.18-12-04732.1998", "volume": "18", "author": "CA Ingham", "year": "1998", "unstructured": "Ingham CA, SH Hood, P Taggart and GW Arbuthnott (1998) Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway.J. Neurosci. 18, 4732\u20134743.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR71", "first-page": "297", "volume": "46", "author": "K Jellinger", "year": "1995", "unstructured": "Jellinger K, L Linert, E Kienzl, E Herlinger and MB Youdim (1995) Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson\u2019s disease.J. Neural Transm. Suppl. 46, 297\u2013314.", "journal-title": "J. Neural Transm. Suppl."}, {"key": "BF03033565_CR72", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/0006-8993(93)90925-D", "volume": "613", "author": "H Jiang", "year": "1993", "unstructured": "Jiang H, V Jackson-Lewis, U Muthane, ADollison, M Ferreira, A Espinosa, B Parsons and S Przedborski (1993) Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.Brain Res. 613, 347\u2013351.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR73", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1146/annurev.ne.03.030180.001125", "volume": "3", "author": "G Jonsson", "year": "1980", "unstructured": "Jonsson G (1980) Chemical neurotoxins as denervation tools in neurobiology.Annu. Rev. Neurosci. 3, 169\u2013187.", "journal-title": "Annu. Rev. Neurosci."}, {"key": "BF03033565_CR74", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1097/00001756-199602290-00008", "volume": "7", "author": "N Kayadjanian", "year": "1996", "unstructured": "Kayadjanian N, RP Heavens, MJ Besson and DJ Sirinathsinghji (1996) Striatal NMDAR2B mRNA expression after bilateral cortical and unilateral nigral deafferentation.Neuroreport 7, 713\u2013716.", "journal-title": "Neuroreport"}, {"key": "BF03033565_CR75", "first-page": "179", "volume": "175", "author": "JE Kelsey", "year": "2005", "unstructured": "Kelsey JE, SD Mague, RS Pijanowski, RC Harris, NW Kleckner and RT Matthews (2005) NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats.Psychopharmacology 175, 179\u2013188.", "journal-title": "Psychopharmacology"}, {"key": "BF03033565_CR76", "doi-asserted-by": "crossref", "first-page": "1973", "DOI": "10.1016/S0024-3205(99)00458-0", "volume": "65", "author": "E Kienzl", "year": "1999", "unstructured": "Kienzl E, K Jellinger, H Stachelberger and W Linert (1999) Iron as catalyst for oxidative stress in the pathogenesis of Parkinson\u2019s disease?Life Sci. 65, 1973\u20131976.", "journal-title": "Life Sci."}, {"key": "BF03033565_CR77", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/0361-9230(94)90013-2", "volume": "34", "author": "RM Kostrzewa", "year": "1994", "unstructured": "Kostrzewa RM, R Brus, JH Kalbfleisch, KW Perry and RW Fuller (1994) Proposed animal model of attention deficit hyperactivity disorder.Brain Res. Bull. 34, 161\u2013167.", "journal-title": "Brain Res. Bull."}, {"key": "BF03033565_CR78", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1007/BF03033376", "volume": "5", "author": "RM Kostrzewa", "year": "2003", "unstructured": "Kostrzewa RM, JP Kostrzewa and R Brus (2003) Dopamine receptor supersensitivity: an outcome and index of neurotoxicity.Neurotox. Res. 5, 111\u2013118.", "journal-title": "Neurotox. Res."}, {"key": "BF03033565_CR79", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1007/978-3-211-45295-0_43", "volume": "70", "author": "RM Kostrzewa", "year": "2006", "unstructured": "Kostrzewa RM, JP Kostrzewa, R Brus, RA Kostrzewa and P Nowak (2006) Proposed animal model of severe Parkinson\u2019s disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum.J. Neural Transm. Suppl. 70, 277\u2013279.", "journal-title": "J. Neural Transm. Suppl."}, {"key": "BF03033565_CR80", "first-page": "27", "volume": "89", "author": "GM Larson", "year": "1984", "unstructured": "Larson GM, BH Ahlman, CT Bombeck and LM Nyhus (1984) The effect of chemical and surgical sympathectomy on gastric secretion and innervation.Scand. J. Gastroenterol. Suppl. 89, 27\u201332.", "journal-title": "Scand. J. Gastroenterol. Suppl."}, {"key": "BF03033565_CR81", "first-page": "84", "volume": "96", "author": "BE Levin", "year": "2005", "unstructured": "Levin BE and HL Katzen (2005) Early cognitive changes and nondementing behavioral abnormalities in Parkinson\u2019s disease.Adv. Neurol. 96, 84\u201394.", "journal-title": "Adv. Neurol."}, {"key": "BF03033565_CR82", "first-page": "71", "volume": "40", "author": "RM Liao", "year": "1997", "unstructured": "Liao RM, SC Fowler and MJ Kallman (1997) Quantifying operant behavior deficits in rats with bilateral 6-hydroxydopamine lesions of the ventrolateral striatum.Chin. J. Physiol. 40, 71\u201378.", "journal-title": "Chin. J. Physiol."}, {"key": "BF03033565_CR83", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0166-4328(98)00160-0", "volume": "102", "author": "MD Lindner", "year": "1999", "unstructured": "Lindner MD, CK Cain, MA Plone, BR Frydel, TJ Blaney, DF Emerich DF and MR Hoane (1999) Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.Behav. Brain Res. 102, 1\u201316.", "journal-title": "Behav. Brain Res."}, {"key": "BF03033565_CR84", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1016/0925-4439(96)00020-8", "volume": "1316", "author": "W Linert", "year": "1996", "unstructured": "Linert W, E Herlinger, RF Jameson, E Kienzl, K Jellinger and MB Youdim (1996) Dopamine, 6-hydroxydopamine, iron, and dioxygen - their mutual interactions and possible implication in the development of Parkinson\u2019s disease.Biochim. Biophys. Acta 1316, 160\u2013168.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "BF03033565_CR85", "doi-asserted-by": "crossref", "first-page": "1284", "DOI": "10.1523/JNEUROSCI.19-04-01284.1999", "volume": "19", "author": "J Lotharius", "year": "1999", "unstructured": "Lotharius J, LL Dugan and KL O\u2019Malley (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.J. Neurosci. 19, 1284\u20131293.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR86", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1046/j.0953-816x.2001.01843.x", "volume": "15", "author": "M Lundblad", "year": "2002", "unstructured": "Lundblad M, M Andersson, C Winkler, D Kirik, N Wierup and MA Cenci (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease.Eur. J. Neurosci. 15, 120\u2013132.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR87", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/j.nbd.2004.01.007", "volume": "16", "author": "M Lundblad", "year": "2004", "unstructured": "Lundblad M, B Picconi, H Lindgren and MA Cenci (2004) A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.Neurobiol. Dis. 16, 110\u2013123.", "journal-title": "Neurobiol. Dis."}, {"key": "BF03033565_CR88", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1016/S0166-4328(89)80121-4", "volume": "33", "author": "J Luthman", "year": "1989", "unstructured": "Luthman J, A Fredriksson, E Sundstrom, G Jonsson and T Archer (1989) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage.Behav. Brain Res. 33, 267\u2013277.", "journal-title": "Behav. Brain Res."}, {"key": "BF03033565_CR89", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/S0166-4328(97)80991-6", "volume": "82", "author": "J Luthman", "year": "1997", "unstructured": "Luthman J, M Bassen, A Fredriksson and T Archer (1997) Functional changes induced by neonatal cerebral 6-hydroxy-dopamine treatment: effects of dose levels on behavioral parameters.Behav. Brain Res. 82, 213\u2013221.", "journal-title": "Behav. Brain Res."}, {"key": "BF03033565_CR90", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1016/0006-8993(85)90698-5", "volume": "330", "author": "RJ Mandel", "year": "1985", "unstructured": "Mandel RJ and PK Randall (1985) Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.Brain Res. 330, 358\u2013363.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR91", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1016/j.expneurol.2004.10.008", "volume": "192", "author": "C Marin", "year": "2005", "unstructured": "Marin C, E Aguilar, M Bonastre, E Tolosa and JA Obeso (2005) Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.Exp. Neurol. 192, 184\u2013193.", "journal-title": "Exp. Neurol."}, {"key": "BF03033565_CR92", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1016/0006-8993(89)91160-8", "volume": "493", "author": "JF Marshall", "year": "1989", "unstructured": "Marshall JF, R Navarrete and JN Joyce (1989) Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysisBrain Res. 493, 247\u2013257.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR93", "first-page": "269", "volume": "50", "author": "E Mempel", "year": "1990", "unstructured": "Mempel E and M Wieczorek (1990) Parkinson\u2019s syndrome induced in cats by the use of 6-hydroxydopamine. Observations of behavior and motor disorders.Acta Neurobiol. Exp. 50, 269\u2013279.", "journal-title": "Acta Neurobiol. Exp."}, {"key": "BF03033565_CR94", "first-page": "125", "volume": "7", "author": "M Menegoz", "year": "1995", "unstructured": "Menegoz M, LF Lau, D Herve, RL Huganir and JA Girault (1995) Tyrosine phosphorylation of NMD A receptor in rat striatum: effects of 6-OH-dopamine lesions.Neuroreport 7, 125\u2013128.", "journal-title": "Neuroreport"}, {"key": "BF03033565_CR95", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0306-4522(98)00189-4", "volume": "88", "author": "CK Meshul", "year": "1999", "unstructured": "Meshul CK, N Emre, CM Nakamura, C Allen, MK Donohue and JF Buckman (1999) Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.Neuroscience 88, 1\u201316.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR96", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1016/S0149-7634(96)00036-X", "volume": "21", "author": "IJ Mitchell", "year": "1997", "unstructured": "Mitchell IJ and CB Carroll (1997) Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action.Neurosci. Biobehav. Rev. 21, 469\u2013475.", "journal-title": "Neurosci. Biobehav. Rev."}, {"key": "BF03033565_CR97", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/0165-0270(91)90048-5", "volume": "36", "author": "CP Montoya", "year": "1991", "unstructured": "Montoya CP, LJ Campbell-Hope, KD Pemberton and SB Dunnett (1991) The \u201cstaircase test\u201d: a measure of independent forelimb reaching and grasping abilities in rats.J. Neurosci. Meth. 36, 219\u2013228.", "journal-title": "J. Neurosci. Meth."}, {"key": "BF03033565_CR98", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/0014-2999(87)90415-8", "volume": "141", "author": "M Morelli", "year": "1987", "unstructured": "Morelli M and G Di Chiara (1987) Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning.Eur. J. Pharmacol. 141, 101\u2013107.", "journal-title": "Eur. J. Pharmacol."}, {"key": "BF03033565_CR99", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1007/BF02244143", "volume": "101", "author": "M Morelli", "year": "1990", "unstructured": "Morelli M and G Di Chiara (1990) Stereospecific blockade ofN-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning.Psychopharmacology 101, 287\u2013288.", "journal-title": "Psychopharmacology"}, {"key": "BF03033565_CR100", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/0024-3205(87)90339-0", "volume": "40", "author": "M Morelli", "year": "1987", "unstructured": "Morelli M, S Fenu and G Di Chiara (1987) Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.Life Sci. 40, 245\u2013251.", "journal-title": "Life Sci."}, {"key": "BF03033565_CR101", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1016/0014-2999(89)90296-3", "volume": "162", "author": "M Morelli", "year": "1989", "unstructured": "Morelli M, S Fenu, L Garau and G Di Chiara (1989) Time and dose dependence of the \u2018priming\u2019 of the expression of dopamine receptor supersensitivity.Eur. J. Pharmacol. 162, 329\u2013335.", "journal-title": "Eur. J. Pharmacol."}, {"key": "BF03033565_CR102", "first-page": "389", "volume": "4", "author": "M Morelli", "year": "1993", "unstructured": "Morelli M, S Fenu, A Pinna, A Cozzolino, A Carta and G Di Chiara (1993a) \u201cPriming\u201d to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the post-synaptic dopamine message.Behav. Pharmacol. 4, 389\u2013397.", "journal-title": "Behav. Pharmacol."}, {"key": "BF03033565_CR103", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1002/syn.890130309", "volume": "13", "author": "M Morelli", "year": "1993", "unstructured": "Morelli M, FE Pontieri, I Linfante, F Orzi and G Di Chiara (1993b) Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist.Synapse 13, 264\u2013269.", "journal-title": "Synapse"}, {"key": "BF03033565_CR104", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1016/j.neuropharm.2004.02.016", "volume": "47", "author": "D Moses", "year": "2004", "unstructured": "Moses D, A Gross and JP Finberg (2004) Rasagiline enhances L-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig.Neuropharmacology 47, 72\u201380.", "journal-title": "Neuropharmacology"}, {"key": "BF03033565_CR105", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1021/jm00006a010", "volume": "38", "author": "A Napolitano", "year": "1995", "unstructured": "Napolitano A, O Crescenzi, A Pezzella and G Prota (1995) Generation of the neurotoxin 6-hydroxydopamine by peroxidase/H2O2 oxidation of dopamine.J. Med. Chem. 38, 917\u2013922.", "journal-title": "J. Med. Chem."}, {"key": "BF03033565_CR106", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/0014-2999(85)90428-5", "volume": "109", "author": "AJ Nichols", "year": "1985", "unstructured": "Nichols AJ, AC Wilson and CR Hiley (1985) Effects of chemical sympathectomy with 6-hydroxydopamine on cardiac output and its distribution in the rat.Eur. J. Pharmacol. 109, 263\u2013268.", "journal-title": "Eur. J. Pharmacol."}, {"key": "BF03033565_CR107", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1007/s00726-001-0118-2", "volume": "23", "author": "JD Oh", "year": "2002", "unstructured": "Oh JD and TN Chase (2002) Glutamate-mediated striatal dys-regulation and the pathogenesis of motor response complications in Parkinson\u2019s disease.Amino Acids 23, 133\u2013139.", "journal-title": "Amino Acids"}, {"key": "BF03033565_CR108", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1016/S0006-8993(98)01049-X", "volume": "813", "author": "JD Oh", "year": "1998", "unstructured": "Oh JD, DS Russell, CL Vaughan and TN Chase (1998) Enhanced tyrosine phosphorylation of striatal NMD A receptor subunits: effect of dopaminergic denervation and L-DOPA administration.Brain Res. 813, 150\u2013159.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR109", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/S0006-8993(99)01121-X", "volume": "821", "author": "JD Oh", "year": "1999", "unstructured": "Oh JD, CL Vaughan and TN Chase (1999) Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.Brain Res. 821, 433\u2013442.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR110", "doi-asserted-by": "crossref", "first-page": "768", "DOI": "10.1002/jnr.10629", "volume": "72", "author": "JD Oh", "year": "2003", "unstructured": "Oh JD, K Chartisathian, SM Ahmed and TN Chase (2003) Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats.J. Neurosci. Res. 72, 768\u2013780.", "journal-title": "J. Neurosci. Res."}, {"key": "BF03033565_CR111", "doi-asserted-by": "crossref", "first-page": "3863", "DOI": "10.1523/JNEUROSCI.15-05-03863.1995", "volume": "15", "author": "M Olsson", "year": "1995", "unstructured": "Olsson M, G Nikkhah, C Bentlage and A Bjorklund (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.J. Neurosci. 15, 3863\u20133875.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR112", "doi-asserted-by": "crossref", "first-page": "2765", "DOI": "10.1111/j.1460-9568.2005.04498.x", "volume": "22", "author": "A Oueslati", "year": "2005", "unstructured": "Oueslati A, N Breysse, M Amalric, L Kerkerian-Le Goff and P Salin (2005) Dysfunction of the cortico-sal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.Eur. J. Neurosci. 22, 2765\u20132774.", "journal-title": "Eur. J. Neurosci."}, {"key": "BF03033565_CR113", "doi-asserted-by": "crossref", "first-page": "1065", "DOI": "10.1016/S0006-2952(96)00716-2", "volume": "53", "author": "A Padiglia", "year": "1997", "unstructured": "Padiglia A, R Medda, A Lorrai, G Biggio, E Sanna and G Floris (1997) Modulation of 6-hydroxydopamine oxidation by various proteins.Biochem. Pharmacol. 53, 1065\u20131068.", "journal-title": "Biochem. Pharmacol."}, {"key": "BF03033565_CR114", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1021/tx990121g", "volume": "12", "author": "A Palumbo", "year": "1999", "unstructured": "Palumbo A, A Napolitano, P Barone and M d\u2019Ischia (1999) Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration.Chem. Res. Toxicol. 12, 1213\u20131222.", "journal-title": "Chem. Res. Toxicol."}, {"key": "BF03033565_CR115", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/0006-8993(94)90796-X", "volume": "662", "author": "SM Papa", "year": "1994", "unstructured": "Papa SM, TM Engber, AM Kask and TN Chase (1994) Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration.Brain Res. 662, 69\u201374.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR116", "doi-asserted-by": "crossref", "first-page": "5863", "DOI": "10.1523/JNEUROSCI.0528-04.2004", "volume": "24", "author": "ST Papadeas", "year": "2004", "unstructured": "Papadeas ST, BL Blake, DJ Knapp and GR Breese (2004) Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.J. Neurosci. 24, 5863\u20135876.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR117", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/0006-8993(89)91611-9", "volume": "504", "author": "AS Perumal", "year": "1989", "unstructured": "Perumal AS, WK Tordzro, M Katz, V Jackson-Lewis, TB Cooper, S Fahn and JL Cadet (1989) Regional effects of 6-hydroxydopamine (6-OHDA) ton free radical scavengers in rat brain.Brain Res. 504, 139\u2013141.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR118", "doi-asserted-by": "crossref", "first-page": "5283", "DOI": "10.1523/JNEUROSCI.1224-04.2004", "volume": "24", "author": "B Picconi", "year": "2004", "unstructured": "Picconi B, F Gardoni, D Centonze, D Mauceri, MA Cenci, G Bernardi, P Calabresi and M Di Luca (2004) Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism.J. Neurosci. 24, 5283\u20135291.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR119", "doi-asserted-by": "crossref", "first-page": "978", "DOI": "10.1111/j.1471-4159.1989.tb02550.x", "volume": "52", "author": "E Pileblad", "year": "1989", "unstructured": "Pileblad E, T Magnusson and B Fornstedt (1989) Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum.J. Neurochem. 52, 978\u2013980.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR120", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/0165-1838(86)90086-X", "volume": "17", "author": "PM Pilowsky", "year": "1986", "unstructured": "Pilowsky PM, MJ Morris, V Kapoor, MJ West and JP Chalmers (1986) Role of renal nerve activity, plasma catecholamines and plasma vasopressin in cardiovascular responses to intracisternal neurotoxins in the rabbit.J. Auton. Nerv. Syst. 17, 109\u2013120.", "journal-title": "J. Auton. Nerv. Syst."}, {"key": "BF03033565_CR121", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/S0014-2999(97)01067-4", "volume": "331", "author": "A Pinna", "year": "1997", "unstructured": "Pinna A, M Morelli, B Drukarch and JC Stoof (1997) Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.Eur. J. Pharmacol. 331, 23\u201326.", "journal-title": "Eur. J. Pharmacol."}, {"key": "BF03033565_CR122", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/S0014-2999(02)01818-6", "volume": "446", "author": "A Pinna", "year": "2002", "unstructured": "Pinna A, C Corsi, AR Carta, V Valentini, F Pedata and M Morelli (2002) Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation.Eur. J. Pharmacol. 446, 75\u201382.", "journal-title": "Eur. J. Pharmacol."}, {"key": "BF03033565_CR123", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1016/S0306-4522(00)00128-7", "volume": "98", "author": "V Ramesh", "year": "2000", "unstructured": "Ramesh V and V Mohan-Kumar (2000) Changes in sleep-wakefulness after 6-hydroxydopamine lesion of the preoptic area.Neuroscience 98, 549\u2013553.", "journal-title": "Neuroscience"}, {"key": "BF03033565_CR124", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/j.nbd.2005.06.003", "volume": "21", "author": "JL Ridet", "year": "2006", "unstructured": "Ridet JL, JC Bensadoun, N Deglon, P Aebischer and AD Zurn (2006) Lentivirus-mediated expression of glutathione per-oxidase: neuroprotection in murine models of Parkinson\u2019s disease.Neurobiol. Dis. 21, 29\u201334.", "journal-title": "Neurobiol. Dis."}, {"key": "BF03033565_CR125", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1016/j.bbr.2005.08.007", "volume": "166", "author": "RM Ridley", "year": "2006", "unstructured": "Ridley RM, RM Cummings, A Leow-Dyke and HF Baker (2006) Neglect of memory after dopaminergic lesions in monkeys.Behav. Brain Res. 166, 253\u2013262.", "journal-title": "Behav. Brain Res."}, {"key": "BF03033565_CR126", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1016/0091-3057(93)90174-R", "volume": "44", "author": "JD Salamone", "year": "1993", "unstructured": "Salamone JD, K Mahan and S Rogers (1993) Ventrolateral striatal dopamine depletions impair feeding and food handling in rats.Pharmacol. Biochem. Behav. 44, 605\u2013610.", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "BF03033565_CR127", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1016/S0301-0082(98)00053-7", "volume": "56", "author": "JD Salamone", "year": "1998", "unstructured": "Salamone JD, AJ Mayorga, JT Trevitt, MS Cousins, A Conlan and A Nawab (1998) Tremulous jaw movements in rats: a model of parkinsonian tremor.Prog. Neurobiol. 56, 591\u2013611.", "journal-title": "Prog. Neurobiol."}, {"key": "BF03033565_CR128", "doi-asserted-by": "crossref", "first-page": "1926", "DOI": "10.1111/j.1471-4159.1990.tb04893.x", "volume": "54", "author": "D Samuel", "year": "1990", "unstructured": "Samuel D, M Errami and A Nieoullon (1990) Localization ofN-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H3-(2-carboxypiperazin-4-yl) propyl-1-phosphonic acid binding.J. Neurochem. 54, 1926\u20131933.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR129", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1016/S0028-3908(00)00005-8", "volume": "39", "author": "T Schallert", "year": "2000", "unstructured": "Schallert T, SM Fleming, JL Leasure, JL Tillerson and ST Bland (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury.Neuropharmacology 39, 777\u2013787.", "journal-title": "Neuropharmacology"}, {"key": "BF03033565_CR130", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1111/j.1471-4159.1991.tb08257.x", "volume": "57", "author": "SN Schiffmann", "year": "1991", "unstructured": "Schiffmann SN, O Jacobs and JJ Vanderhaeghen (1991) Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: anin situ hybridization histochemistry study.J. Neurochem. 57, 1062\u20131067.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR131", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1007/BF02246580", "volume": "123", "author": "SB Schwarzkopf", "year": "1996", "unstructured": "Schwarzkopf SB, JP Bruno, T Mitra and JR Ison (1996) Effects of haloperidol and SCH 23390 on acoustic startle in animals depleted of dopamine as neonates: implications for neuropsychiatric syndromes.Psychopharmacology 123, 258\u2013266.", "journal-title": "Psychopharmacology"}, {"key": "BF03033565_CR132", "doi-asserted-by": "crossref", "first-page": "8814", "DOI": "10.1523/JNEUROSCI.18-21-08814.1998", "volume": "18", "author": "V Sgamto", "year": "1998", "unstructured": "Sgamto V, C Pages, M Rogard, MJ Besson, J Caboche (1998) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation.J. Neurosci. 18, 8814\u20138825.", "journal-title": "J. Neurosci."}, {"key": "BF03033565_CR133", "doi-asserted-by": "crossref", "first-page": "1427", "DOI": "10.1126/science.1646483", "volume": "252", "author": "M Sheng", "year": "1991", "unstructured": "Sheng M, MA Thompson and ME Greenberg (1991) CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases.Science 252, 1427\u20131430.", "journal-title": "Science"}, {"key": "BF03033565_CR134", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/0006-8993(81)90002-0", "volume": "217", "author": "P Somogyi", "year": "1981", "unstructured": "Somogyi P, JP Bolam, S Totterdell and AD Smith (1981) Monosynaptic input from the nucleus accumbens \u2014 ventral striatum region to retrogradely labelled nigrostriatal neurones.Brain Res. 217, 245\u2013263.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR135", "doi-asserted-by": "crossref", "first-page": "1605", "DOI": "10.1046/j.1471-4159.2000.0741605.x", "volume": "74", "author": "R Soto-Otero", "year": "2000", "unstructured": "Soto-Otero R, E Mendez-Alvarez, A Hermida-Ameijeiras, AM Munoz-Patino and JL Landeira-Garcia (2000) Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson\u2019s disease.J. Neurochem. 74, 1605\u20131612.", "journal-title": "J. Neurochem."}, {"key": "BF03033565_CR136", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1007/s007020050023", "volume": "107", "author": "A Storch", "year": "2000", "unstructured": "Storch A, A Kaftan, K Burkhardt and J Schwarz (2000) 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism.J. Neural Transm. 107, 281\u2013293.", "journal-title": "J. Neural Transm."}, {"key": "BF03033565_CR137", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1016/0014-2999(85)90524-2", "volume": "114", "author": "A Sudo", "year": "1985", "unstructured": "Sudo A (1985) Decrease in adrenaline content of various organs of the rat after 6-hydroxydopamine.Eur. J. Pharmacol. 114, 79\u201383.", "journal-title": "Eur. J. Pharmacol."}, {"key": "BF03033565_CR138", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1111/j.1476-5381.1990.tb12985.x", "volume": "99", "author": "N Sunn", "year": "1990", "unstructured": "Sunn N, PJ Harris and C Bell (1990) Effects on renal sympathetic axons in dog of acute 6-hydroxydopamine treatment in combination with selective neuronal uptake inhibitors.Br. J. Pharmacol. 99, 655\u2013660.", "journal-title": "Br. J. Pharmacol."}, {"key": "BF03033565_CR139", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0166-4328(95)00148-4", "volume": "74", "author": "M Takasuna", "year": "1996", "unstructured": "Takasuna M and T Iwasaki (1996) Active and passive avoidance learning in rats neonatally treated with intraventricular 6-hydroxydopamine.Behav. Brain Res. 74, 119\u2013126.", "journal-title": "Behav. Brain Res."}, {"key": "BF03033565_CR140", "author": "H Thoenen", "first-page": "813", "year": "1972", "unstructured": "Thoenen H (1972) Surgical, immunological and chemical sympathectomy, In:Handbook of Experimental Pharmacology (Blaschko H and E Muscholl, Eds.) (Springer:Berlin)33, 813\u2013844.", "volume-title": "Handbook of Experimental Pharmacology"}, {"key": "BF03033565_CR141", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1007/s00213-005-2202-x", "volume": "179", "author": "N Turle-Lorenzo", "year": "2005", "unstructured": "Turle-Lorenzo N, N Breysse, G Baunez and M Amalric (2005) Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson\u2019s disease.Psychopharmacology 179, 117\u2013127.", "journal-title": "Psychopharmacology"}, {"key": "BF03033565_CR142", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.1097/00001756-199607290-00020", "volume": "7", "author": "J Ulas", "year": "1996", "unstructured": "Ulas J and CW Cotman (1996) Dopaminergic denervation of striatum results in elevated expression of NR2A subunit.Neuroreport 7, 1789\u20131793.", "journal-title": "Neuroreport"}, {"key": "BF03033565_CR143", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1016/0006-8993(70)90187-3", "volume": "24", "author": "U Ungerstedt", "year": "1970", "unstructured": "Ungerstedt U and G Arbuthnott (1970) Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system.Brain Res. 24, 485\u2013493.", "journal-title": "Brain Res."}, {"key": "BF03033565_CR144", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1016/S0169-328X(97)00253-2", "volume": "52", "author": "D Vallone", "year": "1997", "unstructured": "Vallone D, MT Pellecchia, M Morelli, P Verde, G DiChiara and P Barone (1997) Behavioural sensitization in 6-hydroxydo- pamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction offos-B- andjun-D-related proteins.Mol. Brain Res. 52, 307\u2013317.", "journal-title": "Mol. Brain Res."}, {"key": "BF03033565_CR145", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/S0169-328X(98)00214-9", "volume": "61", "author": "SV Witte Van de", "year": "1998", "unstructured": "Van de Witte SV, B Drukarch, JC Stoof and P Voorn (1998) Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopa-mine-lesioned rats after challenge with dopamine D1-receptor agonist.Mol. Brain Res. 61, 219\u2013223.", "journal-title": "Mol. Brain Res."}, {"key": "BF03033565_CR146", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1002/1098-2396(20000901)37:3<171::AID-SYN1>3.0.CO;2-R", "volume": "37", "author": "JM Kampen Van", "year": "2000", "unstructured": "Van Kampen JM, EG McGeer and AJ Stoessl (2000) Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.Synapse 37, 171\u2013178.", "journal-title": "Synapse"}, {"key": "BF03033565_CR147", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1111/j.1474-8673.1994.tb00608.x", "volume": "14", "author": "MM Villanueva", "year": "1994", "unstructured": "Villanueva MM, P Soares-da-Silva and W Osswald (1994) Effect of sympathetic denervation on the relaxing responses of rabbit arterial smooth muscle.J. Auton. Pharmacol. 14, 275\u2013281.", "journal-title": "J. Auton. Pharmacol."}, {"key": "BF03033565_CR148", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1038/369233a0", "volume": "369", "author": "YT Wang", "year": "1994", "unstructured": "Wang YT and MW Salter (1994) Regulation of NMDA receptors by tyrosine kinases and phosphatases.Nature 369, 233\u2013235.", "journal-title": "Nature"}, {"key": "BF03033565_CR149", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/S0166-4328(97)00057-0", "volume": "89", "author": "IQ Whishaw", "year": "1997", "unstructured": "Whishaw IQ, NC Woodward, E Miklyaeva and SM Pellis (1997) Analysis of limb use by control rats and unilateral DA-depleted rats in the Montoya staircase test: movements, impairments and compensatory strategies.Behav. Brain Res. 89, 167\u2013177.", "journal-title": "Behav. Brain Res."}, {"key": "BF03033565_CR150", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.1016/j.expneurol.2004.09.005", "volume": "191", "author": "MT Woodlee", "year": "2005", "unstructured": "Woodlee MT, AM Asseo-Garcia, X Zhao, SJ Liu, TA Jones and T Schallert (2005) Testing forelimb placing \u201cacross the midline\u201d reveals distinct, lesion-dependent patterns of recovery in rats.Exp. Neurol. 191, 310\u2013317.", "journal-title": "Exp. Neurol."}, {"key": "BF03033565_CR151", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/S0304-3940(96)13276-6", "volume": "221", "author": "Y Wu", "year": "1996", "unstructured": "Wu Y, D Blum, MF Nissou, AL Benabid and JM Verna (1996) Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition.Neurosci. Lett. 221, 69\u201371.", "journal-title": "Neurosci. Lett."}, {"key": "BF03033565_CR152", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/0304-3940(95)11361-Y", "volume": "187", "author": "J Yanai", "year": "1995", "unstructured": "Yanai J,WF Silverman and D Shamir (1995) An avian model for the reversal of 6-hydroxydopamine induced rotating behaviour by neural grafting.Neurosci. Lett. 187, 153\u2013156.", "journal-title": "Neurosci. Lett."}, {"key": "BF03033565_CR153", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1196/annals.1306.025", "volume": "1012", "author": "MB Youdim", "year": "2004", "unstructured": "Youdim MB, G Stephenson and D Ben Shachar (2004) Ironing iron out in Parkinson\u2019s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.Ann. NYAcad. Sci. 1012, 306\u2013325.", "journal-title": "Ann. NYAcad. Sci."}, {"key": "BF03033565_CR154", "doi-asserted-by": "crossref", "first-page": "1119", "DOI": "10.1080/10715760500233113", "volume": "39", "author": "V Zrsky", "year": "2005", "unstructured": "Zrsky V, KP Datla, S Parkar, DK Rai, OI Aruoma and DT Dexter (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease.Free Radic. Res. 39, 1119\u20131125.", "journal-title": "Free Radic. Res."}], "container-title": ["Neurotoxicity Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF03033565.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF03033565/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF03033565", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 21]], "date-time": "2019-05-21T23:32:22Z", "timestamp": 1558481542000}, "score": 23.56062, "issued": {"date-parts": [[2007, 9]]}, "references-count": 154, "journal-issue": {"published-print": {"date-parts": [[2007, 9]]}, "issue": "3-4"}, "alternative-id": ["BF03033565"], "URL": "http://dx.doi.org/10.1007/bf03033565", "relation": {"cites": []}, "ISSN": ["1029-8428", "1476-3524"], "issn-type": [{"value": "1029-8428", "type": "print"}, {"value": "1476-3524", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:26:17Z", "timestamp": 1574321177016}, "reference-count": 176, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5-6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[2009, 9]]}, "DOI": "10.1097/fbp.0b013e32833109a0", "type": "journal-article", "created": {"date-parts": [[2009, 9, 8]], "date-time": "2009-09-08T07:13:52Z", "timestamp": 1252394032000}, "page": "363-379", "source": "Crossref", "is-referenced-by-count": 27, "title": ["Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson\u02bcs disease"], "prefix": "10.1097", "volume": "20", "author": [{"given": "Sandro", "family": "Fenu", "sequence": "first", "affiliation": []}, {"given": "Jadwiga", "family": "Wardas", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "link": [{"URL": "http://journals.lww.com/behaviouralpharm/Fulltext/10.1097/FBP.0b013e32833109a0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 23]], "date-time": "2019-02-23T07:39:10Z", "timestamp": 1550907550000}, "score": 23.56062, "subtitle": [""], "issued": {"date-parts": [[2009, 9]]}, "references-count": 176, "journal-issue": {"issue": "5-6"}, "URL": "http://dx.doi.org/10.1097/fbp.0b013e32833109a0", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T18:05:40Z", "timestamp": 1574100340836}, "reference-count": 27, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 2, 1]], "date-time": "1997-02-01T00:00:00Z", "timestamp": 854755200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[1997, 2]]}, "DOI": "10.1016/s0014-2999(96)00944-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:49:30Z", "timestamp": 1027619370000}, "page": "143-147", "source": "Crossref", "is-referenced-by-count": 117, "title": ["Adenosine A2A receptor antagonism potentiates l-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats"], "prefix": "10.1016", "volume": "321", "author": [{"given": "Sandro", "family": "Fenu", "sequence": "first", "affiliation": []}, {"given": "Annalisa", "family": "Pinna", "sequence": "additional", "affiliation": []}, {"given": "Ennio", "family": "Ongini", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014299996009442?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014299996009442?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T11:56:35Z", "timestamp": 1556106995000}, "score": 23.30747, "issued": {"date-parts": [[1997, 2]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[1997, 2]]}, "issue": "2"}, "alternative-id": ["S0014299996009442"], "URL": "http://dx.doi.org/10.1016/s0014-2999(96)00944-2", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T00:48:02Z", "timestamp": 1575506882701}, "reference-count": 45, "publisher": "Mary Ann Liebert Inc", "issue": "2", "license": [{"URL": "https://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/", "start": {"date-parts": [[2014, 6, 1]], "date-time": "2014-06-01T00:00:00Z", "timestamp": 1401580800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Caffeine Research"], "published-print": {"date-parts": [[2014, 6]]}, "DOI": "10.1089/jcr.2014.0006", "type": "journal-article", "created": {"date-parts": [[2014, 7, 21]], "date-time": "2014-07-21T19:39:44Z", "timestamp": 1405971584000}, "page": "41-47", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of MDMA on Glial Activation in the Mouse Brain: Relevance to Caffeine\u2013MDMA Interactions"], "prefix": "10.1089", "volume": "4", "author": [{"given": "Amit", "family": "Khairnar", "sequence": "first", "affiliation": [{"name": "CEITEC\u2014Central European Institute of Technology, Masaryk University, Brno, Czech Republic."}]}, {"given": "Lucia", "family": "Frau", "sequence": "additional", "affiliation": [{"name": "Section of Neuropsychopharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy."}]}, {"given": "Antonio", "family": "Plumitallo", "sequence": "additional", "affiliation": [{"name": "Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy."}]}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": [{"name": "Section of Neuropsychopharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy."}, {"name": "National Institute of Neuroscience (INN), University of Cagliari, Cagliari, Italy."}, {"name": "National Research Council (CNR), Neuroscience Institute, University of Cagliari, Cagliari, Italy."}]}, {"given": "Nicola", "family": "Simola", "sequence": "additional", "affiliation": [{"name": "Section of Neuropsychopharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy."}]}], "member": "278", "container-title": ["Journal of Caffeine Research"], "language": "en", "link": [{"URL": "https://www.liebertpub.com/doi/full-xml/10.1089/jcr.2014.0006", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.liebertpub.com/doi/pdf/10.1089/jcr.2014.0006", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 30]], "date-time": "2018-08-30T05:22:01Z", "timestamp": 1535606521000}, "score": 23.30747, "issued": {"date-parts": [[2014, 6]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[2014, 6]]}, "issue": "2"}, "alternative-id": ["10.1089/jcr.2014.0006"], "URL": "http://dx.doi.org/10.1089/jcr.2014.0006", "ISSN": ["2156-5783", "2156-5368"], "issn-type": [{"value": "2156-5783", "type": "print"}, {"value": "2156-5368", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:19:28Z", "timestamp": 1574813968183}, "reference-count": 48, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 10, 1]], "date-time": "2017-10-01T00:00:00Z", "timestamp": 1506816000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2017, 10]]}, "DOI": "10.1016/j.ejphar.2017.07.030", "type": "journal-article", "created": {"date-parts": [[2017, 7, 21]], "date-time": "2017-07-21T18:01:06Z", "timestamp": 1500660066000}, "page": "10-16", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease"], "prefix": "10.1016", "volume": "813", "author": [{"given": "Wai Kin D.", "family": "Ko", "sequence": "first", "affiliation": []}, {"given": "Qin", "family": "Li", "sequence": "additional", "affiliation": []}, {"given": "Long Yun", "family": "Cheng", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}, {"given": "Manolo", "family": "Carta", "sequence": "additional", "affiliation": []}, {"given": "Erwan", "family": "Bezard", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014299917304740?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014299917304740?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 10, 1]], "date-time": "2019-10-01T08:57:32Z", "timestamp": 1569920252000}, "score": 23.20107, "issued": {"date-parts": [[2017, 10]]}, "references-count": 48, "alternative-id": ["S0014299917304740"], "URL": "http://dx.doi.org/10.1016/j.ejphar.2017.07.030", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease", "name": "articletitle", "label": "Article Title"}, {"value": "European Journal of Pharmacology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ejphar.2017.07.030", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:55:35Z", "timestamp": 1574139335775}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 9, 1]], "date-time": "1992-09-01T00:00:00Z", "timestamp": 715305600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Research"], "published-print": {"date-parts": [[1992, 9]]}, "DOI": "10.1016/1043-6618(92)90852-3", "type": "journal-article", "created": {"date-parts": [[2004, 9, 28]], "date-time": "2004-09-28T19:29:25Z", "timestamp": 1096399765000}, "page": "71", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Differential interaction of dopaminergic D-1 and D-2 receptors with glutamatergic, gabaergic and cholinergic transmission in the 6-hyroxydopamine model of Parkinson"], "prefix": "10.1016", "volume": "26", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": []}, {"given": "Sandro", "family": "Fenu", "sequence": "additional", "affiliation": []}, {"given": "Alberto", "family": "Cozzolino", "sequence": "additional", "affiliation": []}, {"given": "Annalisa", "family": "Pinna", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:1043661892908523?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:1043661892908523?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 3]], "date-time": "2019-02-03T12:26:24Z", "timestamp": 1549196784000}, "score": 22.69585, "issued": {"date-parts": [[1992, 9]]}, "references-count": 0, "alternative-id": ["1043661892908523"], "URL": "http://dx.doi.org/10.1016/1043-6618(92)90852-3", "ISSN": ["1043-6618"], "issn-type": [{"value": "1043-6618", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:56:55Z", "timestamp": 1574153815285}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 3, 1]], "date-time": "2003-03-01T00:00:00Z", "timestamp": 1046476800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2003, 3]]}, "DOI": "10.1016/s0014-2999(03)01352-9", "type": "journal-article", "created": {"date-parts": [[2003, 2, 28]], "date-time": "2003-02-28T14:44:40Z", "timestamp": 1046443480000}, "page": "33-38", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats"], "prefix": "10.1016", "volume": "464", "author": [{"given": "Claudia", "family": "Corsi", "sequence": "first", "affiliation": []}, {"given": "Annalisa", "family": "Pinna", "sequence": "additional", "affiliation": []}, {"given": "Marco", "family": "Gianfriddo", "sequence": "additional", "affiliation": []}, {"given": "Alessia", "family": "Melani", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}, {"given": "Felicita", "family": "Pedata", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014299903013529?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014299903013529?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 27]], "date-time": "2019-03-27T11:28:41Z", "timestamp": 1553686121000}, "score": 21.48159, "issued": {"date-parts": [[2003, 3]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2003, 3]]}, "issue": "1"}, "alternative-id": ["S0014299903013529"], "URL": "http://dx.doi.org/10.1016/s0014-2999(03)01352-9", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:54:13Z", "timestamp": 1574499253472}, "publisher-location": "New York, NY", "reference-count": 113, "publisher": "Springer New York", "isbn-type": [{"value": "9781461439028", "type": "print"}, {"value": "9781461439035", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-1-4614-3903-5_18", "type": "book-chapter", "created": {"date-parts": [[2012, 8, 28]], "date-time": "2012-08-28T21:15:10Z", "timestamp": 1346188510000}, "page": "361-384", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson\u2019s Disease"], "prefix": "10.1007", "author": [{"given": "Annalisa", "family": "Pinna", "sequence": "first", "affiliation": []}, {"given": "Nicola", "family": "Simola", "sequence": "additional", "affiliation": []}, {"given": "Lucia", "family": "Frau", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 7, 23]]}, "reference": [{"key": "18_CR1", "doi-asserted-by": "publisher", "first-page": "R283", "DOI": "10.1152/ajpregu.00840.2004", "volume": "289", "author": "TH Adair", "year": "2005", "unstructured": "Adair TH (2005) Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 289:R283\u2013R296", "journal-title": "Am J Physiol Regul Integr Comp Physiol"}, {"key": "18_CR2", "doi-asserted-by": "crossref", "first-page": "10982", "DOI": "10.1523/JNEUROSCI.23-34-10982.2003", "volume": "23", "author": "PD Alfinito", "year": "2003", "unstructured": "Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK (2003) Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. J Neurosci 23:10982\u201310987", "journal-title": "J Neurosci"}, {"key": "18_CR3", "doi-asserted-by": "publisher", "first-page": "1696", "DOI": "10.1212/01.wnl.0000279518.10072.df", "volume": "69", "author": "A Alonso", "year": "2007", "unstructured": "Alonso A, Rodr\u00edguez LA, Logroscino G, Hern\u00e1n MA (2007) Gout and risk of Parkinson disease: a prospective study. Neurology 69:1696\u20131700", "journal-title": "Neurology"}, {"key": "18_CR4", "doi-asserted-by": "publisher", "first-page": "576", "DOI": "10.1016/j.parkreldis.2007.11.001", "volume": "14", "author": "T Annanmaki", "year": "2008", "unstructured": "Annanmaki T, Pessala-Driver A, Hokkanen L, Murros K (2008) Uric acid associates with cognition in Parkinson\u2019s disease. Parkinsonism Relat Disord 14:576\u2013578", "journal-title": "Parkinsonism Relat Disord"}, {"key": "18_CR5", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1002/ana.1052", "volume": "50", "author": "A Ascherio", "year": "2001", "unstructured": "Ascherio A, Zhang SM, Hern\u00e1n MA, Kawachi I, Colditz GA, Speizer FE, Willett WC (2001) Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363", "journal-title": "Ann Neurol"}, {"key": "18_CR6", "doi-asserted-by": "publisher", "first-page": "1460", "DOI": "10.1001/archneurol.2009.247", "volume": "66", "author": "A Ascherio", "year": "2009", "unstructured": "Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB et al (2009) Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 66:1460\u20131468", "journal-title": "Arch Neurol"}, {"key": "18_CR7", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1212/01.WNL.0000073136.00548.D4", "volume": "61", "author": "W Bara-Jimenez", "year": "2003", "unstructured": "Bara-Jimenez W, Sherzai A, Dimitrova T, Favit A, Bibbiani F, Gillespie M, Morris MJ, Mouradian MM, Chase TN (2003) Adenosine A(2A) receptor antagonist treatment of Parkinson\u2019s disease. Neurology 61:293\u2013296", "journal-title": "Neurology"}, {"key": "18_CR8", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1016/S0014-4886(03)00250-4", "volume": "184", "author": "F Bibbiani", "year": "2003", "unstructured": "Bibbiani F, Oh JD, Petzer JP, Castagnoli N Jr, Chen JF, Schwarzschild MA, Chase TN (2003) A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson\u2019s disease. Exp Neurol 184:285\u2013294", "journal-title": "Exp Neurol"}, {"issue": "Suppl 2", "key": "18_CR9", "first-page": "A317", "volume": "74", "author": "KJ Black", "year": "2010", "unstructured": "Black KJ, Campbell MC, Dickerson W, Creech ML, Koller JM, Chung S, Bandak SI (2010) A randomized, double-blind, placebo-controlled cross-over trial of the adenosine A2A antagonist SYN115 in Parkinson disease. Neurology 74(Suppl 2):A317", "journal-title": "Neurology"}, {"key": "18_CR10", "doi-asserted-by": "publisher", "first-page": "362", "DOI": "10.1007/s00221-005-2302-1", "volume": "165", "author": "J Bov\u00e9", "year": "2005", "unstructured": "Bov\u00e9 J, Serrats J, Mengod G, Cort\u00e9s R, Tolosa E, Marin C (2005) Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways. Exp Brain Res 165:362\u2013374", "journal-title": "Exp Brain Res"}, {"key": "18_CR11", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1002/syn.20259", "volume": "59", "author": "J Bov\u00e9", "year": "2006", "unstructured": "Bov\u00e9 J, Serrats J, Mengod G, Cort\u00e9s R, Aguilar E, Marin C (2006) Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats. Synapse 59:435\u2013444", "journal-title": "Synapse"}, {"key": "18_CR12", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1016/S0197-4580(02)00065-9", "volume": "24", "author": "H Braak", "year": "2003", "unstructured": "Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211", "journal-title": "Neurobiol Aging"}, {"issue": "suppl 1", "key": "18_CR13", "first-page": "S257", "volume": "24", "author": "DJ Brooks", "year": "2009", "unstructured": "Brooks DJ, Warrington S, Tendolkar A, Cutler DL, Hunter J (2009) Positron emission tomography (PET) study of preladenant in healthy male subjects. Mov Disord 24(suppl 1):S257", "journal-title": "Mov Disord"}, {"key": "18_CR14", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1097/WNF.0b013e3181d137d2", "volume": "33", "author": "DJ Brooks", "year": "2010", "unstructured": "Brooks DJ, Papapetropoulos S, Vandenhende F, Tomic D, He P, Coppell A, O\u2019Neill G (2010) An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers. Clin Neuropharmacol 33:55\u201360", "journal-title": "Clin Neuropharmacol"}, {"key": "18_CR15", "doi-asserted-by": "publisher", "first-page": "1075", "DOI": "10.1093/brain/awh128", "volume": "127", "author": "F Calon", "year": "2004", "unstructured": "Calon F, Dridi M, Hornykiewicz O, Bedard PJ, Rajput AH, Di Paolo T (2004) Increased adenosine A2A receptors in the brain of Parkinson\u2019s disease patients with dyskinesias. Brain 127:1075\u20131084", "journal-title": "Brain"}, {"key": "18_CR16", "doi-asserted-by": "publisher", "first-page": "72", "DOI": "10.1016/j.brainres.2006.06.087", "volume": "1111", "author": "J Camarasa", "year": "2006", "unstructured": "Camarasa J, Pubill D, Escubedo E (2006) Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug. Brain Res 1111:72\u201382", "journal-title": "Brain Res"}, {"key": "18_CR17", "doi-asserted-by": "publisher", "first-page": "2249", "DOI": "10.1038/sj.npp.1301375", "volume": "32", "author": "P Carriba", "year": "2007", "unstructured": "Carriba P, Ortiz O, Patkar K, Justinova Z, Stroik J, Themann A, M\u00fcller C, Woods AS, Hope BT, Ciruela F et al (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32:2249\u20132259", "journal-title": "Neuropsychopharmacology"}, {"key": "18_CR18", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1002/syn.10066", "volume": "44", "author": "AR Carta", "year": "2002", "unstructured": "Carta AR, Pinna A, Cauli O, Morelli M (2002) Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-DOPA and A2A receptor blockade plus L-DOPA in dopamine-denervated rats. Synapse 44:166\u2013174", "journal-title": "Synapse"}, {"key": "18_CR19", "doi-asserted-by": "publisher", "first-page": "2563", "DOI": "10.1046/j.1460-9568.2003.02983.x", "volume": "18", "author": "AR Carta", "year": "2003", "unstructured": "Carta AR, Fenu S, Pala P, Tronci E, Morelli M (2003) Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. Eur J Neurosci 18:2563\u20132572", "journal-title": "Eur J Neurosci"}, {"key": "18_CR20", "doi-asserted-by": "publisher", "first-page": "1478", "DOI": "10.1111/j.1471-4159.2009.06425.x", "volume": "111", "author": "AR Carta", "year": "2009", "unstructured": "Carta AR, Kachroo A, Schintu N, Xu K, Schwarzschild MA, Wardas J, Morelli M (2009) Inactivation of neuronal forebrain A2A receptors protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurochem 111:1478\u20131489", "journal-title": "J Neurochem"}, {"key": "18_CR21", "doi-asserted-by": "publisher", "first-page": "S107", "DOI": "10.1212/01.WNL.0000095223.08711.48", "volume": "61", "author": "TN Chase", "year": "2003", "unstructured": "Chase TN, Bibbiani F, Bara-Jimenez W, Dimitrova T, Oh-Lee JD (2003) Translating A2A antagonist KW6002 from animal models to parkinsonian patients. Neurology 61:S107\u2013S111", "journal-title": "Neurology"}, {"key": "18_CR22", "doi-asserted-by": "crossref", "first-page": "9192", "DOI": "10.1523/JNEUROSCI.19-21-09192.1999", "volume": "19", "author": "JF Chen", "year": "1999", "unstructured": "Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, Schwarzschild MA (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 19:9192\u20139200", "journal-title": "J Neurosci"}, {"key": "18_CR23", "doi-asserted-by": "publisher", "first-page": "1970", "DOI": "10.1073/pnas.98.4.1970", "volume": "98", "author": "JF Chen", "year": "2001", "unstructured": "Chen JF, Moratalla R, Impagnatiello F, Grandy DK, Cuellar B, Rubinstein M, Beilstein MA, Hackett E, Fink JS, Low MJ et al (2001a) The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci USA 98:1970\u20131975", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "18_CR24", "doi-asserted-by": "crossref", "first-page": "RC143", "DOI": "10.1523/JNEUROSCI.21-10-j0001.2001", "volume": "21", "author": "JF Chen", "year": "2001", "unstructured": "Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N Jr, Schwarzschild MA (2001b) Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease. J Neurosci 21:RC143", "journal-title": "J Neurosci"}, {"key": "18_CR25", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1016/0361-9230(94)90285-2", "volume": "33", "author": "WH Church", "year": "1994", "unstructured": "Church WH, Ward VL (1994) Uric acid is reduced in the substantia nigra in Parkinson\u2019s disease: effect on dopamine oxidation. Brain Res Bull 33:419\u2013425", "journal-title": "Brain Res Bull"}, {"key": "18_CR26", "doi-asserted-by": "publisher", "first-page": "701", "DOI": "10.2217/bmm.10.94", "volume": "4", "author": "S Cipriani", "year": "2010", "unstructured": "Cipriani S, Chen X, Schwarzschild MA (2010) Urate: a novel biomarker of Parkinson\u2019s disease risk, diagnosis and prognosis. Biomark Med 4:701\u2013712", "journal-title": "Biomark Med"}, {"key": "18_CR27", "doi-asserted-by": "publisher", "first-page": "2080", "DOI": "10.1523/JNEUROSCI.3574-05.2006", "volume": "26", "author": "F Ciruela", "year": "2006", "unstructured": "Ciruela F, Casad\u00f3 V, Rodrigues RJ, Luj\u00e1n R, Burgue\u00f1o J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J et al (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080\u20132087", "journal-title": "J Neurosci"}, {"key": "18_CR28", "doi-asserted-by": "publisher", "first-page": "1451", "DOI": "10.1038/sj.npp.1300444", "volume": "29", "author": "R Coccurello", "year": "2004", "unstructured": "Coccurello R, Breysse N, Amalric M (2004) Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology 29:1451\u20131461", "journal-title": "Neuropsychopharmacology"}, {"key": "18_CR29", "doi-asserted-by": "publisher", "first-page": "889", "DOI": "10.1016/S0896-6273(03)00568-3", "volume": "39", "author": "W Dauer", "year": "2003", "unstructured": "Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909", "journal-title": "Neuron"}, {"key": "18_CR30", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1038/nn1632", "volume": "9", "author": "M Day", "year": "2006", "unstructured": "Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR et al (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9:251\u2013259", "journal-title": "Nat Neurosci"}, {"key": "18_CR31", "doi-asserted-by": "publisher", "first-page": "1549", "DOI": "10.1002/art.24193", "volume": "59", "author": "M Vera De", "year": "2008", "unstructured": "De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H (2008) Gout and the risk of Parkinson\u2019s disease: a cohort study. Arthritis Rheum 59:1549\u20131554", "journal-title": "Arthritis Rheum"}, {"key": "18_CR32", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1016/0735-6757(92)90211-F", "volume": "10", "author": "RW Derlet", "year": "1992", "unstructured": "Derlet RW, Tseng JC, Albertson TE (1992) Potentiation of cocaine and d-amphetamine toxicity with caffeine. Am J Emerg Med 10:211\u2013216", "journal-title": "Am J Emerg Med"}, {"key": "18_CR33", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1007/s00395-006-0621-4", "volume": "101", "author": "A Deussen", "year": "2006", "unstructured": "Deussen A, Brand M, Pexa A, Weichsel J (2006) Metabolic coronary flow regulation\u2014current concepts. Basic Res Cardiol 101:453\u2013464", "journal-title": "Basic Res Cardiol"}, {"key": "18_CR34", "doi-asserted-by": "publisher", "first-page": "68", "DOI": "10.1038/sj.bjp.0704240", "volume": "134", "author": "M El Yacoubi", "year": "2001", "unstructured": "El Yacoubi M, Ledent C, Parmentier M, Bertorelli R, Ongini E, Costentin J, Vaugeois JM (2001) Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol 134:68\u201377", "journal-title": "Br J Pharmacol"}, {"key": "18_CR35", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1016/j.parkreldis.2010.02.014", "volume": "16", "author": "S Factor", "year": "2010", "unstructured": "Factor S, Mark MH, Watts R, Struck L, Mori A, Ballerini R, Sussman NM (2010) A long-term study of istradefylline in subjects with fluctuating Parkinson\u2019s disease. Parkinsonism Relat Disord 16:423\u2013426", "journal-title": "Parkinsonism Relat Disord"}, {"key": "18_CR36", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/S0014-2999(96)00944-2", "volume": "321", "author": "S Fenu", "year": "1997", "unstructured": "Fenu S, Pinna A, Ongini E, Morelli M (1997) Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 321:143\u2013147", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR37", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1097/FBP.0b013e32833109a0", "volume": "20", "author": "S Fenu", "year": "2009", "unstructured": "Fenu S, Wardas J, Morelli M (2009) Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson\u2019s disease. Behav Pharmacol 20:363\u2013379", "journal-title": "Behav Pharmacol"}, {"key": "18_CR38", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1016/j.parkreldis.2009.06.008", "volume": "16", "author": "HH Fernandez", "year": "2010", "unstructured": "Fernandez HH, Greeley DR, Zweig RM, Wojcieszek J, Mori A, Sussman NM (2010) Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial. Parkinsonism Relat Disord 16:16\u201320", "journal-title": "Parkinsonism Relat Disord"}, {"key": "18_CR39", "doi-asserted-by": "publisher", "first-page": "482", "DOI": "10.1016/S0166-2236(97)01096-5", "volume": "20", "author": "S Ferr\u00e9", "year": "1997", "unstructured": "Ferr\u00e9 S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482\u2013487", "journal-title": "Trends Neurosci"}, {"key": "18_CR40", "doi-asserted-by": "publisher", "first-page": "11940", "DOI": "10.1073/pnas.172393799", "volume": "99", "author": "S Ferr\u00e9", "year": "2002", "unstructured": "Ferr\u00e9 S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueno J, Gutierrez MA, Casad\u00f3 V, Fuxe K, Goldberg SR, Lluis C et al (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA 99:11940\u201311945", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "18_CR41", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1002/syn.20833", "volume": "65", "author": "L Frau", "year": "2011", "unstructured": "Frau L, Borsini F, Wardas J, Khairnar AS, Schintu N, Morelli M (2011) Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson\u2019s disease. Synapse 65:181\u2013188", "journal-title": "Synapse"}, {"issue": "1", "key": "18_CR42", "first-page": "83", "volume": "51", "author": "BB Fredholm", "year": "1999", "unstructured": "Fredholm BB, B\u00e4ttig K, Holm\u00e9n J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1):83\u2013133", "journal-title": "Pharmacol Rev"}, {"key": "18_CR43", "doi-asserted-by": "publisher", "first-page": "831", "DOI": "10.1093/aje/kwm385", "volume": "167", "author": "X Gao", "year": "2008", "unstructured": "Gao X, Chen H, Choi HK, Curhan G, Schwarzschild MA, Ascherio A (2008) Diet, urate, and Parkinson\u2019s disease risk in men. Am J Epidemiol 167:831\u2013838", "journal-title": "Am J Epidemiol"}, {"key": "18_CR44", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1016/S0361-9230(01)00501-9", "volume": "55", "author": "MS Gevaerd", "year": "2001", "unstructured": "Gevaerd MS, Takahashi RN, Silveira R, Da Cunha C (2001) Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats. Brain Res Bull 55:101\u2013106", "journal-title": "Brain Res Bull"}, {"key": "18_CR45", "doi-asserted-by": "publisher", "first-page": "42", "DOI": "10.1016/j.nlm.2006.05.004", "volume": "87", "author": "L Gim\u00e9nez-Llort", "year": "2007", "unstructured": "Gim\u00e9nez-Llort L, Schiffmann SN, Shmidt T, Canela L, Cam\u00f3n L, Wassholm M, Canals M, Terasmaa A, Fern\u00e1ndez-Teruel A, Tobe\u00f1a A et al (2007) Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain. Neurobiol Learn Mem 87:42\u201356", "journal-title": "Neurobiol Learn Mem"}, {"key": "18_CR46", "doi-asserted-by": "publisher", "first-page": "1673", "DOI": "10.1212/WNL.52.8.1673", "volume": "52", "author": "R Grondin", "year": "1999", "unstructured": "Grondin R, B\u00e9dard PJ, Hadj Tahar A, Gr\u00e9goire L, Mori A, Kase H (1999) Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 52:1673\u20131677", "journal-title": "Neurology"}, {"key": "18_CR47", "doi-asserted-by": "publisher", "first-page": "2177", "DOI": "10.1002/mds.22095", "volume": "23", "author": "RA Hauser", "year": "2008", "unstructured": "Hauser RA, Shulman LM, Trugman JM, Roberts J, Mori A, Ballerini R, Sussman NM (2008) Study of istradefylline in patients with Parkinson\u2019s disease on levodopa with motor fluctuations. Mov Disord 23:2177\u20132185", "journal-title": "Mov Disord"}, {"key": "18_CR48", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1016/S1474-4422(11)70012-6", "volume": "10", "author": "RA Hauser", "year": "2011", "unstructured": "Hauser RA, Cantillon M, Pourcher E, Micheli F, Mok V, Onofrj M, Huyck S, Wolski K (2011) Preladenant in patients with Parkinson\u2019s disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurol 10:221\u2013229", "journal-title": "Lancet Neurol"}, {"key": "18_CR49", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1002/eji.200425738", "volume": "35", "author": "MS Hershfield", "year": "2005", "unstructured": "Hershfield MS (2005) New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur J Immunol 35:25\u201330", "journal-title": "Eur J Immunol"}, {"key": "18_CR50", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1002/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W", "volume": "431", "author": "BD Hettinger", "year": "2001", "unstructured": "Hettinger BD, Lee A, Linden J, Rosin DL (2001) Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 431:331\u2013346", "journal-title": "J Comp Neurol"}, {"key": "18_CR51", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.1016/j.bbr.2007.07.013", "volume": "185", "author": "GA Higgins", "year": "2007", "unstructured": "Higgins GA, Grzelak ME, Pond AJ, Cohen-Williams ME, Hodgson RA, Varty GB (2007) The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors. Behav Brain Res 185:32\u201342", "journal-title": "Behav Brain Res"}, {"key": "18_CR52", "doi-asserted-by": "publisher", "first-page": "958", "DOI": "10.1038/nn.2592", "volume": "13", "author": "MJ Higley", "year": "2010", "unstructured": "Higley MJ, Sabatini BL (2010) Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nat Neurosci 13:958\u2013966", "journal-title": "Nat Neurosci"}, {"key": "18_CR53", "doi-asserted-by": "publisher", "first-page": "18091", "DOI": "10.1074/jbc.M107731200", "volume": "77", "author": "J Hillion", "year": "2002", "unstructured": "Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J et al (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 77:18091\u201318097", "journal-title": "J Biol Chem"}, {"key": "18_CR54", "doi-asserted-by": "publisher", "first-page": "294", "DOI": "10.1124/jpet.108.149617", "volume": "330", "author": "RA Hodgson", "year": "2009", "unstructured": "Hodgson RA, Bertorelli R, Varty GB, Lachowicz JE, Forlani A, Fredduzzi S, Cohen-Williams ME, Higgins GA, Impagnatiello F, Nicolussi E et al (2009) Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 in rodent models of movement disorders and depression. J Pharmacol Exp Ther 330:294\u2013303", "journal-title": "J Pharmacol Exp Ther"}, {"key": "18_CR55", "doi-asserted-by": "publisher", "first-page": "384", "DOI": "10.1016/j.expneurol.2010.07.011", "volume": "225", "author": "RA Hodgson", "year": "2010", "unstructured": "Hodgson RA, Bedard PJ, Varty GB, Kazdoba TM, Di Paolo T, Grzelak ME, Pond AJ, Hadjtahar A, Belanger N, Gregoire L et al (2010) Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders. Exp Neurol 225:384\u2013390", "journal-title": "Exp Neurol"}, {"key": "18_CR56", "doi-asserted-by": "crossref", "first-page": "858", "DOI": "10.1038/nn1491", "volume": "8", "author": "ZL Huang", "year": "2005", "unstructured": "Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB, Urade Y, Hayaishi O (2005) Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 8:858\u2013859", "journal-title": "Nat Neurosci"}, {"key": "18_CR57", "doi-asserted-by": "publisher", "first-page": "S49", "DOI": "10.1002/ana.10481", "volume": "53", "author": "S Hunot", "year": "2003", "unstructured": "Hunot S, Hirsch EC (2003) Neuroinflammatory processes in Parkinson\u2019s disease. Ann Neurol 53:S49\u2013S58", "journal-title": "Ann Neurol"}, {"key": "18_CR58", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1046/j.0022-3042.2001.00694.x", "volume": "80", "author": "K Ikeda", "year": "2002", "unstructured": "Ikeda K, Kurokawa M, Aoyama S, Kuwana Y (2002) Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson\u2019s disease. J Neurochem 80:262\u2013270", "journal-title": "J Neurochem"}, {"key": "18_CR59", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1007/978-3-7091-6139-5_33", "volume": "62", "author": "KA Jellinger", "year": "2002", "unstructured": "Jellinger KA (2002) Recent developments in the pathology of Parkinson\u2019s disease. J Neural Transm Suppl 62:347\u2013376", "journal-title": "J Neural Transm Suppl"}, {"key": "18_CR60", "doi-asserted-by": "publisher", "first-page": "729", "DOI": "10.1517/13543784.14.6.729", "volume": "14", "author": "P Jenner", "year": "2005", "unstructured": "Jenner P (2005) Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson\u2019s disease. Expert Opin Investig Drugs 14:729\u2013738", "journal-title": "Expert Opin Investig Drugs"}, {"key": "18_CR61", "first-page": "11", "volume": "20", "author": "P Jenner", "year": "1986", "unstructured": "Jenner P, Marsden CD (1986) The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson\u2019s disease. J Neural Transm Suppl 20:11\u201339", "journal-title": "J Neural Transm Suppl"}, {"key": "18_CR62", "doi-asserted-by": "publisher", "first-page": "10414", "DOI": "10.1523/JNEUROSCI.3660-05.2005", "volume": "25", "author": "A Kachroo", "year": "2005", "unstructured": "Kachroo A, Orlando LR, Grandy DK, Chen JF, Young AB, Schwarzschild MA (2005) Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci 25:10414\u201310419", "journal-title": "J Neurosci"}, {"key": "18_CR63", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1002/ana.410430415", "volume": "43", "author": "T Kanda", "year": "1998", "unstructured": "Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, Kuwana Y, Jenner P (1998a) Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann Neurol 43:507\u2013513", "journal-title": "Ann Neurol"}, {"key": "18_CR64", "doi-asserted-by": "publisher", "first-page": "2857", "DOI": "10.1097/00001756-199808240-00032", "volume": "9", "author": "T Kanda", "year": "1998", "unstructured": "Kanda T, Tashiro T, Kuwana Y, Jenner P (1998b) Adenosine A2A receptors modify motor function in MPTP-treated common marmosets. Neuroreport 9:2857\u20132860", "journal-title": "Neuroreport"}, {"key": "18_CR65", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1006/exnr.2000.7350", "volume": "162", "author": "T Kanda", "year": "2000", "unstructured": "Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, Kuwana Y, Jenner P (2000) Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Exp Neurol 162:321\u2013327", "journal-title": "Exp Neurol"}, {"key": "18_CR66", "doi-asserted-by": "publisher", "first-page": "1122", "DOI": "10.1016/j.neuroscience.2008.09.009", "volume": "158", "author": "M Kerschensteiner", "year": "2009", "unstructured": "Kerschensteiner M, Meinl E, Hohlfeld R (2009) Neuro-immune crosstalk in CNS diseases. Neuroscience 158:1122\u20131132", "journal-title": "Neuroscience"}, {"key": "18_CR67", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1007/s12640-009-9125-y", "volume": "17", "author": "A Khairnar", "year": "2010", "unstructured": "Khairnar A, Plumitallo A, Frau L, Schintu N, Morelli M (2010) Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) in mouse brain. Neurotox Res 17:435\u2013439", "journal-title": "Neurotox Res"}, {"key": "18_CR68", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/j.forsciint.2007.02.034", "volume": "170", "author": "K Kuwayama", "year": "2007", "unstructured": "Kuwayama K, Inoue H, Kanamori T, Tsujikawa K, Miyaguchi H, Iwata Y, Miyauchi S, Kamo N, Kishi T (2007) Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats. Forensic Sci Int 170:183\u2013188", "journal-title": "Forensic Sci Int"}, {"key": "18_CR69", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1016/j.expneurol.2005.06.006", "volume": "197", "author": "EL Lane", "year": "2006", "unstructured": "Lane EL, Cheetham SC, Jenner P (2006) Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson\u2019s disease? Exp Neurol 197:284\u2013290", "journal-title": "Exp Neurol"}, {"key": "18_CR70", "doi-asserted-by": "publisher", "first-page": "2067", "DOI": "10.1016/0024-3205(94)00387-4", "volume": "55", "author": "KW Lange", "year": "1994", "unstructured": "Lange KW, Riederer P (1994) Glutamatergic drugs in Parkinson\u2019s disease. Life Sci 55:2067\u20132075", "journal-title": "Life Sci"}, {"key": "18_CR71", "doi-asserted-by": "publisher", "first-page": "10067", "DOI": "10.1523/JNEUROSCI.6730-10.2011", "volume": "6", "author": "M Lazarus", "year": "2011", "unstructured": "Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, Bass CE, Winsky-Sommerer R, Semba K, Fredholm BB, Boison D, Hayaishi O, Urade Y, Chen JF (2011) Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 6:10067\u201310075", "journal-title": "J Neurosci"}, {"key": "18_CR72", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1002/ana.21315", "volume": "63", "author": "PA LeWitt", "year": "2008", "unstructured": "LeWitt PA, Guttman M, Tetrud JW, Tuite PJ, Mori A, Chaikin P, Sussman NM (2008) Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces OFF time in Parkinson\u2019s disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann Neurol 63:295\u2013302", "journal-title": "Ann Neurol"}, {"key": "18_CR73", "doi-asserted-by": "crossref", "first-page": "3196", "DOI": "10.1152/jn.1999.82.6.3196", "volume": "82", "author": "LV Lopes", "year": "1999", "unstructured": "Lopes LV, Cunha RA, Ribeiro JA (1999) Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82:3196\u20133203", "journal-title": "J Neurophysiol"}, {"key": "18_CR74", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.4049/jimmunol.173.1.21", "volume": "173", "author": "D Lukashev", "year": "2004", "unstructured": "Lukashev D, Ohta A, Apasov S, Chen JF, Sitkovsky M (2004) Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J Immunol 173:21\u201324", "journal-title": "J Immunol"}, {"key": "18_CR75", "doi-asserted-by": "publisher", "first-page": "1398", "DOI": "10.1046/j.1471-4159.2003.01632.x", "volume": "84", "author": "M Lundblad", "year": "2003", "unstructured": "Lundblad M, Vaudano E, Cenci MA (2003) Cellular and behavioural effects of the adenosine A2A receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia. J Neurochem 84:1398\u20131410", "journal-title": "J Neurochem"}, {"key": "18_CR76", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1179/016164105X21850", "volume": "27", "author": "SA Masino", "year": "2005", "unstructured": "Masino SA, Dulla CG (2005) Adenosine, glutamate and pH: interactions and implications. Neurol Res 27:149\u2013152", "journal-title": "Neurol Res"}, {"key": "18_CR77", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1016/j.neuropharm.2005.08.006", "volume": "50", "author": "R McNamara", "year": "2006", "unstructured": "McNamara R, Kerans A, O\u2019Neill B, Harkin A (2006) Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (\u201cEcstasy\u201d) and MDA (\u201cLove\u201d). Neuropharmacology 50:69\u201380", "journal-title": "Neuropharmacology"}, {"key": "18_CR78", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1016/j.ejphar.2006.10.063", "volume": "555", "author": "R McNamara", "year": "2007", "unstructured": "McNamara R, Maginn M, Harkin A (2007) Caffeine induces a profound and persistent tachycardia in response to MDMA (\u201cEcstasy\u201d) administration. Eur J Pharmacol 555:194\u2013198", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR79", "doi-asserted-by": "publisher", "first-page": "1437", "DOI": "10.1002/mds.23107", "volume": "25", "author": "Y Mizuno", "year": "2010", "unstructured": "Mizuno Y, Hasegawa K, Kondo T, Kuno S, Yamamoto M (2010) Clinical efficacy of istradefylline (KW-6002) in Parkinson\u2019s disease: a randomized, controlled study. Mov Disord 25:1437\u20131443", "journal-title": "Mov Disord"}, {"key": "18_CR80", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/S0079-6123(10)83010-9", "volume": "183", "author": "M Morelli", "year": "2010", "unstructured": "Morelli M, Carta AR, Kachroo A, Schwarzschild MA (2010) Pathophysiological roles for purines: adenosine, caffeine and urate. Prog Brain Res 183:183\u2013208", "journal-title": "Prog Brain Res"}, {"key": "18_CR81", "doi-asserted-by": "publisher", "first-page": "1322", "DOI": "10.1073/pnas.0237126100", "volume": "100", "author": "A Nishi", "year": "2003", "unstructured": "Nishi A, Liu F, Matsuyama S, Hamada M, Higashi H, Nairn AC, Greengard P (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc Natl Acad Sci USA 100:1322\u20131327", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "18_CR82", "doi-asserted-by": "publisher", "first-page": "46", "DOI": "10.1007/s00213-005-0240-z", "volume": "184", "author": "M O\u2019Neill", "year": "2006", "unstructured": "O\u2019Neill M, Brown VJ (2006) The effect of the adenosine A(2A) antagonist KW-6002 on motor and motivational processes in the rat. Psychopharmacology (Berl) 184:46\u201355", "journal-title": "Psychopharmacology (Berl)"}, {"key": "18_CR83", "doi-asserted-by": "publisher", "first-page": "S8", "DOI": "10.1016/S1471-1931(00)00028-8", "volume": "23", "author": "JA Obeso", "year": "2000", "unstructured": "Obeso JA, Rodr\u00edguez-Oroz MC, Rodr\u00edguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW (2000) Pathophysiology of the basal ganglia in Parkinson\u2019s disease. Trends Neurosci 23:S8\u2013S19", "journal-title": "Trends Neurosci"}, {"key": "18_CR84", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1007/s00726-001-0118-2", "volume": "23", "author": "JD Oh", "year": "2002", "unstructured": "Oh JD, Chase TN (2002) Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson\u2019s disease. Amino Acids 23:133\u2013139", "journal-title": "Amino Acids"}, {"key": "18_CR85", "doi-asserted-by": "publisher", "first-page": "916", "DOI": "10.1038/414916a", "volume": "414", "author": "A Ohta", "year": "2001", "unstructured": "Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916\u2013920", "journal-title": "Nature"}, {"key": "18_CR86", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1016/j.neuropharm.2004.11.009", "volume": "48", "author": "M Pierri", "year": "2005", "unstructured": "Pierri M, Vaudano E, Sager T, Englund U (2005) KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse. Neuropharmacology 48:517\u2013524", "journal-title": "Neuropharmacology"}, {"key": "18_CR87", "doi-asserted-by": "publisher", "first-page": "1619", "DOI": "10.1517/13543780903241615", "volume": "18", "author": "A Pinna", "year": "2009", "unstructured": "Pinna A (2009) Novel investigational adenosine A2A receptor antagonists for Parkinson\u2019s disease. Expert Opin Investig Drugs 18:1619\u20131631", "journal-title": "Expert Opin Investig Drugs"}, {"key": "18_CR88", "doi-asserted-by": "publisher", "first-page": "1176", "DOI": "10.1111/j.1460-9568.1996.tb01285.x", "volume": "8", "author": "A Pinna", "year": "1996", "unstructured": "Pinna A, Di Chiara G, Wardas J, Morelli M (1996) Blockade of A2A adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats. Eur J Neurosci 8:1176\u20131181", "journal-title": "Eur J Neurosci"}, {"key": "18_CR89", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K", "volume": "39", "author": "A Pinna", "year": "2001", "unstructured": "Pinna A, Fenu S, Morelli M (2001) Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. Synapse 39:233\u2013238", "journal-title": "Synapse"}, {"key": "18_CR90", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1016/j.ejphar.2005.01.057", "volume": "512", "author": "A Pinna", "year": "2005", "unstructured": "Pinna A, Volpini R, Cristalli G, Morelli M (2005) New adenosine A2A receptor antagonists: actions on Parkinson\u2019s disease models. Eur J Pharmacol 512:157\u2013164", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR91", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1016/j.bbr.2006.03.021", "volume": "171", "author": "A Pinna", "year": "2006", "unstructured": "Pinna A, Pontis S, Morelli M (2006) Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment. Behav Brain Res 171:175\u2013178", "journal-title": "Behav Brain Res"}, {"key": "18_CR92", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1016/j.neuropharm.2009.11.012", "volume": "58", "author": "A Pinna", "year": "2010", "unstructured": "Pinna A, Tronci E, Schintu N, Simola N, Volpini R, Pontis S, Cristalli G, Morelli M (2010) A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. Neuropharmacology 58:613\u2013623", "journal-title": "Neuropharmacology"}, {"key": "18_CR93", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1615/CritRevNeurobiol.v16.i12.110", "volume": "16", "author": "P Popoli", "year": "2004", "unstructured": "Popoli P, Minghetti L, Tebano MT, Pintor A, Domenici MR, Massotti M (2004) Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadows. Crit Rev Neurobiol 16:99\u2013106", "journal-title": "Crit Rev Neurobiol"}, {"key": "18_CR94", "doi-asserted-by": "publisher", "first-page": "1151", "DOI": "10.1046/j.1471-4159.2003.02245.x", "volume": "88", "author": "D Quarta", "year": "2004", "unstructured": "Quarta D, Ferr\u00e9 S, Solinas M, You ZB, Hockemeyer J, Popoli P, Goldberg SR (2004) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens: effects of chronic caffeine exposure. J Neurochem 88:1151\u20131158", "journal-title": "J Neurochem"}, {"key": "18_CR95", "doi-asserted-by": "publisher", "first-page": "536", "DOI": "10.1212/01.wnl.0000266670.35219.0c", "volume": "69", "author": "K Ritchie", "year": "2007", "unstructured": "Ritchie K, Carri\u00e8re I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML (2007) The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology 69:536\u2013545", "journal-title": "Neurology"}, {"key": "18_CR96", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1016/j.ejphar.2006.07.017", "volume": "546", "author": "S Rose", "year": "2006", "unstructured": "Rose S, Jackson MJ, Smith LA, Stockwell K, Johnson L, Carminati P, Jenner P (2006) The novel adenosine A2A receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets. Eur J Pharmacol 546:82\u201387", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR97", "doi-asserted-by": "publisher", "first-page": "2674", "DOI": "10.1001/jama.283.20.2674", "volume": "283", "author": "GW Ross", "year": "2000", "unstructured": "Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD et al (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674\u20132679", "journal-title": "JAMA"}, {"key": "18_CR98", "doi-asserted-by": "publisher", "first-page": "591", "DOI": "10.1016/S0301-0082(98)00053-7", "volume": "56", "author": "JD Salamone", "year": "1998", "unstructured": "Salamone JD, Mayorga AJ, Trevitt JT, Cousins MS, Conlan A, Nawab A (1998) Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol 56:591\u2013611", "journal-title": "Prog Neurobiol"}, {"key": "18_CR99", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1016/j.pneurobio.2007.05.001", "volume": "83", "author": "SN Schiffmann", "year": "2007", "unstructured": "Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferr\u00e9 S (2007) Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 83:277\u2013292", "journal-title": "Prog Neurobiol"}, {"key": "18_CR100", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1001/archneur.2008.65.6.nct70003", "volume": "65", "author": "MA Schwarzschild", "year": "2008", "unstructured": "Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Hyson C, Parkinson Study Group PRECEPT Investigators et al (2008) Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol 65:716\u2013723", "journal-title": "Arch Neurol"}, {"key": "18_CR101", "first-page": "466", "volume": "13", "author": "U Shah", "year": "2010", "unstructured": "Shah U, Hodgson R (2010) Recent progress in the discovery of adenosine A(2A) receptor antagonists for the treatment of Parkinson\u2019s disease. Curr Opin Drug Discov Devel 13:466\u2013480", "journal-title": "Curr Opin Drug Discov Devel"}, {"key": "18_CR102", "doi-asserted-by": "publisher", "first-page": "182", "DOI": "10.1016/j.expneurol.2004.05.027", "volume": "189", "author": "N Simola", "year": "2004", "unstructured": "Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M (2004) Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Exp Neurol 189:182\u2013188", "journal-title": "Exp Neurol"}, {"key": "18_CR103", "doi-asserted-by": "publisher", "first-page": "5590", "DOI": "10.1021/jm900298c", "volume": "52", "author": "A Soriano", "year": "2009", "unstructured": "Soriano A, Ventura R, Molero A, Hoen R, Casad\u00f3 V, Cort\u00e9s A, Fanelli F, Albericio F, Llu\u00eds C, Franco R et al (2009) Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers. J Med Chem 52:5590\u20135602", "journal-title": "J Med Chem"}, {"key": "18_CR104", "doi-asserted-by": "publisher", "first-page": "2233", "DOI": "10.1212/01.wnl.0000313834.22171.17", "volume": "70", "author": "M Stacy", "year": "2008", "unstructured": "Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P, Sussman NM (2008) A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology 70:2233\u20132240", "journal-title": "Neurology"}, {"key": "18_CR105", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1017/S1461145705006188", "volume": "9", "author": "MA Stasi", "year": "2006", "unstructured": "Stasi MA, Borsini F, Varani K, Vincenzi F, Di Cesare MA, Minetti P, Ghirardi O, Carminati P (2006) ST 1535: a preferential A2A adenosine receptor antagonist. Int J Neuropsychopharmacol 9:575\u2013584", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "18_CR106", "doi-asserted-by": "publisher", "first-page": "2614", "DOI": "10.2741/2870", "volume": "13", "author": "RN Takahashi", "year": "2008", "unstructured": "Takahashi RN, Pamplona FA, Prediger RD (2008) Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front Biosci 13:2614\u20132632", "journal-title": "Front Biosci"}, {"key": "18_CR107", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1016/j.ejphar.2007.03.021", "volume": "566", "author": "E Tronci", "year": "2007", "unstructured": "Tronci E, Simola N, Borsini F, Schintu N, Frau L, Carminati P, Morelli M (2007) Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. Eur J Pharmacol 566:94\u2013102", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR108", "doi-asserted-by": "publisher", "first-page": "220", "DOI": "10.1016/j.ejphar.2010.10.012", "volume": "650", "author": "N Vanattou-Sa\u00effoudine", "year": "2011", "unstructured": "Vanattou-Sa\u00effoudine N, Gossen A, Harkin A, Neuropsychopharmacology Research Group (2011) A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA \u201cEcstasy\u201d-induced striatal dopamine release. Eur J Pharmacol 650:220\u2013228", "journal-title": "Eur J Pharmacol"}, {"key": "18_CR109", "doi-asserted-by": "publisher", "first-page": "438", "DOI": "10.1016/j.expneurol.2006.01.005", "volume": "199", "author": "JH Wang", "year": "2006", "unstructured": "Wang JH, Ma YY, van den Buuse M (2006) Improved spatial recognition memory in mice lacking adenosine A2A receptors. Exp Neurol 199:438\u2013445", "journal-title": "Exp Neurol"}, {"key": "18_CR110", "first-page": "1633", "volume": "89", "author": "XJ Wang", "year": "2009", "unstructured": "Wang XJ, Luo WF, Wang LJ, Mao CJ, Wang L, Liu CF (2009) Study on uric acid and the related factors associated with cognition in the patients with Parkinson\u2019s disease. Zhonghua Yi Xue Za Zhi 89:1633\u20131635", "journal-title": "Zhonghua Yi Xue Za Zhi"}, {"key": "18_CR111", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1002/syn.1070", "volume": "41", "author": "J Wardas", "year": "2001", "unstructured": "Wardas J, Konieczny J, Lorenc-Koci E (2001) SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats. Synapse 41:160\u2013171", "journal-title": "Synapse"}, {"key": "18_CR112", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1101/lm.2136011", "volume": "18", "author": "CJ Wei", "year": "2011", "unstructured": "Wei CJ, Singer P, Coelho J, Boison D, Feldon J, Yee BK, Chen JF (2011) Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn Mem 18:459\u2013474", "journal-title": "Learn Mem"}, {"key": "18_CR113", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1002/ana.21313", "volume": "63", "author": "L Yu", "year": "2008", "unstructured": "Yu L, Shen HY, Coelho JE, Ara\u00fajo IM, Huang QY, Day YJ, Rebola N, Canas PM, Rapp EK, Ferrara J et al (2008) Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann Neurol 63:338\u2013346", "journal-title": "Ann Neurol"}], "container-title": ["Adenosine"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4614-3903-5_18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 27]], "date-time": "2019-01-27T14:08:52Z", "timestamp": 1548598132000}, "score": 21.36723, "issued": {"date-parts": [[2012, 7, 23]]}, "ISBN": ["9781461439028", "9781461439035"], "references-count": 113, "URL": "http://dx.doi.org/10.1007/978-1-4614-3903-5_18", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T19:00:17Z", "timestamp": 1575486017631}, "publisher-location": "New York, NY", "reference-count": 72, "publisher": "Springer New York", "isbn-type": [{"value": "9781461458357", "type": "print"}, {"value": "9781461458364", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2014]]}, "DOI": "10.1007/978-1-4614-5836-4_103", "type": "book-chapter", "created": {"date-parts": [[2014, 6, 3]], "date-time": "2014-06-03T05:36:32Z", "timestamp": 1401773792000}, "page": "2281-2298", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists"], "prefix": "10.1007", "author": [{"given": "Nicola", "family": "Simola", "sequence": "first", "affiliation": []}, {"given": "Annalisa", "family": "Pinna", "sequence": "additional", "affiliation": []}, {"given": "Lucia", "family": "Frau", "sequence": "additional", "affiliation": []}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 4, 29]]}, "reference": [{"key": "103_CR1", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1016/j.pbb.2006.05.027", "volume": "84", "author": "LM Aguiar", "year": "2006", "unstructured": "Aguiar, L. M., Nobre, H. V., Jr., Mac\u00eado, D. S., Oliveira, A. A., Freitas, R. M., Vasconcelos, S. M., Cunha, G. M., Sousa, F. C., & Viana, G. S. (2006). Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. Pharmacology, Biochemistry, and Behavior, 84, 415\u2013419.", "journal-title": "Pharmacology, Biochemistry, and Behavior"}, {"key": "103_CR2", "doi-asserted-by": "crossref", "first-page": "10982", "DOI": "10.1523/JNEUROSCI.23-34-10982.2003", "volume": "23", "author": "PD Alfinito", "year": "2003", "unstructured": "Alfinito, P. D., Wang, S. P., Manzino, L., Rijhsinghani, S., Zeevalk, G. D., & Sonsalla, P. K. (2003). Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. Journal of Neuroscience, 23, 10982\u201310987.", "journal-title": "Journal of Neuroscience"}, {"key": "103_CR3", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.nbd.2005.09.010", "volume": "22", "author": "MT Armentero", "year": "2006", "unstructured": "Armentero, M. T., Fancellu, R., Nappi, G., Bramanti, P., & Blandini, F. (2006). Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson\u2019s disease. Neurobiology of Disease, 22, 1\u20139.", "journal-title": "Neurobiology of Disease"}, {"key": "103_CR4", "doi-asserted-by": "publisher", "first-page": "280", "DOI": "10.1016/j.pharmthera.2011.07.004", "volume": "132", "author": "MT Armentero", "year": "2011", "unstructured": "Armentero, M. T., Pinna, A., Ferr\u00e9, S., Lanciego, J. L., M\u00fcller, C. E., & Franco, R. (2011). Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson\u2019s disease. Pharmacology and Therapeutics, 132, 280\u2013299.", "journal-title": "Pharmacology and Therapeutics"}, {"key": "103_CR5", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1002/ana.1052", "volume": "50", "author": "A Ascherio", "year": "2001", "unstructured": "Ascherio, A., Zhang, S. M., Hern\u00e1n, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001). Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Annals of Neurology, 50, 56\u201363.", "journal-title": "Annals of Neurology"}, {"key": "103_CR6", "doi-asserted-by": "publisher", "first-page": "790", "DOI": "10.1212/01.WNL.0000046523.05125.87", "volume": "60", "author": "A Ascherio", "year": "2003", "unstructured": "Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003). Caffeine, postmenopausal estrogen, and risk of Parkinson\u2019s disease. Neurology, 60, 790\u2013795.", "journal-title": "Neurology"}, {"key": "103_CR7", "doi-asserted-by": "publisher", "first-page": "977", "DOI": "10.1093/aje/kwh312", "volume": "160", "author": "A Ascherio", "year": "2004", "unstructured": "Ascherio, A., Weisskopf, M. G., O\u2019Reilly, E. J., McCullough, M. L., Calle, E. E., Rodriguez, C., & Thun, M. J. (2004). Coffee consumption, gender, and Parkinson\u2019s disease mortality in the cancer prevention study II cohort: The modifying effects of estrogen. American Journal of Epidemiology, 160, 977\u2013984.", "journal-title": "American Journal of Epidemiology"}, {"key": "103_CR8", "doi-asserted-by": "publisher", "first-page": "1350", "DOI": "10.1212/WNL.55.9.1350", "volume": "55", "author": "MD Benedetti", "year": "2000", "unstructured": "Benedetti, M. D., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2000). Smoking, alcohol, and coffee consumption preceding Parkinson\u2019s disease: A case\u2013control study. Neurology, 55, 1350\u20131358.", "journal-title": "Neurology"}, {"key": "103_CR9", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1002/ana.104", "volume": "49", "author": "F Blandini", "year": "2001", "unstructured": "Blandini, F., Nappi, G., & Greenamyre, J. T. (2001). Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson\u2019s disease. Annals of Neurology, 49, 525\u2013529.", "journal-title": "Annals of Neurology"}, {"key": "103_CR10", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1002/cne.22751", "volume": "520", "author": "JW Bogenpohl", "year": "2012", "unstructured": "Bogenpohl, J. W., Ritter, S. L., Hall, R. A., & Smith, Y. (2012). Adenosine A(2A) receptor in the monkey basal ganglia: Ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum. The Journal of Comparative Neurology, 520, 570\u2013589.", "journal-title": "The Journal of Comparative Neurology"}, {"key": "103_CR11", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1016/j.neulet.2010.06.013", "volume": "480", "author": "HM Brothers", "year": "2010", "unstructured": "Brothers, H. M., Marchalant, Y., & Wenk, G. L. (2010). Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neuroscience Letters, 480, 97\u2013100.", "journal-title": "Neuroscience Letters"}, {"key": "103_CR12", "doi-asserted-by": "publisher", "first-page": "1478", "DOI": "10.1111/j.1471-4159.2009.06425.x", "volume": "111", "author": "AR Carta", "year": "2009", "unstructured": "Carta, A. R., Kachroo, A., Schintu, N., Xu, K., Schwarzschild, M. A., Wardas, J., & Morelli, M. (2009). Inactivation of neuronal forebrain a receptors protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. Journal of Neurochemistry, 111, 1478\u20131489.", "journal-title": "Journal of Neurochemistry"}, {"key": "103_CR13", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1006/exnr.2001.7742", "volume": "171", "author": "GA Carvalho", "year": "2001", "unstructured": "Carvalho, G. A., & Nikkhah, G. (2001). Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Experimental Neurology, 171, 405\u2013417.", "journal-title": "Experimental Neurology"}, {"key": "103_CR14", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1097/00008877-200503000-00001", "volume": "16", "author": "O Cauli", "year": "2005", "unstructured": "Cauli, O., & Morelli, M. (2005). Caffeine and the dopaminergic system. Behavioural Pharmacology, 16, 63\u201377.", "journal-title": "Behavioural Pharmacology"}, {"key": "103_CR15", "doi-asserted-by": "crossref", "first-page": "RC143", "DOI": "10.1523/JNEUROSCI.21-10-j0001.2001", "volume": "21", "author": "JF Chen", "year": "2001", "unstructured": "Chen, J. F., Xu, K., Petzer, J. P., Staal, R., Xu, Y. H., Beilstein, M., Sonsalla, P. K., Castagnoli, K., Castagnoli, N., Jr., & Schwarzschild, M. A. (2001). Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease. Journal of Neuroscience, 21, RC143.", "journal-title": "Journal of Neuroscience"}, {"key": "103_CR16", "doi-asserted-by": "crossref", "first-page": "S221", "DOI": "10.3233/JAD-2010-091525", "volume": "20", "author": "J Costa", "year": "2010", "unstructured": "Costa, J., Lunet, N., Santos, C., Santos, J., & Vaz-Carneiro, A. (2010). Caffeine exposure and the risk of Parkinson\u2019s disease: A systematic review and meta-analysis of observational studies. Journal of Alzheimer\u2019s Disease, 20, S221\u2013S238.", "journal-title": "Journal of Alzheimer\u2019s Disease"}, {"key": "103_CR17", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1016/S0197-0186(00)00034-6", "volume": "38", "author": "RA Cunha", "year": "2001", "unstructured": "Cunha, R. A. (2001). Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors. Neurochemistry International, 38, 107\u2013125.", "journal-title": "Neurochemistry International"}, {"key": "103_CR18", "first-page": "S21", "volume": "54", "author": "MC Rijk de", "year": "2000", "unstructured": "de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C., & Hofman, A. (2000). Prevalence of Parkinson\u2019s disease in Europe: A collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology, 54, S21\u2013S23.", "journal-title": "Neurology"}, {"key": "103_CR19", "first-page": "1320", "volume": "271", "author": "KT Delle Donne", "year": "1994", "unstructured": "Delle Donne, K. T., & Sonsalla, P. K. (1994). Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. Journal of Pharmacology and Experimental Therapeutics, 271, 1320\u20131326.", "journal-title": "Journal of Pharmacology and Experimental Therapeutics"}, {"key": "103_CR20", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1146/annurev.neuro.24.1.31", "volume": "24", "author": "TV Dunwiddie", "year": "2001", "unstructured": "Dunwiddie, T. V., & Masino, S. A. (2001). The role and regulation of adenosine in the central nervous system. Annual Review of Neuroscience, 24, 31\u201355.", "journal-title": "Annual Review of Neuroscience"}, {"key": "103_CR21", "doi-asserted-by": "publisher", "first-page": "482", "DOI": "10.1016/S0166-2236(97)01096-5", "volume": "20", "author": "S Ferre", "year": "1997", "unstructured": "Ferre, S., Fredholm, B. B., Morelli, M., Popoli, P., & Fuxe, K. (1997). Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends in Neurosciences, 20, 482\u2013487.", "journal-title": "Trends in Neurosciences"}, {"key": "103_CR22", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1016/j.ejphar.2005.06.035", "volume": "520", "author": "B Floran", "year": "2005", "unstructured": "Floran, B., Gonzalez, B., Flor\u00e1n, L., Erlij, D., & Aceves, J. (2005). Interactions between adenosine A(2A) and dopamine D2 receptors in the control of [(3)H]GABA release in the globus pallidus of the rat. European Journal of Pharmacology, 520, 43\u201350.", "journal-title": "European Journal of Pharmacology"}, {"key": "103_CR23", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1002/syn.20833", "volume": "65", "author": "L Frau", "year": "2011", "unstructured": "Frau, L., Borsini, F., Wardas, J., Khairnar, A. S., Schintu, N., & Morelli, M. (2011). Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson\u2019s disease. Synapse, 65, 181\u2013188.", "journal-title": "Synapse"}, {"key": "103_CR24", "first-page": "83", "volume": "51", "author": "BB Fredholm", "year": "1999", "unstructured": "Fredholm, B. B., B\u00e4ttig, K., Holm\u00e9n, J., Nehlig, A., & Zvartau, E. E. (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews, 51, 83\u2013133.", "journal-title": "Pharmacological Reviews"}, {"key": "103_CR25", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1016/S0074-7742(05)63007-3", "volume": "63", "author": "BB Fredholm", "year": "2005", "unstructured": "Fredholm, B. B., Chen, J. F., Cunha, R. A., Svenningsson, P., & Vaugeois, J. M. (2005). Adenosine and brain function. International Review of Neurobiology, 63, 191\u2013270.", "journal-title": "International Review of Neurobiology"}, {"key": "103_CR26", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1016/S0014-2999(02)02301-4", "volume": "451", "author": "Z Gerevich", "year": "2002", "unstructured": "Gerevich, Z., Wirkner, K., & Illes, P. (2002). Adenosine A2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons. European Journal of Pharmacology, 451, 161\u2013164.", "journal-title": "European Journal of Pharmacology"}, {"key": "103_CR27", "doi-asserted-by": "publisher", "first-page": "918", "DOI": "10.1016/j.cell.2010.02.016", "volume": "140", "author": "CK Glass", "year": "2010", "unstructured": "Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell, 140, 918\u2013934.", "journal-title": "Cell"}, {"key": "103_CR28", "doi-asserted-by": "publisher", "first-page": "422", "DOI": "10.1016/S0893-133X(01)00343-8", "volume": "26", "author": "TA Green", "year": "2002", "unstructured": "Green, T. A., & Schenk, S. (2002). Dopaminergic mechanism for caffeine-produced cocaine seeking in rats. Neuropsychopharmacology, 26, 422\u2013430.", "journal-title": "Neuropsychopharmacology"}, {"key": "103_CR29", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1097/00002826-200103000-00001", "volume": "24", "author": "JT Greenamyre", "year": "2001", "unstructured": "Greenamyre, J. T. (2001). Glutamatergic influences on the basal ganglia. Clinical Neuropharmacology, 24, 65\u201370.", "journal-title": "Clinical Neuropharmacology"}, {"key": "103_CR30", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1002/mds.23455", "volume": "26", "author": "GM Halliday", "year": "2011", "unstructured": "Halliday, G. M., & Stevens, C. H. (2011). Glia: Initiators and progressors of pathology in Parkinson\u2019s disease. Movement Disorders, 26, 6\u201317.", "journal-title": "Movement Disorders"}, {"key": "103_CR31", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1016/j.nurt.2008.10.033", "volume": "6", "author": "I Halperin", "year": "2009", "unstructured": "Halperin, I., Morelli, M., Korczyn, A. D., Youdim, M. B., & Mandel, S. A. (2009). Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer\u2019s and Parkinson\u2019s diseases. Neurotherapeutics, 6, 128\u2013140.", "journal-title": "Neurotherapeutics"}, {"key": "103_CR32", "doi-asserted-by": "publisher", "first-page": "471", "DOI": "10.2165/00002512-200522060-00002", "volume": "22", "author": "RA Hauser", "year": "2005", "unstructured": "Hauser, R. A., & Schwarzschild, M. A. (2005). Adenosine A(2A) receptor antagonists for Parkinson\u2019s disease: Rationale, therapeutic potential and clinical experience. Drugs & Aging, 22, 471\u2013482.", "journal-title": "Drugs & Aging"}, {"key": "103_CR33", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1002/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W", "volume": "431", "author": "BD Hettinger", "year": "2001", "unstructured": "Hettinger, B. D., Lee, A., Linden, J., & Rosin, D. L. (2001). Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. The Journal of Comparative Neurology, 431, 331\u2013346.", "journal-title": "The Journal of Comparative Neurology"}, {"key": "103_CR34", "doi-asserted-by": "publisher", "first-page": "382", "DOI": "10.1016/S1474-4422(09)70062-6", "volume": "8", "author": "EC Hirsch", "year": "2009", "unstructured": "Hirsch, E. C., & Hunot, S. (2009). Neuroinflammation in Parkinson\u2019s disease: A target for neuroprotection? Lancet Neurology, 8, 382\u2013397.", "journal-title": "Lancet Neurology"}, {"key": "103_CR35", "doi-asserted-by": "publisher", "first-page": "2242", "DOI": "10.1002/mds.21706", "volume": "22", "author": "G Hu", "year": "2007", "unstructured": "Hu, G., Bidel, S., Jousilahti, P., Antikainen, R., & Tuomilehto, J. (2007). Coffee and tea consumption and the risk of Parkinson\u2019s disease. Movement Disorders, 22, 2242\u20132248.", "journal-title": "Movement Disorders"}, {"key": "103_CR36", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1007/BF03159935", "volume": "14", "author": "KA Jellinger", "year": "1991", "unstructured": "Jellinger, K. A. (1991). Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway. Molecular and Chemical Neuropathology, 14, 153\u2013197.", "journal-title": "Molecular and Chemical Neuropathology"}, {"key": "103_CR37", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1124/jpet.111.187443", "volume": "340", "author": "CK Jones", "year": "2012", "unstructured": "Jones, C. K., Bubser, M., Thompson, A. D., Dickerson, J. W., Turle-Lorenzo, N., Amalric, M., Blobaum, A. L., Bridges, T. M., Morrison, R. D., Jadhav, S., Engers, D. W., Italiano, K., Bode, J., Daniels, J. S., Lindsley, C. W., Hopkins, C. R., Conn, P. J., & Niswender, C. M. (2012). The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson\u2019s disease. Journal of Pharmacology and Experimental Therapeutics, 340, 404\u2013421.", "journal-title": "Journal of Pharmacology and Experimental Therapeutics"}, {"key": "103_CR38", "doi-asserted-by": "publisher", "first-page": "657", "DOI": "10.1016/j.expneurol.2010.02.007", "volume": "223", "author": "A Kachroo", "year": "2010", "unstructured": "Kachroo, A., Irizarry, M. C., & Schwarzschild, M. A. (2010). Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration. Experimental Neurology, 223, 657\u2013661.", "journal-title": "Experimental Neurology"}, {"key": "103_CR39", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1007/s00213-008-1319-0", "volume": "201", "author": "JE Kelsey", "year": "2009", "unstructured": "Kelsey, J. E., Langelier, N. A., Oriel, B. S., & Reedy, C. (2009). The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A(2A) and A(1) antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat. Psychopharmacology, 201, 529\u2013539.", "journal-title": "Psychopharmacology"}, {"key": "103_CR40", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1007/s12640-009-9125-y", "volume": "17", "author": "A Khairnar", "year": "2010", "unstructured": "Khairnar, A., Plumitallo, A., Frau, L., Schintu, N., & Morelli, M. (2010). Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) in mouse brain. Neurotoxicity Research, 17, 435\u2013439.", "journal-title": "Neurotoxicity Research"}, {"key": "103_CR41", "doi-asserted-by": "publisher", "first-page": "1882", "DOI": "10.1046/j.1471-4159.1996.66051882.x", "volume": "66", "author": "M Kurokawa", "year": "1996", "unstructured": "Kurokawa, M., Koga, K., Kase, H., Nakamura, J., & Kuwana, Y. (1996). Adenosine A(2A) receptor-mediated modulation of striatal acetylcholine release in vivo. Journal of Neurochemistry, 66, 1882\u20131888.", "journal-title": "Journal of Neurochemistry"}, {"key": "103_CR42", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1016/S0079-6123(08)60446-X", "volume": "116", "author": "E Lancelot", "year": "1998", "unstructured": "Lancelot, E., & Beal, M. F. (1998). Glutamate toxicity in chronic neurodegenerative disease. Progress in Brain Research, 116, 331\u2013347.", "journal-title": "Progress in Brain Research"}, {"key": "103_CR43", "first-page": "2011", "volume": "30", "author": "D Litteljohn", "year": "2010", "unstructured": "Litteljohn, D., Mangano, E., Clarke, M., Bobyn, J., Moloney, K., & Hayley, S. (2010). Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease. Parkinsons Dis. 30, 2011:713517.", "journal-title": "Parkinsons Dis"}, {"key": "103_CR44", "doi-asserted-by": "publisher", "first-page": "1087", "DOI": "10.2174/156802611795347591", "volume": "11", "author": "LV Lopes", "year": "2011", "unstructured": "Lopes, L. V., Sebasti\u00e3o, A. M., & Ribeiro, J. A. (2011). Adenosine and related drugs in brain diseases: Present and future in clinical trials. Current Topics in Medicinal Chemistry, 11, 1087\u20131101.", "journal-title": "Current Topics in Medicinal Chemistry"}, {"key": "103_CR45", "first-page": "379", "volume": "59", "author": "S \u0141ukasiewicz", "year": "2007", "unstructured": "\u0141ukasiewicz, S., B\u0142asiak, E., Faron-G\u00f3recka, A., Polit, A., Tworzyd\u0142o, M., G\u00f3recki, A., Wasylewski, Z., & Dziedzicka-Wasylewska, M. (2007). Fluorescence studies of homooligomerization of adenosine A(2A) and serotonin 5-HT(1A) receptors reveal the specificity of receptor interactions in the plasma membrane. Pharmacological Reports, 59, 379\u2013392.", "journal-title": "Pharmacological Reports"}, {"key": "103_CR46", "doi-asserted-by": "publisher", "first-page": "243", "DOI": "10.1016/S0006-8993(02)03753-8", "volume": "959", "author": "A Melani", "year": "2003", "unstructured": "Melani, A., Pantoni, L., Bordoni, F., Gianfriddo, M., Bianchi, L., Vannucchi, M. G., Bertorelli, R., Monopoli, A., & Pedata, F. (2003). The selective A(2A) receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Research, 959, 243\u2013250.", "journal-title": "Brain Research"}, {"key": "103_CR47", "doi-asserted-by": "publisher", "first-page": "1003", "DOI": "10.1227/00006123-199505000-00017", "volume": "36", "author": "HL Mitchell", "year": "1995", "unstructured": "Mitchell, H. L., Frisella, W. A., Brooker, R. W., & Yoon, K. W. (1995). Attenuation of traumatic cell death by an adenosine A(1) agonist in rat hippocampal cells. Neurosurgery, 36, 1003\u20131008.", "journal-title": "Neurosurgery"}, {"key": "103_CR48", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/S0079-6123(10)83010-9", "volume": "183", "author": "M Morelli", "year": "2010", "unstructured": "Morelli, M., Carta, A. R., Kachroo, A., & Schwarzschild, M. A. (2010). Pathophysiological roles for purines: Adenosine, caffeine and urate. Progress in Brain Research, 183, 183\u2013208.", "journal-title": "Progress in Brain Research"}, {"key": "103_CR49", "doi-asserted-by": "publisher", "first-page": "146", "DOI": "10.1016/j.neulet.2007.12.034", "volume": "432", "author": "K Nakaso", "year": "2008", "unstructured": "Nakaso, K., Ito, S., & Nakashima, K. (2008). Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson\u2019s disease model of SH-SY5Y cells. Neuroscience Letters, 432, 146\u2013150.", "journal-title": "Neuroscience Letters"}, {"key": "103_CR50", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1016/j.neuint.2009.09.001", "volume": "56", "author": "HV Nobre Jr", "year": "2010", "unstructured": "Nobre, H. V., Jr., Cunha, G. M., de Vasconcelos, L. M., Magalh\u00e3es, H. I., Oliveira Neto, R. N., Maia, F. D., de Moraes, M. O., Leal, L. K., & Viana, G. S. (2010). Caffeine and CSC, adenosine A(2A) antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. Neurochemistry International, 56, 51\u201358.", "journal-title": "Neurochemistry International"}, {"key": "103_CR51", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1016/j.nbd.2011.08.030", "volume": "45", "author": "JD Peterson", "year": "2012", "unstructured": "Peterson, J. D., Goldberg, J. A., & Surmeier, D. J. (2012). Adenosine A(2A) receptor antagonists attenuate striatal adaptations following dopamine depletion. Neurobiology of Disease, 45, 409\u2013416.", "journal-title": "Neurobiology of Disease"}, {"key": "103_CR52", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1016/j.pbb.2007.10.014", "volume": "90", "author": "AG Phillips", "year": "2008", "unstructured": "Phillips, A. G., Vacca, G., & Ahn, S. (2008). A top-down perspective on dopamine, motivation and memory. Pharmacology, Biochemistry, and Behavior, 90, 236\u2013249.", "journal-title": "Pharmacology, Biochemistry, and Behavior"}, {"key": "103_CR53", "doi-asserted-by": "publisher", "first-page": "1408", "DOI": "10.1111/j.1460-9568.1996.tb01603.x", "volume": "8", "author": "B Piallat", "year": "1996", "unstructured": "Piallat, B., Benazzouz, A., & Benabid, A. L. (1996). Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: Behavioural and immunohistochemical studies. European Journal of Neuroscience, 8, 1408\u20131414.", "journal-title": "European Journal of Neuroscience"}, {"key": "103_CR54", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1111/j.1468-1331.2008.02056.x", "volume": "15", "author": "W Poewe", "year": "2008", "unstructured": "Poewe, W. (2008). Non-motor symptoms in Parkinson\u2019s disease. European Journal of Neurology, 15, 14\u201320.", "journal-title": "European Journal of Neurology"}, {"key": "103_CR55", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1016/0014-2999(95)00679-6", "volume": "287", "author": "P Popoli", "year": "1995", "unstructured": "Popoli, P., Betto, P., Reggio, R., & Ricciarello, G. (1995). Adenosine A(2A) receptor stimulation enhances striatal extracellular glutamate levels in rats. European Journal of Pharmacology, 287, 215\u2013217.", "journal-title": "European Journal of Pharmacology"}, {"key": "103_CR56", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1016/j.bbi.2008.07.003", "volume": "23", "author": "M Reale", "year": "2009", "unstructured": "Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M., & Onofrj, M. (2009). Peripheral cytokines profile in Parkinson\u2019s disease. Brain, Behavior, and Immunity, 23, 55\u201363.", "journal-title": "Brain, Behavior, and Immunity"}, {"key": "103_CR57", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1093/cercor/bhm066", "volume": "17", "author": "TW Robbins", "year": "2007", "unstructured": "Robbins, T. W., & Roberts, A. C. (2007). Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cerebral Cortex, 17, 151\u2013160.", "journal-title": "Cerebral Cortex"}, {"key": "103_CR58", "doi-asserted-by": "publisher", "first-page": "2674", "DOI": "10.1001/jama.283.20.2674", "volume": "283", "author": "GW Ross", "year": "2000", "unstructured": "Ross, G. W., Abbott, R. D., Petrovitch, H., Morens, D. M., Grandinetti, A., Tung, K. H., Tanner, C. M., Masaki, K. H., Blanchette, P. L., Curb, J. D., Popper, J. S., & White, L. R. (2000). Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA : The Journal of the American Medical Association, 283, 2674\u20132679.", "journal-title": "JAMA : The Journal of the American Medical Association"}, {"key": "103_CR59", "doi-asserted-by": "publisher", "first-page": "908", "DOI": "10.1038/sj.ejcn.1602788", "volume": "62", "author": "K S\u00e4\u00e4ksj\u00e4rvi", "year": "2008", "unstructured": "S\u00e4\u00e4ksj\u00e4rvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & M\u00e4nnist\u00f6, S. (2008). Prospective study of coffee consumption and risk of Parkinson\u2019s disease. European Journal of Clinical Nutrition, 62, 908\u2013915.", "journal-title": "European Journal of Clinical Nutrition"}, {"key": "103_CR60", "doi-asserted-by": "publisher", "first-page": "S10", "DOI": "10.1212/WNL.66.10_suppl_4.S10", "volume": "66", "author": "AH Schapira", "year": "2006", "unstructured": "Schapira, A. H. (2006). Etiology of Parkinson\u2019s disease. Neurology, 66, S10\u2013S23.", "journal-title": "Neurology"}, {"key": "103_CR61", "doi-asserted-by": "crossref", "first-page": "1080", "DOI": "10.1523/JNEUROSCI.13-03-01080.1993", "volume": "13", "author": "SN Schiffmann", "year": "1993", "unstructured": "Schiffmann, S. N., & Vanderhaeghen, J. J. (1993). Adenosine A(2) receptors regulate the gene expression of striatopallidal and striatonigral neurons. Journal of Neuroscience, 13, 1080\u20131087.", "journal-title": "Journal of Neuroscience"}, {"key": "103_CR62", "author": "MA Schwarzschild", "first-page": "147", "year": "2004", "unstructured": "Schwarzschild, M. A., & Ascherio, A. (2004). Caffeine and Parkinson\u2019s disease. In A. Nehlig (Ed.), Coffee, tea, chocolate and the brain (pp. 147\u2013163). Boca Raton: CRC Press.", "volume-title": "Coffee, tea, chocolate and the brain"}, {"key": "103_CR63", "doi-asserted-by": "publisher", "first-page": "1082", "DOI": "10.1002/mds.10585", "volume": "18", "author": "MA Schwarzschild", "year": "2003", "unstructured": "Schwarzschild, M. A., Chen, J. F., Tennis, M., Messing, S., Kamp, C., Ascherio, A., Holloway, R. G., Marek, K., Tanner, C. M., McDermott, M., Lang, A. E., & The Parkinson Study Group. (2003a). Relating caffeine consumption to Parkinson\u2019s disease progression and dyskinesias development. Movement Disorders, 18, 1082\u20131083.", "journal-title": "Movement Disorders"}, {"key": "103_CR64", "doi-asserted-by": "publisher", "first-page": "S55", "DOI": "10.1212/01.WNL.0000095214.53646.72", "volume": "61", "author": "MA Schwarzschild", "year": "2003", "unstructured": "Schwarzschild, M. A., Xu, K., Oztas, E., Petzer, J. P., Castagnoli, K., Castagnoli, N., Jr., & Chen, J. F. (2003b). Neuroprotection by caffeine and more specific A(2A) receptor antagonists in animal models of Parkinson\u2019s disease. Neurology, 61, S55\u2013S61.", "journal-title": "Neurology"}, {"key": "103_CR65", "doi-asserted-by": "publisher", "first-page": "647", "DOI": "10.1016/j.tins.2006.09.004", "volume": "29", "author": "MA Schwarzschild", "year": "2006", "unstructured": "Schwarzschild, M. A., Agnati, L., Fuxe, K., Chen, J. F., & Morelli, M. (2006). Targeting adenosine A(2A) receptors in Parkinson\u2019s disease. Trends in Neurosciences, 29, 647\u2013654.", "journal-title": "Trends in Neurosciences"}, {"key": "103_CR66", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1016/j.neulet.2003.08.059", "volume": "352", "author": "T Shindou", "year": "2003", "unstructured": "Shindou, T., Richardson, P. J., Mori, A., Kase, H., & Ichimura, M. (2003). Adenosine modulates the striatal GABAergic inputs to the globus pallidus via adenosine A(2A) receptors in rats. Neuroscience Letters, 352, 167\u2013170.", "journal-title": "Neuroscience Letters"}, {"key": "103_CR67", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/j.expneurol.2006.05.015", "volume": "202", "author": "N Simola", "year": "2006", "unstructured": "Simola, N., Fenu, S., Baraldi, P. G., Tabrizi, M. A., & Morelli, M. (2006). Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists. Experimental Neurology, 202, 255\u2013257.", "journal-title": "Experimental Neurology"}, {"key": "103_CR68", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1097/WNF.0b013e31815a3f03", "volume": "31", "author": "DK Simon", "year": "2008", "unstructured": "Simon, D. K., Swearingen, C. J., Hauser, R. A., Trugman, J. M., Aminoff, M. J., Singer, C., Truong, D., Tilley, B. C., & Investigators, N. E. T.-D. (2008). Caffeine and progression of Parkinson disease. Clinical Neuropharmacology, 31, 189\u2013196.", "journal-title": "Clinical Neuropharmacology"}, {"key": "103_CR69", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1007/978-3-540-89615-9_17", "volume": "193", "author": "TW Stone", "year": "2009", "unstructured": "Stone, T. W., Ceruti, S., & Abbracchio, M. P. (2009). Adenosine receptors and neurological disease: Neuroprotection and neurodegeneration. Handbook of Experimental Pharmacology, 193, 535\u2013587.", "journal-title": "Handbook of Experimental Pharmacology"}, {"key": "103_CR70", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1523/JNEUROSCI.3008-05.2006", "volume": "26", "author": "K Xu", "year": "2006", "unstructured": "Xu, K., Xu, Y., Brown-Jermyn, D., Chen, J. F., Ascherio, A., Dluzen, D. E., & Schwarzschild, M. A. (2006). Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Journal of Neuroscience, 26, 535\u2013541.", "journal-title": "Journal of Neuroscience"}, {"key": "103_CR71", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1016/j.neuroscience.2010.02.020", "volume": "167", "author": "K Xu", "year": "2010", "unstructured": "Xu, K., Xu, Y. H., Chen, J. F., & Schwarzschild, M. A. (2010). Neuroprotection by caffeine: Time course and role of its metabolites in the MPTP model of Parkinson\u2019s disease. Neuroscience, 167, 475\u2013481.", "journal-title": "Neuroscience"}, {"key": "103_CR72", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1002/ana.21313", "volume": "63", "author": "L Yu", "year": "2008", "unstructured": "Yu, L., Shen, H. Y., Coelho, J. E., Ara\u00fajo, I. M., Huang, Q. Y., Day, Y. J., Rebola, N., Canas, P. M., Rapp, E. K., Ferrara, J., Taylor, D., M\u00fcller, C. E., Linden, J., Cunha, R. A., & Chen, J. F. (2008). Adenosine A(2A) receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Annals of Neurology, 63, 338\u2013346.", "journal-title": "Annals of Neurology"}], "container-title": ["Handbook of Neurotoxicity"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4614-5836-4_103", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 27]], "date-time": "2019-05-27T00:52:24Z", "timestamp": 1558918344000}, "score": 21.36723, "issued": {"date-parts": [[2014]]}, "ISBN": ["9781461458357", "9781461458364"], "references-count": 72, "URL": "http://dx.doi.org/10.1007/978-1-4614-5836-4_103", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T14:28:19Z", "timestamp": 1575469699391}, "reference-count": 168, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 451, "content-version": "tdm"}], "funder": [{"name": "CIBERNED", "award": ["CB06/05/0055", "CB05/05/505"]}, {"name": "CIBERNED", "award": ["CB06/05/0055", "CB05/05/505"]}, {"name": "Comunidad de Madrid", "award": ["S2011/BMD-2336"]}, {"name": "German Bundesministerium f\u00ef\u00bf\u00bdr Bildung und Forschung", "award": ["01GN1006B"]}, {"name": "ICyTDF M\u00ef\u00bf\u00bdxico", "award": []}, {"name": "P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia", "award": []}, {"name": "Spanish Ministries de Econom\u00ef\u00bf\u00bda y Competitividad and of Sanidad Pol\u00ef\u00bf\u00bdtica Social e Igualdad, ISCIII", "award": ["BFU2010-20664"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Neurochem."], "published-print": {"date-parts": [[2014, 8]]}, "DOI": "10.1111/jnc.12751", "type": "journal-article", "created": {"date-parts": [[2014, 4, 29]], "date-time": "2014-04-29T09:59:02Z", "timestamp": 1398765542000}, "page": "472-489", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions"], "prefix": "10.1111", "volume": "130", "author": [{"given": "Rolf", "family": "Heumann", "sequence": "first", "affiliation": [{"name": "Molecular Neurobiochemistry; Ruhr-University Bochum; Bochum Germany"}]}, {"given": "Rosario", "family": "Moratalla", "sequence": "additional", "affiliation": [{"name": "Cajal Institute; CSIC and CIBERNED; ISCIII; Madrid Spain"}]}, {"given": "Maria Trinidad", "family": "Herrero", "sequence": "additional", "affiliation": [{"name": "Clinical & Experimental Neuroscience (NiCE-CIBERNED); School of Health Sciences; University Jaume I; Castell\u00f3, and School of Medicine; University of Murcia; Murcia Spain"}]}, {"given": "Koushik", "family": "Chakrabarty", "sequence": "additional", "affiliation": [{"name": "Molecular Neurobiochemistry; Ruhr-University Bochum; Bochum Germany"}]}, {"given": "Ren\u00e9", "family": "Drucker-Col\u00edn", "sequence": "additional", "affiliation": [{"name": "Instituto de Fisiolog\u00eda Celular; Universidad Nacional Aut\u00f3noma de M\u00e9xico; Mexico City M\u00e9xico"}]}, {"given": "Jose Ruben", "family": "Garcia-Montes", "sequence": "additional", "affiliation": [{"name": "Cajal Institute; CSIC and CIBERNED; ISCIII; Madrid Spain"}]}, {"given": "Nicola", "family": "Simola", "sequence": "additional", "affiliation": [{"name": "Department of Biomedical Sciences; Section of Neuropsychopharmacology; University of Cagliari; Cagliari Italy"}]}, {"given": "Micaela", "family": "Morelli", "sequence": "additional", "affiliation": [{"name": "Department of Biomedical Sciences; Section of Neuropsychopharmacology; University of Cagliari; Cagliari Italy"}, {"name": "National Institute of Neuroscience (INN); University of Cagliari; Cagliari Italy"}, {"name": "National Research Council (CNR); Neuroscience Institute; Cagliari Italy"}, {"name": "Center of Excellence on Neurobiology of Dependence; University of Cagliari; Cagliari Italy"}]}], "member": "311", "published-online": {"date-parts": [[2014, 6, 7]]}, "reference": [{"key": "10.1111/jnc.12751-BIB0001|jnc12751-cit-0001", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/j.neuroscience.2013.03.039", "article-title": "Exercise attenuates levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned mice", "volume": "243", "author": "Aguiar", "year": "2013", "journal-title": "Neuroscience"}, {"key": "10.1111/jnc.12751-BIB0002|jnc12751-cit-0002", "first-page": "426", "article-title": "Cell transplantation in Parkinson's disease: problems and perspectives", "volume": "23", "author": "Allan", "year": "2010", "journal-title": "Curr. Opin. Neurol."}, {"key": "10.1111/jnc.12751-BIB0003|jnc12751-cit-0003", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/j.bbr.2007.01.028", "article-title": "Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease", "volume": "179", "author": "Anstrom", "year": "2007", "journal-title": "Behav. Brain Res."}, {"key": "10.1111/jnc.12751-BIB0004|jnc12751-cit-0004", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1007/s12640-010-9168-0", "article-title": "Physical exercise attenuates MPTP-induced deficits in mice", "volume": "18", "author": "Archer", "year": "2010", "journal-title": "Neurotox. Res."}, {"key": "10.1111/jnc.12751-BIB0005|jnc12751-cit-0005", "doi-asserted-by": "crossref", "first-page": "2953", "DOI": "10.1111/j.0953-816X.2004.03409.x", "article-title": "Neuronal activation of Ras regulates synaptic connectivity", "volume": "19", "author": "Arendt", "year": "2004", "journal-title": "Eur. J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0006|jnc12751-cit-0006", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1002/ana.20296", "article-title": "Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia", "volume": "57", "author": "Aubert", "year": "2005", "journal-title": "Ann. Neurol."}, {"key": "10.1111/jnc.12751-BIB0007|jnc12751-cit-0007", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1002/mds.20778", "article-title": "Plasticity of the motor cortex in Parkinson's disease patients on and off therapy", "volume": "21", "author": "Bagnato", "year": "2006", "journal-title": "Mov. Disord."}, {"key": "10.1111/jnc.12751-BIB0008|jnc12751-cit-0008", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1016/j.parkreldis.2012.08.012", "article-title": "Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia", "volume": "19", "author": "Barbin", "year": "2013", "journal-title": "Parkinsonism Relat. Disord."}, {"key": "10.1111/jnc.12751-BIB0009|jnc12751-cit-0009", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1016/j.stem.2010.07.003", "article-title": "Graft-induced dyskinesias in Parkinson's disease: what is it all about?", "volume": "7", "author": "Barker", "year": "2010", "journal-title": "Cell Stem Cell"}, {"key": "10.1111/jnc.12751-BIB0010|jnc12751-cit-0010", "doi-asserted-by": "crossref", "first-page": "1106", "DOI": "10.1016/S0140-6736(85)92413-4", "article-title": "Non-invasive magnetic stimulation of human motor cortex", "volume": "1", "author": "Barker", "year": "1985", "journal-title": "Lancet"}, {"key": "10.1111/jnc.12751-BIB0011|jnc12751-cit-0011", "doi-asserted-by": "crossref", "first-page": "14845", "DOI": "10.1073/pnas.1009874107", "article-title": "Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors", "volume": "107", "author": "Bateup", "year": "2010", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/jnc.12751-BIB0012|jnc12751-cit-0012", "first-page": "3", "article-title": "Utilization of multiple electrodes implanted in the subcortical structure of the human brain for the treatment of hyperkinesis", "volume": "63", "author": "Bekhtereva", "year": "1963", "journal-title": "Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"}, {"key": "10.1111/jnc.12751-BIB0013|jnc12751-cit-0013", "first-page": "344", "article-title": "Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease", "volume": "50", "author": "Benabid", "year": "1987", "journal-title": "Appl. Neurophysiol."}, {"key": "10.1111/jnc.12751-BIB0014|jnc12751-cit-0014", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1016/0140-6736(91)91175-T", "article-title": "Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus", "volume": "337", "author": "Benabid", "year": "1991", "journal-title": "Lancet"}, {"key": "10.1111/jnc.12751-BIB0015|jnc12751-cit-0015", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1016/S0079-6123(09)17525-8", "article-title": "Functional neurosurgery for movement disorders: a historical perspective", "volume": "175", "author": "Benabid", "year": "2009", "journal-title": "Prog. Brain Res."}, {"key": "10.1111/jnc.12751-BIB0016|jnc12751-cit-0016", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1006/exnr.1999.7110", "article-title": "Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host", "volume": "159", "author": "Bentlage", "year": "1999", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0017|jnc12751-cit-0017", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/j.expneurol.2010.09.014", "article-title": "Recent advances in the pathophysiology of Parkinson's disease: evidence from fMRI and TMS studies", "volume": "227", "author": "Berardelli", "year": "2011", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0018|jnc12751-cit-0018", "doi-asserted-by": "crossref", "first-page": "1436", "DOI": "10.1126/science.2402638", "article-title": "Reversal of experimental parkinsonism by lesions of the subthalamic nucleus", "volume": "249", "author": "Bergman", "year": "1990", "journal-title": "Science"}, {"key": "10.1111/jnc.12751-BIB0019|jnc12751-cit-0019", "doi-asserted-by": "crossref", "first-page": "4829", "DOI": "10.1523/JNEUROSCI.5884-08.2009", "article-title": "Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia", "volume": "29", "author": "Berthet", "year": "2009", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0020|jnc12751-cit-0020", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1038/nm875", "article-title": "Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function", "volume": "9", "author": "Bezard", "year": "2003", "journal-title": "Nat. Med."}, {"key": "10.1111/jnc.12751-BIB0021|jnc12751-cit-0021", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1002/mds.25343", "article-title": "Cell therapy for Parkinson's disease: what next?", "volume": "28", "author": "Bjorklund", "year": "2013", "journal-title": "Mov. Disord."}, {"key": "10.1111/jnc.12751-BIB0022|jnc12751-cit-0022", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1038/253446a0", "article-title": "Re-establishment of functional connections by regenerating central adrenergic and cholinergic axons", "volume": "253", "author": "Bjorklund", "year": "1975", "journal-title": "Nature"}, {"key": "10.1111/jnc.12751-BIB0023|jnc12751-cit-0023", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1016/0896-6273(89)90233-X", "article-title": "ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons", "volume": "2", "author": "Borasio", "year": "1989", "journal-title": "Neuron"}, {"key": "10.1111/jnc.12751-BIB0024|jnc12751-cit-0024", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1007/s00441-004-0956-9", "article-title": "Stages in the development of Parkinson's disease-related pathology", "volume": "318", "author": "Braak", "year": "2004", "journal-title": "Cell Tissue Res."}, {"key": "10.1111/jnc.12751-BIB0025|jnc12751-cit-0025", "doi-asserted-by": "crossref", "first-page": "1917", "DOI": "10.1016/j.clinph.2006.03.033", "article-title": "Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease", "volume": "117", "author": "Brusa", "year": "2006", "journal-title": "Clin. Neurophysiol."}, {"key": "10.1111/jnc.12751-BIB0026|jnc12751-cit-0026", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1038/nature10284", "article-title": "Direct generation of functional dopaminergic neurons from mouse and human fibroblasts", "volume": "476", "author": "Caiazzo", "year": "2011", "journal-title": "Nature"}, {"key": "10.1111/jnc.12751-BIB0027|jnc12751-cit-0027", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/0166-2236(96)81862-5", "article-title": "The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia", "volume": "19", "author": "Calabresi", "year": "1996", "journal-title": "Trends Neurosci."}, {"key": "10.1111/jnc.12751-BIB0028|jnc12751-cit-0028", "doi-asserted-by": "crossref", "first-page": "4536", "DOI": "10.1523/JNEUROSCI.17-12-04536.1997", "article-title": "Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors", "volume": "17", "author": "Calabresi", "year": "1997", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0029|jnc12751-cit-0029", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1212/01.WNL.0000140288.48796.8E", "article-title": "Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study", "volume": "63", "author": "Carroll", "year": "2004", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0030|jnc12751-cit-0030", "doi-asserted-by": "crossref", "first-page": "1819", "DOI": "10.1093/brain/awm082", "article-title": "Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats", "volume": "130", "author": "Carta", "year": "2007", "journal-title": "Brain"}, {"key": "10.1111/jnc.12751-BIB0031|jnc12751-cit-0031", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1002/syn.20527", "article-title": "Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat", "volume": "62", "author": "Carta", "year": "2008a", "journal-title": "Synapse"}, {"issue": "Suppl 2", "key": "10.1111/jnc.12751-BIB0032|jnc12751-cit-0032", "doi-asserted-by": "crossref", "first-page": "S165", "DOI": "10.1016/j.parkreldis.2008.04.023", "article-title": "Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence", "volume": "14", "author": "Carta", "year": "2008b", "journal-title": "Parkinsonism Relat. Disord."}, {"key": "10.1111/jnc.12751-BIB0033|jnc12751-cit-0033", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1016/j.expneurol.2010.04.016", "article-title": "Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression", "volume": "224", "author": "Carta", "year": "2010", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0034|jnc12751-cit-0034", "doi-asserted-by": "crossref", "first-page": "2694", "DOI": "10.1046/j.1460-9568.1998.00285.x", "article-title": "L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA", "volume": "10", "author": "Cenci", "year": "1998", "journal-title": "Eur. J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0035|jnc12751-cit-0035", "doi-asserted-by": "crossref", "first-page": "8506", "DOI": "10.1523/JNEUROSCI.23-24-08506.2003", "article-title": "Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity", "volume": "23", "author": "Centonze", "year": "2003", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0036|jnc12751-cit-0036", "doi-asserted-by": "crossref", "first-page": "1971", "DOI": "10.1111/j.1460-9568.2007.05457.x", "article-title": "Enhancement of dopaminergic properties and protection mediated by neuronal activation of Ras in mouse ventral mesencephalic neurones", "volume": "25", "author": "Chakrabarty", "year": "2007", "journal-title": "Eur. J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0037|jnc12751-cit-0037", "doi-asserted-by": "crossref", "first-page": "1398", "DOI": "10.1212/WNL.48.5.1398", "article-title": "Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation", "volume": "48", "author": "Chen", "year": "1997", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0038|jnc12751-cit-0038", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/j.ejphar.2003.08.045", "article-title": "Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter", "volume": "478", "author": "Chen", "year": "2003", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/jnc.12751-BIB0039|jnc12751-cit-0039", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1046/j.1471-4159.2003.01657.x", "article-title": "Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF", "volume": "85", "author": "Cohen", "year": "2003", "journal-title": "J. Neurochem."}, {"key": "10.1111/jnc.12751-BIB0040|jnc12751-cit-0040", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1016/B978-0-444-59575-1.00012-0", "article-title": "Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy", "volume": "200", "author": "Cooper", "year": "2012", "journal-title": "Prog. Brain Res."}, {"key": "10.1111/jnc.12751-BIB0041|jnc12751-cit-0041", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1038/nbt.2329", "article-title": "Lessons from human teratomas to guide development of safe stem cell therapies", "volume": "30", "author": "Cunningham", "year": "2012", "journal-title": "Nat. Biotechnol."}, {"key": "10.1111/jnc.12751-BIB0042|jnc12751-cit-0042", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1016/j.biopsych.2009.04.025", "article-title": "Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation", "volume": "66", "author": "Darmopil", "year": "2009", "journal-title": "Biol. Psychiatry"}, {"key": "10.1111/jnc.12751-BIB0043|jnc12751-cit-0043", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1038/nn1632", "article-title": "Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models", "volume": "9", "author": "Day", "year": "2006", "journal-title": "Nat. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0044|jnc12751-cit-0044", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1159/000105792", "article-title": "Technique of intracranial electrode implacement for recording and stimulation and its possible therapeutic value in psychotic patients", "volume": "12", "author": "Delgado", "year": "1952", "journal-title": "Confin. Neurol."}, {"key": "10.1111/jnc.12751-BIB0045|jnc12751-cit-0045", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1006/exnr.2002.7891", "article-title": "Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway", "volume": "175", "author": "Deumens", "year": "2002", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0046|jnc12751-cit-0046", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1023/B:CEMN.0000022764.94760.3f", "article-title": "Cell transplantation for Parkinson's disease: present status", "volume": "24", "author": "Drucker-Colin", "year": "2004", "journal-title": "Cell. Mol. Neurobiol."}, {"key": "10.1111/jnc.12751-BIB0047|jnc12751-cit-0047", "doi-asserted-by": "crossref", "first-page": "1137", "DOI": "10.1007/s10072-011-0925-5", "article-title": "Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease", "volume": "33", "author": "Dutra", "year": "2012", "journal-title": "Neurol. Sci."}, {"key": "10.1111/jnc.12751-BIB0048|jnc12751-cit-0048", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1002/mds.22364", "article-title": "Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials", "volume": "24", "author": "Elahi", "year": "2009", "journal-title": "Mov. Disord."}, {"key": "10.1111/jnc.12751-BIB0049|jnc12751-cit-0049", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.3389/fnint.2012.00047", "article-title": "Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease?", "volume": "6", "author": "Eusebio", "year": "2012", "journal-title": "Front. Integr. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0050|jnc12751-cit-0050", "doi-asserted-by": "crossref", "first-page": "1180", "DOI": "10.1002/mds.10289", "article-title": "Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease", "volume": "17", "author": "Fox", "year": "2002", "journal-title": "Mov. Disord."}, {"key": "10.1111/jnc.12751-BIB0051|jnc12751-cit-0051", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1016/j.expneurol.2013.03.002", "article-title": "Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons", "volume": "247", "author": "Frau", "year": "2013", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0052|jnc12751-cit-0052", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1007/s00415-012-6585-4", "article-title": "Asymmetry and freezing of gait in parkinsonian patients", "volume": "260", "author": "Frazzitta", "year": "2013", "journal-title": "J. Neurol."}, {"key": "10.1111/jnc.12751-BIB0053|jnc12751-cit-0053", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/j.tins.2011.01.003", "article-title": "Rewiring the brain with cell transplantation in Parkinson's disease", "volume": "34", "author": "Gaillard", "year": "2011", "journal-title": "Trends Neurosci."}, {"key": "10.1111/jnc.12751-BIB0054|jnc12751-cit-0054", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.ejphar.2009.03.021", "article-title": "Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide", "volume": "610", "author": "Garcia Mdel", "year": "2009", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/jnc.12751-BIB0055|jnc12751-cit-0055", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.2174/1871527311201070897", "article-title": "Is nicotine protective against Parkinson's disease? An experimental analysis", "volume": "11", "author": "Garcia-Montes", "year": "2012", "journal-title": "CNS Neurol. Disord. Drug Targets"}, {"key": "10.1111/jnc.12751-BIB0056|jnc12751-cit-0056", "doi-asserted-by": "crossref", "first-page": "5042", "DOI": "10.1523/JNEUROSCI.22-12-05042.2002", "article-title": "D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase", "volume": "22", "author": "Gerfen", "year": "2002", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0057|jnc12751-cit-0057", "first-page": "358176", "article-title": "Corticostriatal plastic changes in experimental L-DOPA-induced dyskinesia", "volume": "2012", "author": "Ghiglieri", "year": "2012", "journal-title": "Parkinsons Dis."}, {"key": "10.1111/jnc.12751-BIB0058|jnc12751-cit-0058", "doi-asserted-by": "crossref", "first-page": "1040", "DOI": "10.1212/WNL.43.5.1040", "article-title": "Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise", "volume": "43", "author": "Goetz", "year": "1993", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0059|jnc12751-cit-0059", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1016/j.nbd.2013.10.008", "article-title": "Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson s disease", "volume": "62", "author": "Gonzalez-Aparicio", "year": "2013", "journal-title": "Neurobiol. Dis."}, {"key": "10.1111/jnc.12751-BIB0060|jnc12751-cit-0060", "doi-asserted-by": "crossref", "first-page": "1268", "DOI": "10.1007/s00415-011-5923-2", "article-title": "Effects of rTMS on Parkinson's disease: a longitudinal fMRI study", "volume": "258", "author": "Gonzalez-Garcia", "year": "2011", "journal-title": "J. Neurol."}, {"key": "10.1111/jnc.12751-BIB0061|jnc12751-cit-0061", "doi-asserted-by": "crossref", "first-page": "435", "DOI": "10.1016/S0896-6273(00)80798-9", "article-title": "Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade", "volume": "23", "author": "Greengard", "year": "1999", "journal-title": "Neuron"}, {"key": "10.1111/jnc.12751-BIB0062|jnc12751-cit-0062", "doi-asserted-by": "crossref", "first-page": "2084", "DOI": "10.1016/j.ajpath.2012.01.011", "article-title": "Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells", "volume": "180", "author": "Griscelli", "year": "2012", "journal-title": "Am. J. Pathol."}, {"key": "10.1111/jnc.12751-BIB0063|jnc12751-cit-0063", "doi-asserted-by": "crossref", "first-page": "452", "DOI": "10.1016/j.nbd.2007.02.001", "article-title": "Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates", "volume": "26", "author": "Guigoni", "year": "2007", "journal-title": "Neurobiol. Dis."}, {"key": "10.1111/jnc.12751-BIB0064|jnc12751-cit-0064", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1002/mds.22330", "article-title": "Backward walking in Parkinson's disease", "volume": "24", "author": "Hackney", "year": "2009", "journal-title": "Mov. Disord."}, {"key": "10.1111/jnc.12751-BIB0065|jnc12751-cit-0065", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1002/gps.2149", "article-title": "Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease", "volume": "24", "author": "Halpern", "year": "2009", "journal-title": "Int. J. Geriatr. Psychiatry"}, {"key": "10.1111/jnc.12751-BIB0066|jnc12751-cit-0066", "doi-asserted-by": "crossref", "first-page": "15921", "DOI": "10.1073/pnas.1010209107", "article-title": "Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats", "volume": "107", "author": "Hargus", "year": "2010", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/jnc.12751-BIB0067|jnc12751-cit-0067", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/B978-0-444-53497-2.00006-1", "article-title": "Therapeutic stimulation versus ablation", "volume": "116", "author": "Hariz", "year": "2013", "journal-title": "Handb Clin. Neurol."}, {"key": "10.1111/jnc.12751-BIB0068|jnc12751-cit-0068", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1007/BF02741385", "article-title": "Drugs of abuse and immediate-early genes in the forebrain", "volume": "16", "author": "Harlan", "year": "1998", "journal-title": "Mol. Neurobiol."}, {"key": "10.1111/jnc.12751-BIB0069|jnc12751-cit-0069", "doi-asserted-by": "crossref", "first-page": "5887", "DOI": "10.1093/emboj/20.21.5887", "article-title": "Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses", "volume": "20", "author": "Hartmann", "year": "2001", "journal-title": "EMBO J."}, {"key": "10.1111/jnc.12751-BIB0070|jnc12751-cit-0070", "doi-asserted-by": "crossref", "first-page": "21377", "DOI": "10.1073/pnas.0903676106", "article-title": "Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth", "volume": "106", "author": "Hasbi", "year": "2009", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/jnc.12751-BIB0071|jnc12751-cit-0071", "doi-asserted-by": "crossref", "first-page": "6152", "DOI": "10.1523/JNEUROSCI.0799-04.2004", "article-title": "Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases", "volume": "24", "author": "Hayashi", "year": "2004", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0072|jnc12751-cit-0072", "doi-asserted-by": "crossref", "first-page": "838", "DOI": "10.1038/292838a0", "article-title": "A second messenger required for nerve growth factor biological activity?", "volume": "292", "author": "Heumann", "year": "1981", "journal-title": "Nature"}, {"key": "10.1111/jnc.12751-BIB0073|jnc12751-cit-0073", "doi-asserted-by": "crossref", "first-page": "8735", "DOI": "10.1073/pnas.84.23.8735", "article-title": "Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages", "volume": "84", "author": "Heumann", "year": "1987", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/jnc.12751-BIB0074|jnc12751-cit-0074", "doi-asserted-by": "crossref", "first-page": "1537", "DOI": "10.1083/jcb.151.7.1537", "article-title": "Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration", "volume": "151", "author": "Heumann", "year": "2000", "journal-title": "J. Cell Biol."}, {"key": "10.1111/jnc.12751-BIB0075|jnc12751-cit-0075", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1007/978-1-62703-348-0_13", "article-title": "Generation of transgene-free iPSC lines from human normal and neoplastic blood cells using episomal vectors", "volume": "997", "author": "Hu", "year": "2013", "journal-title": "Methods Mol. Biol."}, {"key": "10.1111/jnc.12751-BIB0076|jnc12751-cit-0076", "doi-asserted-by": "crossref", "first-page": "665", "DOI": "10.1038/nrn2471", "article-title": "Molecular mechanisms of L-DOPA-induced dyskinesia", "volume": "9", "author": "Jenner", "year": "2008", "journal-title": "Nat. Rev. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0077|jnc12751-cit-0077", "doi-asserted-by": "crossref", "first-page": "304", "DOI": "10.1016/j.bbr.2009.04.035", "article-title": "The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease", "volume": "203", "author": "Kelsey", "year": "2009", "journal-title": "Behav. Brain Res."}, {"key": "10.1111/jnc.12751-BIB0078|jnc12751-cit-0078", "doi-asserted-by": "crossref", "first-page": "1471", "DOI": "10.1161/01.STR.0000221233.55497.51", "article-title": "Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke", "volume": "37", "author": "Kim", "year": "2006", "journal-title": "Stroke"}, {"key": "10.1111/jnc.12751-BIB0079|jnc12751-cit-0079", "doi-asserted-by": "crossref", "first-page": "1464", "DOI": "10.1038/nprot.2009.173", "article-title": "Generation of induced pluripotent stem cells from neural stem cells", "volume": "4", "author": "Kim", "year": "2009", "journal-title": "Nat. Protoc."}, {"key": "10.1111/jnc.12751-BIB0080|jnc12751-cit-0080", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.2522/ptj.20080214", "article-title": "Delaying mobility disability in people with Parkinson disease using a sensorimotor agility exercise program", "volume": "89", "author": "King", "year": "2009", "journal-title": "Phys. Ther."}, {"key": "10.1111/jnc.12751-BIB0081|jnc12751-cit-0081", "doi-asserted-by": "crossref", "first-page": "180", "DOI": "10.3389/fneur.2013.00180", "article-title": "Do studies on cortical plasticity provide a rationale for using non-invasive brain stimulation as a treatment for Parkinson's disease patients?", "volume": "4", "author": "Koch", "year": "2013", "journal-title": "Front. Neurol."}, {"key": "10.1111/jnc.12751-BIB0082|jnc12751-cit-0082", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1212/01.wnl.0000172861.36430.95", "article-title": "rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease", "volume": "65", "author": "Koch", "year": "2005", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0083|jnc12751-cit-0083", "doi-asserted-by": "crossref", "first-page": "956", "DOI": "10.1016/j.neuropharm.2009.01.019", "article-title": "Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats", "volume": "56", "author": "Kumar", "year": "2009", "journal-title": "Neuropharmacology"}, {"key": "10.1111/jnc.12751-BIB0084|jnc12751-cit-0084", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/S0079-6123(10)84015-4", "article-title": "Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia", "volume": "184", "author": "Lane", "year": "2010", "journal-title": "Prog. Brain Res."}, {"key": "10.1111/jnc.12751-BIB0085|jnc12751-cit-0085", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/j.nbd.2009.12.027", "article-title": "Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat", "volume": "38", "author": "Lebel", "year": "2010", "journal-title": "Neurobiol. Dis."}, {"key": "10.1111/jnc.12751-BIB0086|jnc12751-cit-0086", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1016/j.clinph.2004.11.017", "article-title": "Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation", "volume": "116", "author": "Lefaucheur", "year": "2005", "journal-title": "Clin. Neurophysiol."}, {"key": "10.1111/jnc.12751-BIB0087|jnc12751-cit-0087", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/S1836-9553(13)70141-3", "article-title": "Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson's disease: a systematic review", "volume": "59", "author": "Lima", "year": "2013", "journal-title": "J. Physiother."}, {"key": "10.1111/jnc.12751-BIB0088|jnc12751-cit-0088", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1007/s13311-011-0069-6", "article-title": "Cell therapeutics in Parkinson's disease", "volume": "8", "author": "Lindvall", "year": "2011", "journal-title": "Neurotherapeutics"}, {"key": "10.1111/jnc.12751-BIB0089|jnc12751-cit-0089", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1023/B:MEBR.0000027416.13070.c3", "article-title": "Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle", "volume": "19", "author": "Mabandla", "year": "2004", "journal-title": "Metab. Brain Dis."}, {"key": "10.1111/jnc.12751-BIB0090|jnc12751-cit-0090", "doi-asserted-by": "crossref", "first-page": "831", "DOI": "10.1056/NEJM198704023161402", "article-title": "Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease", "volume": "316", "author": "Madrazo", "year": "1987", "journal-title": "N. Engl. J. Med."}, {"key": "10.1111/jnc.12751-BIB0091|jnc12751-cit-0091", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1111/j.1471-4159.2009.05890.x", "article-title": "Regulation and function of neuronal GTP-Ras in facial motor nerve regeneration", "volume": "108", "author": "Makwana", "year": "2009", "journal-title": "J. Neurochem."}, {"key": "10.1111/jnc.12751-BIB0092|jnc12751-cit-0092", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1038/sj.npp.1301558", "article-title": "Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors", "volume": "33", "author": "Martin", "year": "2008", "journal-title": "Neuropsychopharmacology"}, {"key": "10.1111/jnc.12751-BIB0093|jnc12751-cit-0093", "doi-asserted-by": "crossref", "first-page": "15657", "DOI": "10.1523/JNEUROSCI.2824-12.2012", "article-title": "Effective deep brain stimulation suppresses low-frequency network oscillations in the basal ganglia by regularizing neural firing patterns", "volume": "32", "author": "McConnell", "year": "2012", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0094|jnc12751-cit-0094", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1111/j.1471-4159.2007.04456.x", "article-title": "Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease", "volume": "101", "author": "Mela", "year": "2007", "journal-title": "J. Neurochem."}, {"key": "10.1111/jnc.12751-BIB0095|jnc12751-cit-0095", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1016/j.neuropharm.2009.08.017", "article-title": "The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats", "volume": "58", "author": "Mela", "year": "2010", "journal-title": "Neuropharmacology"}, {"key": "10.1111/jnc.12751-BIB0096|jnc12751-cit-0096", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1001/2013.jamaneurol.45", "article-title": "History, applications, and mechanisms of deep brain stimulation", "volume": "70", "author": "Miocinovic", "year": "2013", "journal-title": "JAMA Neurol."}, {"key": "10.1111/jnc.12751-BIB0097|jnc12751-cit-0097", "doi-asserted-by": "crossref", "first-page": "615", "DOI": "10.1016/j.medengphy.2009.01.005", "article-title": "Linking brain dynamics, neural mechanisms, and deep brain stimulation in Parkinson's disease: an integrated perspective", "volume": "31", "author": "Modolo", "year": "2009", "journal-title": "Med. Eng. Phys."}, {"key": "10.1111/jnc.12751-BIB0098|jnc12751-cit-0098", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1016/0014-2999(89)90296-3", "article-title": "Time and dose dependence of the \u2018priming\u2019 of the expression of dopamine receptor supersensitivity", "volume": "162", "author": "Morelli", "year": "1989", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/jnc.12751-BIB0099|jnc12751-cit-0099", "doi-asserted-by": "crossref", "first-page": "1059", "DOI": "10.1093/brain/awl031", "article-title": "Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias", "volume": "129", "author": "Morgante", "year": "2006", "journal-title": "Brain"}, {"key": "10.1111/jnc.12751-BIB0100|jnc12751-cit-0100", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/j.expneurol.2007.07.021", "article-title": "Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors", "volume": "208", "author": "Morgese", "year": "2007", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0101|jnc12751-cit-0101", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1007/978-1-62703-444-9_2", "article-title": "Neural induction with a dopaminergic phenotype from human pluripotent stem cells through a feeder-free floating aggregation culture", "volume": "1018", "author": "Morizane", "year": "2013", "journal-title": "Methods Mol. Biol."}, {"key": "10.1111/jnc.12751-BIB0102|jnc12751-cit-0102", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1007/s002210000614", "article-title": "Role of the human motor cortex in rapid motor learning", "volume": "136", "author": "Muellbacher", "year": "2001", "journal-title": "Exp. Brain Res."}, {"key": "10.1111/jnc.12751-BIB0103|jnc12751-cit-0103", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.3389/fnana.2011.00051", "article-title": "Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation", "volume": "5", "author": "Murer", "year": "2011", "journal-title": "Front. Neuroanat."}, {"key": "10.1111/jnc.12751-BIB0104|jnc12751-cit-0104", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1016/j.nbd.2010.11.007", "article-title": "Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease", "volume": "41", "author": "Navailles", "year": "2011", "journal-title": "Neurobiol. Dis."}, {"key": "10.1111/jnc.12751-BIB0105|jnc12751-cit-0105", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.3389/fnana.2011.00043", "article-title": "Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons", "volume": "5", "author": "Nishi", "year": "2011", "journal-title": "Front. Neuroanat."}, {"key": "10.1111/jnc.12751-BIB0106|jnc12751-cit-0106", "doi-asserted-by": "crossref", "first-page": "4245", "DOI": "10.1073/pnas.0230529100", "article-title": "Pitx3 is required for development of substantia nigra dopaminergic neurons", "volume": "100", "author": "Nunes", "year": "2003", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/jnc.12751-BIB0107|jnc12751-cit-0107", "doi-asserted-by": "crossref", "first-page": "1141", "DOI": "10.1016/j.neuroscience.2006.10.042", "article-title": "Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection", "volume": "144", "author": "O'Dell", "year": "2007", "journal-title": "Neuroscience"}, {"key": "10.1111/jnc.12751-BIB0108|jnc12751-cit-0108", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1002/ana.410400302", "article-title": "GPi pallidotomy-have we made a dent in Parkinson's disease?", "volume": "40", "author": "Olanow", "year": "1996", "journal-title": "Ann. Neurol."}, {"key": "10.1111/jnc.12751-BIB0109|jnc12751-cit-0109", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1016/0006-8993(72)90385-X", "article-title": "Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats", "volume": "44", "author": "Olson", "year": "1972", "journal-title": "Brain Res."}, {"key": "10.1111/jnc.12751-BIB0110|jnc12751-cit-0110", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1146/annurev.neuro.25.112701.142937", "article-title": "Learning and memory functions of the Basal Ganglia", "volume": "25", "author": "Packard", "year": "2002", "journal-title": "Annu. Rev. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0111|jnc12751-cit-0111", "doi-asserted-by": "crossref", "first-page": "2541", "DOI": "10.1523/JNEUROSCI.22-07-02541.2002", "article-title": "Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression", "volume": "22", "author": "Partridge", "year": "2002", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0112|jnc12751-cit-0112", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.1212/WNL.44.5.892", "article-title": "Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation", "volume": "44", "author": "Pascual-Leone", "year": "1994", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0113|jnc12751-cit-0113", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/j.biopsych.2005.05.044", "article-title": "ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice", "volume": "59", "author": "Pavon", "year": "2006", "journal-title": "Biol. Psychiatry"}, {"key": "10.1111/jnc.12751-BIB0114|jnc12751-cit-0114", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1007/s00441-012-1432-6", "article-title": "The role of Nogo-A in axonal plasticity, regrowth and repair", "volume": "349", "author": "Pernet", "year": "2012", "journal-title": "Cell Tissue Res."}, {"key": "10.1111/jnc.12751-BIB0115|jnc12751-cit-0115", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1038/nn1040", "article-title": "Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia", "volume": "6", "author": "Picconi", "year": "2003", "journal-title": "Nat. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0116|jnc12751-cit-0116", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1016/j.bbr.2006.03.021", "article-title": "Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment", "volume": "171", "author": "Pinna", "year": "2006", "journal-title": "Behav. Brain Res."}, {"key": "10.1111/jnc.12751-BIB0117|jnc12751-cit-0117", "doi-asserted-by": "crossref", "first-page": "3977", "DOI": "10.1172/JCI59426", "article-title": "PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking", "volume": "122", "author": "Porras", "year": "2012", "journal-title": "J. Clin. Invest."}, {"key": "10.1111/jnc.12751-BIB0118|jnc12751-cit-0118", "doi-asserted-by": "crossref", "first-page": "6", "DOI": "10.1186/1471-2202-10-6", "article-title": "Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration", "volume": "10", "author": "Pothakos", "year": "2009", "journal-title": "BMC Neurosci."}, {"key": "10.1111/jnc.12751-BIB0119|jnc12751-cit-0119", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.3389/fncel.2012.00032", "article-title": "Dopaminergic axon guidance: which makes what?", "volume": "6", "author": "Prestoz", "year": "2012", "journal-title": "Front. Cell. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0120|jnc12751-cit-0120", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1111/j.1471-4159.2006.04383.x", "article-title": "CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum", "volume": "101", "author": "Price", "year": "2007", "journal-title": "J. Neurochem."}, {"key": "10.1111/jnc.12751-BIB0121|jnc12751-cit-0121", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/j.expneurol.2012.09.013", "article-title": "Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations", "volume": "245", "author": "Priori", "year": "2013", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0122|jnc12751-cit-0122", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1177/107385802237703", "article-title": "Cellular replacement therapy for Parkinson's disease-where we are today?", "volume": "8", "author": "Redmond", "year": "2002", "journal-title": "Neuroscientist"}, {"key": "10.1111/jnc.12751-BIB0123|jnc12751-cit-0123", "doi-asserted-by": "crossref", "first-page": "1544", "DOI": "10.1097/00005768-199911000-00008", "article-title": "Therapeutic value of exercise training in Parkinson's disease", "volume": "31", "author": "Reuter", "year": "1999", "journal-title": "Med. Sci. Sports Exerc."}, {"key": "10.1111/jnc.12751-BIB0124|jnc12751-cit-0124", "doi-asserted-by": "crossref", "first-page": "862", "DOI": "10.1002/1531-8257(200009)15:5<862::AID-MDS1015>3.0.CO;2-S", "article-title": "The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa", "volume": "15", "author": "Reuter", "year": "2000", "journal-title": "Mov. Disord."}, {"key": "10.1111/jnc.12751-BIB0125|jnc12751-cit-0125", "doi-asserted-by": "crossref", "first-page": "2049", "DOI": "10.1046/j.1460-9568.2002.02280.x", "article-title": "Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype", "volume": "16", "author": "Rivera", "year": "2002", "journal-title": "Eur. J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0126|jnc12751-cit-0126", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1016/j.apmr.2012.11.025", "article-title": "Improved clinical status, quality of life, and walking capacity in Parkinson's disease after body weight-supported high-intensity locomotor training", "volume": "94", "author": "Rose", "year": "2013", "journal-title": "Arch. Phys. Med. Rehabil."}, {"key": "10.1111/jnc.12751-BIB0127|jnc12751-cit-0127", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.1016/j.nbd.2010.05.001", "article-title": "A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys", "volume": "39", "author": "Rylander", "year": "2010", "journal-title": "Neurobiol. Dis."}, {"key": "10.1111/jnc.12751-BIB0128|jnc12751-cit-0128", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/S0165-0173(03)00191-7", "article-title": "Combining transcranial magnetic stimulation and functional imaging in cognitive brain research: possibilities and limitations", "volume": "43", "author": "Sack", "year": "2003", "journal-title": "Brain Res. Rev."}, {"key": "10.1111/jnc.12751-BIB0129|jnc12751-cit-0129", "doi-asserted-by": "crossref", "first-page": "2230", "DOI": "10.1016/j.yexcr.2013.06.004", "article-title": "Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome", "volume": "319", "author": "Sandberg", "year": "2013", "journal-title": "Exp. Cell Res."}, {"key": "10.1111/jnc.12751-BIB0130|jnc12751-cit-0130", "doi-asserted-by": "crossref", "first-page": "6995", "DOI": "10.1523/JNEUROSCI.0852-07.2007", "article-title": "Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia", "volume": "27", "author": "Santini", "year": "2007", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0131|jnc12751-cit-0131", "doi-asserted-by": "crossref", "first-page": "ra36", "DOI": "10.1126/scisignal.2000308", "article-title": "Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia", "volume": "2", "author": "Santini", "year": "2009", "journal-title": "Sci. Signal."}, {"key": "10.1111/jnc.12751-BIB0132|jnc12751-cit-0132", "doi-asserted-by": "crossref", "first-page": "4013", "DOI": "10.1073/pnas.95.7.4013", "article-title": "Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons", "volume": "95", "author": "Saucedo-Cardenas", "year": "1998", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/jnc.12751-BIB0133|jnc12751-cit-0133", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1212/01.wnl.0000250253.03919.fb", "article-title": "Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial", "volume": "68", "author": "Schupbach", "year": "2007", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0134|jnc12751-cit-0134", "doi-asserted-by": "crossref", "first-page": "4311", "DOI": "10.1523/JNEUROSCI.4720-07.2008", "article-title": "The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease", "volume": "28", "author": "Schuster", "year": "2008", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0135|jnc12751-cit-0135", "doi-asserted-by": "crossref", "first-page": "1400", "DOI": "10.1212/WNL.0b013e31828c2f66", "article-title": "Supplementary motor area stimulation for Parkinson disease: a randomized controlled study", "volume": "80", "author": "Shirota", "year": "2013", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0136|jnc12751-cit-0136", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1517/14712598.2011.558837", "article-title": "New approaches for the generation of induced pluripotent stem cells", "volume": "11", "author": "Sidhu", "year": "2011", "journal-title": "Expert Opin. Biol. Ther."}, {"key": "10.1111/jnc.12751-BIB0137|jnc12751-cit-0137", "doi-asserted-by": "crossref", "first-page": "2108", "DOI": "10.1212/WNL.57.11.2108", "article-title": "Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study", "volume": "57", "author": "Sieradzan", "year": "2001", "journal-title": "Neurology"}, {"key": "10.1111/jnc.12751-BIB0138|jnc12751-cit-0138", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1002/syn.20739", "article-title": "Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate", "volume": "64", "author": "Silverdale", "year": "2010", "journal-title": "Synapse"}, {"key": "10.1111/jnc.12751-BIB0139|jnc12751-cit-0139", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1007/BF03033565", "article-title": "The 6-hydroxydopamine model of Parkinson's disease", "volume": "11", "author": "Simola", "year": "2007", "journal-title": "Neurotox. Res."}, {"key": "10.1111/jnc.12751-BIB0140|jnc12751-cit-0140", "doi-asserted-by": "crossref", "first-page": "1625", "DOI": "10.1016/j.neuroscience.2008.11.009", "article-title": "Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction", "volume": "158", "author": "Simola", "year": "2009", "journal-title": "Neuroscience"}, {"key": "10.1111/jnc.12751-BIB0141|jnc12751-cit-0141", "doi-asserted-by": "crossref", "first-page": "e42641", "DOI": "10.1371/journal.pone.0042641", "article-title": "Spatial and temporal lineage analysis of a Pitx3-driven Cre-recombinase knock-in mouse model", "volume": "7", "author": "Smidt", "year": "2012", "journal-title": "PLoS ONE"}, {"key": "10.1111/jnc.12751-BIB0142|jnc12751-cit-0142", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/j.brainres.2011.02.003", "article-title": "Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse", "volume": "1386", "author": "Smith", "year": "2011", "journal-title": "Brain Res."}, {"key": "10.1111/jnc.12751-BIB0143|jnc12751-cit-0143", "doi-asserted-by": "crossref", "first-page": "964", "DOI": "10.1016/j.cell.2009.02.013", "article-title": "Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors", "volume": "136", "author": "Soldner", "year": "2009", "journal-title": "Cell"}, {"key": "10.1111/jnc.12751-BIB0144|jnc12751-cit-0144", "doi-asserted-by": "crossref", "first-page": "839", "DOI": "10.1038/42166", "article-title": "Alpha-synuclein in Lewy bodies", "volume": "388", "author": "Spillantini", "year": "1997", "journal-title": "Nature"}, {"issue": "Pt 3", "key": "10.1111/jnc.12751-BIB0145|jnc12751-cit-0145", "doi-asserted-by": "crossref", "first-page": "572", "DOI": "10.1093/brain/123.3.572", "article-title": "Induction of plasticity in the human motor cortex by paired associative stimulation", "volume": "123", "author": "Stefan", "year": "2000", "journal-title": "Brain"}, {"key": "10.1111/jnc.12751-BIB0146|jnc12751-cit-0146", "first-page": "39", "article-title": "Genetic instability of modified stem cells - a first step towards malignant transformation?", "volume": "2", "author": "Steinemann", "year": "2013", "journal-title": "Am. J. Stem Cells"}, {"key": "10.1111/jnc.12751-BIB0147|jnc12751-cit-0147", "doi-asserted-by": "crossref", "first-page": "1198", "DOI": "10.1016/S1388-2457(00)00316-3", "article-title": "Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study", "volume": "111", "author": "Strafella", "year": "2000", "journal-title": "Clin. Neurophysiol."}, {"key": "10.1111/jnc.12751-BIB0148|jnc12751-cit-0148", "doi-asserted-by": "crossref", "first-page": "2609", "DOI": "10.1093/brain/awg268", "article-title": "Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex", "volume": "126", "author": "Strafella", "year": "2003", "journal-title": "Brain"}, {"key": "10.1111/jnc.12751-BIB0149|jnc12751-cit-0149", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1016/j.biopsych.2013.05.006", "article-title": "L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice", "volume": "75", "author": "Suarez", "year": "2013", "journal-title": "Biol. Psychiatry"}, {"key": "10.1111/jnc.12751-BIB0150|jnc12751-cit-0150", "doi-asserted-by": "crossref", "first-page": "1309", "DOI": "10.1016/j.lfs.2012.10.003", "article-title": "Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice", "volume": "91", "author": "Sung", "year": "2012", "journal-title": "Life Sci."}, {"key": "10.1111/jnc.12751-BIB0151|jnc12751-cit-0151", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1016/j.cell.2006.07.024", "article-title": "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", "volume": "126", "author": "Takahashi", "year": "2006", "journal-title": "Cell"}, {"key": "10.1111/jnc.12751-BIB0152|jnc12751-cit-0152", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1097/00001756-199902250-00034", "article-title": "Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats", "volume": "10", "author": "Tanaka", "year": "1999", "journal-title": "NeuroReport"}, {"key": "10.1111/jnc.12751-BIB0153|jnc12751-cit-0153", "first-page": "267", "article-title": "Update on deep brain stimulation for Parkinson's disease", "volume": "56", "author": "Terzic", "year": "2012", "journal-title": "J. Neurosurg. Sci."}, {"key": "10.1111/jnc.12751-BIB0154|jnc12751-cit-0154", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.5966/sctm.2012-0133", "article-title": "Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors", "volume": "2", "author": "Theka", "year": "2013", "journal-title": "Stem Cells Transl. Med."}, {"key": "10.1111/jnc.12751-BIB0155|jnc12751-cit-0155", "doi-asserted-by": "crossref", "first-page": "R183", "DOI": "10.1093/hmg/ddm159", "article-title": "Parkinson's disease", "volume": "16", "author": "Thomas", "year": "2007", "journal-title": "Hum. Mol. Genet."}, {"key": "10.1111/jnc.12751-BIB0156|jnc12751-cit-0156", "doi-asserted-by": "crossref", "first-page": "4427", "DOI": "10.1523/JNEUROSCI.21-12-04427.2001", "article-title": "Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine", "volume": "21", "author": "Tillerson", "year": "2001", "journal-title": "J. Neurosci."}, {"key": "10.1111/jnc.12751-BIB0157|jnc12751-cit-0157", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1002/ana.20692", "article-title": "Altered plasticity of the human motor cortex in Parkinson's disease", "volume": "59", "author": "Ueki", "year": "2006", "journal-title": "Ann. Neurol."}, {"key": "10.1111/jnc.12751-BIB0158|jnc12751-cit-0158", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1016/j.expneurol.2008.09.025", "article-title": "Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys", "volume": "215", "author": "Villalba", "year": "2009", "journal-title": "Exp. Neurol."}, {"key": "10.1111/jnc.12751-BIB0159|jnc12751-cit-0159", "doi-asserted-by": "crossref", "first-page": "2720", "DOI": "10.1093/brain/awn214", "article-title": "A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease", "volume": "131", "author": "Voon", "year": "2008", "journal-title": "Brain"}, {"key": "10.1111/jnc.12751-BIB0160|jnc12751-cit-0160", "doi-asserted-by": "crossref", "first-page": "1113", "DOI": "10.1136/jnnp-2012-304396", "article-title": "Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial", "volume": "84", "author": "Weintraub", "year": "2013", "journal-title": "J. Neurol. Neurosurg. Psychiatry"}, {"key": "10.1111/jnc.12751-BIB0161|jnc12751-cit-0161", "doi-asserted-by": "crossref", "first-page": "5856", "DOI": "10.1073/pnas.0801677105", "article-title": "Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease", "volume": "105", "author": "Wernig", "year": "2008", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/jnc.12751-BIB0162|jnc12751-cit-0162", "doi-asserted-by": "crossref", "first-page": "800", "DOI": "10.1016/j.biopsych.2006.11.032", "article-title": "Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors", "volume": "62", "author": "Westin", "year": "2007", "journal-title": "Biol. Psychiatry"}, {"key": "10.1111/jnc.12751-BIB0163|jnc12751-cit-0163", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1016/j.conb.2003.10.013", "article-title": "Neural mechanisms of reward-related motor learning", "volume": "13", "author": "Wickens", "year": "2003", "journal-title": "Curr. Opin. Neurobiol."}, {"key": "10.1111/jnc.12751-BIB0164|jnc12751-cit-0164", "doi-asserted-by": "crossref", "first-page": "4546", "DOI": "10.1172/JCI68341", "article-title": "Deep brain stimulation (DBS) at the interface of neurology and psychiatry", "volume": "123", "author": "Williams", "year": "2013", "journal-title": "J. Clin. Invest."}, {"key": "10.1111/jnc.12751-BIB0165|jnc12751-cit-0165", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/S1474-4422(10)70093-4", "article-title": "Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial", "volume": "9", "author": "Williams", "year": "2010", "journal-title": "Lancet. Neurol."}, {"key": "10.1111/jnc.12751-BIB0166|jnc12751-cit-0166", "doi-asserted-by": "crossref", "first-page": "5047", "DOI": "10.1016/j.biomaterials.2012.03.061", "article-title": "Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors", "volume": "33", "author": "Zhang", "year": "2012", "journal-title": "Biomaterials"}, {"key": "10.1111/jnc.12751-BIB0167|jnc12751-cit-0167", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/j.stem.2009.04.005", "article-title": "Generation of induced pluripotent stem cells using recombinant proteins", "volume": "4", "author": "Zhou", "year": "2009", "journal-title": "Cell Stem Cell"}, {"issue": "Suppl 3", "key": "10.1111/jnc.12751-BIB0168|jnc12751-cit-0168", "doi-asserted-by": "crossref", "first-page": "S42", "DOI": "10.1016/S1353-8020(09)70778-3", "article-title": "Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency", "volume": "15", "author": "Zigmond", "year": "2009", "journal-title": "Parkinsonism Relat. Disord."}], "container-title": ["Journal of Neurochemistry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjnc.12751", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T23:58:57Z", "timestamp": 1565395137000}, "score": 21.185453, "issued": {"date-parts": [[2014, 6, 7]]}, "references-count": 168, "journal-issue": {"published-print": {"date-parts": [[2014, 8]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/jnc.12751", "relation": {"cites": []}, "ISSN": ["0022-3042"], "issn-type": [{"value": "0022-3042", "type": "print"}], "subject": ["Biochemistry", "Cellular and Molecular Neuroscience"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:21:30Z", "timestamp": 1574454090118}, "reference-count": 184, "publisher": "Elsevier", "isbn-type": [{"value": "9780444536143", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1016/s0079-6123(10)83010-9", "type": "book-chapter", "created": {"date-parts": [[2010, 8, 8]], "date-time": "2010-08-08T08:37:25Z", "timestamp": 1281256645000}, "page": "183-208", "source": "Crossref", "is-referenced-by-count": 53, "title": ["Pathophysiological roles for purines"], "prefix": "10.1016", "author": [{"given": "Micaela", "family": "Morelli", "sequence": "first", "affiliation": []}, {"given": "Anna R.", "family": "Carta", "sequence": "additional", "affiliation": []}, {"given": "Anil", "family": "Kachroo", "sequence": "additional", "affiliation": []}, {"given": "Michael A.", "family": "Schwarzschild", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Progress in Brain Research", "Recent Advances in Parkinson\u2019s Disease: Basic Research"], "deposited": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T12:37:23Z", "timestamp": 1559392643000}, "score": 20.715668, "issued": {"date-parts": [[2010]]}, "ISBN": ["9780444536143"], "references-count": 184, "URL": "http://dx.doi.org/10.1016/s0079-6123(10)83010-9", "ISSN": ["0079-6123"], "issn-type": [{"value": "0079-6123", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}